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ABSTRACT 
 
Development and use of genetic reporters to identify Mycobacterium tuberculosis exported proteins 
important for virulence 
 
Jessica Rose McCann 
(Under the direction of Miriam Braunstein) 
 
Mycobacterium tuberculosis is the causative agent of tuberculosis, a disease that kills nearly two 
million people each year globally. To cause disease, M. tuberculosis must survive and replicate in 
macrophages in the lung within phagosomal compartments.  Macrophages typically neutralize bacterial 
invaders, but M. tuberculosis has developed defenses against macrophage attack.  The relatively recent 
ability to construct M. tuberculosis mutants has greatly advanced our understanding of the protein 
transport systems and the importance of exported proteins to virulence of this pathogen.  Exported 
proteins, which we define here as those exposed on the surface or exported out of the bacterium, make 
excellent bacterial virulence factors as they are best localized to counteract host defenses against 
infection.  The main objective of the research described in this dissertation was to develop genetic tools 
and then use them to identify M. tuberculosis exported proteins important to pathogenesis. For many of 
the proteins identified in this research, these studies provide the first experimental evidence of export.  
In the chapters that follow, three different genetic export reporter systems are described.  We 
constructed a new reporter system to specifically identify M. tuberculosis proteins exported by the twin 
arginine translocation pathway.  We also developed a new reporter system with the unique ability to 
report on protein export during M. tuberculosis growth in host cells.  This system was then modified into 
 iv 
a new reporter transposon used to simultaneously identify exported proteins of M. tuberculosis and 
collect mutants lacking these proteins.  The resulting library of M. tuberculosis mutants was successfully 
screened for mutants defective for growth in macrophages as a strategy to identify new exported 
virulence factors. Future investigations are sure to focus more directly on how proteins exported by this 
pathogen interact with the host and cause disease. 
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CHAPTER 1 
INTRODUCTION 
Mycobacterium tuberculosis was discovered as the causative agent of tuberculosis (TB) over 125 
years ago.  Even so, the virulence mechanisms used by this successful bacterial pathogen remain poorly 
understood.  TB kills nearly two million people a year and it is estimated that a third of the world’s 
population is currently infected with M. tuberculosis (105). Most individuals who become infected have 
a one in ten chance of developing active TB over the course of their lifetime.  However, that risk of 
disease increases to 10% each year for people with HIV.  In fact, one of the major forces behind the 
increase in tuberculosis disease is the deadly synergy between HIV and TB.  A significant proportion of 
people who die of AIDS actually succumb to M. tuberculosis infections (28). Another emerging problem 
in TB disease is the rise of multiply and extensively drug resistant strains of M. tuberculosis (MDR and 
XDR, respectively) (106).  
TB is spread from person to person when an actively infected individual coughs and sprays 
aerosolized bacteria into the air, which is then inhaled by a passerby (34, 86).  If the bacteria travel deep 
into the alveoli of the lung, they are engulfed by macrophages. Macrophages typically phagocytose 
foreign organisms and disassemble them into presentable antigens.  They thereby serve as alert sentinels 
of the immune system.  M. tuberculosis, however, is an intracellular pathogen able to avoid this 
destruction and grow in macrophages.  A hallmark of intracellular M. tuberculosis is that it resides in 
phagosomes that do not mature normally into acidified phagolysomes.  The ability of the bacterium to 
alter phagosome maturation is one activity that may be important for intracellular survival (43, 103).  M. 
tuberculosis survival in macrophages may also depend on the ability of the bacterium to resist attack of 
reactive radicals, inhibit host immune responses and/or manipulate programmed cell death pathways of 
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host cells (33, 43, 73, 83).  Later in M. tuberculosis infection, most immunocompetent individuals 
produce an antigen specific T cell response that activates macrophages to become more 
antimycobacterial and establishes granulomas to control growth of the bacteria and the initial infection.  
However, another impressive feature of M. tuberculosis is its ability to persist long-term in granulomas 
and later reactivate to cause active TB disease.  The many aspects of disease caused by M. tuberculosis 
can be studied in mice and cultured macrophages.  These model systems are useful tools for studying the 
virulence factors M. tuberculosis employs to survive and spread in the host.  
Numerous efforts are underway to identify the M. tuberculosis virulence factors involved in the 
above activities.  The exported proteins of bacterial pathogens, which we will define as proteins 
transported beyond the cytoplasm to the bacterial cell surface or secreted into the environment, are well-
positioned to modify the host and/or protect the bacterium from antimicrobial attack.  This is especially 
true for intracellular pathogens, whose contact with the host is as intimate as can be achieved.  There are 
now several examples of M. tuberculosis exported proteins that are proven virulence factors (48).  One 
such exported virulence factor is exported repetitive protein, or Erp (5, 6).  However, the function of Erp 
in virulence remains unknown.  
Mycobacteria possess a complex and unique cell envelope (11, 23) (Fig. 1.1).  Given that the 
mycobacterial cell wall constitutes a formidable barrier to drugs and the host immune system, it is also 
likely to pose a challenge to directed export of proteins out of the bacterial cytosol.  At the core of the 
mycobacterial cell envelope is a covalently linked network of peptidoglycan, arabinogalactan and novel 
long chain mycolic acids.  The complex lipids phthiocerol dimycocerosate (PDIM) and trehalose 
dimycolate (TDM) are associated with the core.  PDIM and TDM are non-covalently attached to the 
mycolic acid layer.  Exported proteins can be found integrated into the cytoplasmic membrane, 
peripherally associated with the cytoplasmic membrane, distributed throughout the cell wall layers, or 
secreted out into the extracellular space.   As may be inferred from its complex cell envelope structure, 
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M. tuberculosis is not a typical Gram-negative or Gram-positive bacterium.  Sometimes identified as 
Gram-positive, M. tuberculosis does not Gram stain well and instead is identified by acid-fast staining.   
The objective of this dissertation was to develop genetic tools that could then be used to identify 
M. tuberculosis exported proteins important for pathogenesis.  In this introductory Chapter, I will first 
describe what is known about the conserved and specialized protein export pathways in M. tuberculosis.  
I will then discuss other genetic systems used previously to identify M. tuberculosis exported proteins.  
Finally, I will review genome-wide strategies that have been used to identify M. tuberculosis mutants 
attenuated for growth in macrophage and mouse models of tuberculosis.  
Conserved Mycobacterial Export Pathways 
Sec Pathway 
The Sec pathway is a conserved protein export system found in all bacteria (67, 74).  This 
pathway recognizes proteins that are synthesized as precursors with a characteristic N-terminal tripartite 
signal sequence.  It transports these proteins in an unfolded state from the cytosol across the cytoplasmic 
membrane to the cell envelope.  Once the protein has traversed the cytoplasmic membrane, its signal 
sequence is cleaved and the protein folds into its final conformation.  The signal sequence is critical for 
recognition by the Sec pathway, and the conserved elements of these signal sequences enable 
predictions of Sec exported proteins using bioinformatic algorithms (29).  Proteins exported out of the 
cytosol by the Sec pathway can permanently reside in the cell envelope or be further secreted into the 
environment through the action of subsequent systems.   
At the core of the Sec pathway is a membrane spanning translocase channel, composed of the 
integral membrane SecY, SecE and SecG proteins (67, 74).  Another central component is the SecA 
ATPase which provides energy for translocation.  The Sec pathway is the major protein export system of 
bacteria.  It is responsible for the export of numerous substrates, many of which have essential roles in 
cell physiology.  Thus, it is not surprising that the Sec pathway is essential for viability in all bacteria in  
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Figure 1.1.  A model of the M. tuberculosis cell envelope.  M. tuberculosis has a complex cell envelope 
that is considered neither Gram-negative nor Gram-positive.  PDIM, phthiocerol dimycocerosate.  TDM, 
trehalose dimycocerosate.  Different classes of exported proteins are indicated.  
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which it has been tested.  The Sec pathway also exports many examples of bacterial virulence factors 
(30).  Mycobacteria have a functional Sec pathway.  Orthologs of all the essential Sec components are 
present in mycobacterial genomes, including pathogenic M. tuberculosis and non-pathogenic M. 
smegmatis (7, 21).  Further support for a functional mycobacterial Sec pathway comes from proven 
surface and secreted proteins of M. tuberculosis that are synthesized with Sec signal sequences (48).  For 
some of these proteins there is also more direct evidence of signal sequence cleavage (61).   
Interestingly, all mycobacterial genomes analyzed encode two SecA homologs: SecA1 and 
SecA2 (8).  This is highly unusual, although it is now recognized that there are also some Gram-positive 
bacteria with two SecAs (4, 18, 55).  Both mycobacterial SecAs are highly homologous to the single 
well-studied SecA of E. coli and both have demonstrated ATPase activity (42).  However, SecA1 has an 
overall higher level of sequence similarity to E. coli SecA.  SecA1 is also the essential SecA in M. 
smegmatis and M. tuberculosis, like the single SecA of other bacteria, while SecA2 is not (8).  Finally, 
experiments using a conditional secA1 M. smegmatis strain also show SecA1 to be necessary for export 
of the Sec signal sequence-containing MspA porin to the cell wall (40).  On the basis of these results, 
SecA1 is believed to be the “housekeeping” SecA.  In contrast, SecA2 is believed to be a “specialized” 
SecA.  The SecA2-dependent export pathway is discussed in detail below.   
 
Tat Pathway 
The twin-arginine translocation (Tat) pathway is another conserved protein export pathway (54).  
This pathway is present in many, but not all, bacteria (27).  Like the Sec pathway, the Tat pathway 
exports proteins synthesized with N-terminal tripartite signal sequences across the cytoplasmic 
membrane.  Following protein export the signal sequence is cleaved, and the proteins may remain 
associated with the cell envelope or be further secreted (54, 104).  Unlike Sec-exported proteins, Tat 
substrates typically have a twin-arginine motif in the charged domain of their signal sequence designated 
R-R-x-φ-φ (φ=hydrophobic).  Site-directed mutagenesis experiments involving conservative substitution 
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of the ‘RR’ dipeptide with ‘KK’ demonstrate the importance of the twin-arginine motif (97).  Other Tat 
targeting elements also exist (102).  Another difference between the Sec and Tat pathways is that the Tat 
pathway exports proteins in a folded state and relies on energy from the proton motive force.   
The Tat translocation apparatus is comprised of the integral membrane proteins TatA, TatB, and 
TatC.  Current models hypothesize that TatA forms a homo-oligomeric complex that serves as the 
channel through which the protein is transported and that TatB and TatC are important for recognition of 
the precursor protein and delivery to the channel (54).   
Orthologs of TatA, TatB, and TatC are present in mycobacteria.  Tat signal sequence prediction 
programs also identify candidate Tat-exported substrates (27).  Mutational analysis demonstrates the Tat 
pathway is functional in mycobacteria.  In the fast growing and non-pathogenic M. smegmatis, mutants 
deleted for tatA, tatB, or tatC were constructed (65, 76).  These tat mutants have a growth defect on 
nutrient agar as well as several other phenotypes including hypersensitivity to the detergent sodium 
dodecyl sulfate and sensitivity to β-lactam antibiotics.   The pleiotropic effects of the tat mutations 
imply there are multiple Tat exported proteins.  They include the mycobacterial β-lactamases, which 
possess functional Tat signal sequences and require export by the Tat pathway to protect the bacterium 
from β-lactam antibiotics.  In M. tuberculosis it has not been possible to delete tatA, tatB, or tatC (87).  
Thus, at least under standard laboratory conditions, the Tat pathway is essential in slow-growing virulent 
mycobacteria.   
There are several examples of bacterial pathogens in which the Tat pathway contributes to 
virulence (15, 25, 53, 68, 77).  One of the best characterized examples of this is the pathogen 
Pseuodomonas aeruginosa.   P. aeruginosa tat mutants are attenuated in an animal model of virulence.  
The phospholipase C (Plc) enzymes, which are proven P. aeruginosa virulence factors, are synthesized 
with Tat signal sequences and exported in a Tat-dependent manner (68, 95).   
There are also Plc enzymes with Tat signal sequences and demonstrated roles in virulence in M. 
tuberculosis (45, 79).  For PlcB of M. tuberculosis, the N-terminal signal sequence was shown to be 
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functional in promoting Tat export using a β-lactamase reporter system (65).  In this reporter system, a 
truncated M. tuberculosis β-lactamase (‘BlaC) lacking a signal for export is fused to a foreign signal 
sequence and export of the resulting ‘BlaC fusion protein is demonstrated by the ability of the reporter 
to protect against cell wall targeting β-lactam antibiotics.  When expressed in M. smegmatis, a PlcB 
signal sequence fused to ‘BlaC is able to protect from β-lactam as long as a functional Tat pathway is 
present.  In addition, in both M. smegmatis and M. tuberculosis conservative substitution of the twin 
‘RR’ dipeptide with a ‘KK’ dipeptide in the PlcB signal sequence of the fusion eliminates export (65).  
These experiments demonstrate that the M. tuberculosis PlcB signal sequence is functional in Tat export, 
and it suggests that the Tat pathway is important to the virulence of M. tuberculosis.   The Tat pathway 
and its substrates in M. tuberculosis are further discussed in Chapter 2 of this dissertation.  
 
 
Specialized Mycobacterial Export Pathways  
In numerous Gram-negative bacterial pathogens, there exist specialized protein export pathways 
that secrete virulence factors across the bacterial outer membrane and often directly translocate them 
into host cells (19, 75, 88).  Specialized export systems also exist for Gram-positive pathogens and 
mycobacteria, although less is known about these more recently identified systems. 
 
SecA2-Dependent Protein Export Pathway 
As mentioned above, an unusual property of mycobacteria is the presence of two SecAs.  
Although it is not a universal property of Gram-positive bacteria, there are some examples of Gram-
positive organisms with two SecAs.  These examples include several pathogens: Listeria 
monocytogenes, Streptococcus gordonii, and Streptococcus parasanguis (4, 18, 55).  As discussed 
above, SecA1 is believed to be the “housekeeping” SecA with the major function in transporting 
proteins beyond the cytosol.  On the other hand, SecA2 is not essential and is considered the 
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“specialized” SecA protein.  The secA2 mutant of M. smegmatis has several altered phenotypes when 
compared to wild-type organisms (8).  The secA2 mutant of M. tuberculosis is attenuated for growth in 
cultured macrophages and virulence in mice, which demonstrates a role for SecA2 in pathogenesis (49).  
Like SecA1, SecA2 has proven ATPase activity (42).  Further, a ΔsecA2 mutant of M. smegmatis or M. 
tuberculosis cannot be complemented with SecA2 bearing a conservative amino acid substitution in its 
ATP binding domain indicating that ATPase activity is required for its function (42, 84).  Using M. 
smegmatis it was shown that the SecA1 and SecA2 proteins are not functionally redundant (8).  Mutant 
phenotypes associated with the absence of one of the proteins cannot be suppressed by overexpression 
of the other, indicating that SecA1 and SecA2 have different roles in mycobacteria. 
Substrates of the SecA2 Export Pathway 
Experiments with the secA2 mutants of M. smegmatis and M. tuberculosis demonstrate a role for 
SecA2 in protein export and, more specifically, in the export of a specific subset of proteins.  In M. 
smegmatis (37) a proteomic approach identified cell envelope proteins that depend on SecA2 for 
localization.  Comparison of the protein profiles of cell wall and cell membrane fractions from the secA2 
mutant and wild-type M. smegmatis using two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE) revealed the majority of proteins were unaffected by SecA2.  However, two proteins (Msmeg 
1704 and Msmeg 1712) are exported to these fractions only when SecA2 is present.  Both these SecA2-
dependent proteins are lipoproteins with sequence similarity to periplasmic sugar binding proteins of 
other bacteria, and both have predicted Sec signal sequences.  It is important to note that not all 
lipoproteins in M. smegmatis are SecA2-dependent.  In fact, the majority of M. smegmatis lipoproteins 
are unaffected by SecA2 indicating specificity in the substrates recognized by SecA2.   
A similar proteomics study in M. tuberculosis (9) compared the proteins secreted into the culture 
filtrate by secA2 mutant and wild-type M. tuberculosis using 2D-PAGE.  The culture filtrate is a cell-
free fraction composed of the proteins secreted into the culture medium during exponential growth.  
Three proteins show diminished export in a secA2 mutant, including the antioxidant enzymes superoxide 
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dismutase (SodA) and catalase-peroxidase (KatG).  In contrast to the SecA2 dependent lipoproteins 
found in M. smegmatis, SodA and KatG of M. tuberculosis are secreted via SecA2 but lack any 
recognizable signal sequence (9).   Interestingly, L. monocytogenes also exports a superoxide dismutase 
(MnSod) lacking a signal peptide in a SecA2 dependent manner (2).   
The discovery that antioxidants are secreted via SecA2 has interesting implications for 
understanding how M. tuberculosis SecA2 contributes to virulence.  This is because bacterial 
antioxidants secreted into the host could protect bacteria from the harmful effects of the oxidative burst 
of macrophages.  This could be part of the explanation for the role of M. tuberculosis SecA2 in 
virulence.  However, M. tuberculosis SecA2 also limits host immune responses and promotes growth in 
macrophages even in the absence of the oxidative burst (50).  Therefore, protection from oxygen 
radicals can only be part of the function of SecA2 in virulence.       
How SecA2 in mycobacteria works remains to be elucidated.  Because there are both proteins 
with and proteins without signal sequences that have been identified as SecA2-dependent, there may in 
fact be multiple roles for SecA2 in promoting protein export.  One role may be in the export of a subset 
of signal sequence-containing proteins, such as those identified in M. smegmatis.  Another role may be 
in the export of substrates lacking a conventional signal sequence, such as those identified in M. 
tuberculosis (Fig. 1.2).  There is evidence that for the M. smegmatis SecA2-dependent proteins 
containing signal sequences SecA2 works in conjunction with SecA1.  Depletion of SecA1 in M. 
smegmatis, reduces export of the SecA2 dependent substrate Msmeg1712 to a level comparable that 
observed in a secA2 mutant (84).  It is possible that SecA2 is required for the delivery of certain 
substrates to the canonical SecA1/SecYEG pathway, where export then continues in a conventional 
manner.  For the examples of non-signal sequence bearing SecA2-dependent proteins, SecA2 could 
directly participate in the transport of these proteins either working in conjunction with the conserved 
SecA1/SecYEG channel or with an unknown channel.  Another possibility is that the role of SecA2 in 
the export of proteins without signal sequences is indirect.  SecA2 could actually export a signal 
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sequence-containing protein to the cell envelope which is itself a component of a novel secretion system 
for unconventional exported proteins such as SodA (Fig. 1.2). 
 
 
ESX-1 secretion pathway 
A second specialized export system initially identified in mycobacteria and now recognized to also exist 
in some Gram-positive bacteria is the ESAT-6 secretion system (Esx-1) (14, 35, 72).  This system is 
named for the small highly immunogenic protein known as the Early Secreted Antigenic Target 6 
(ESAT-6, EsxA, Rv3875) that is secreted by M. tuberculosis via this pathway (1, 96).  In complex with 
ESAT-6, the ESX-1 system secretes an ESAT-6 like protein named Culture Filtrate Protein 10 (CFP-10, 
EsxB, Rv3874).  In addition, there are two more secreted substrates of this system which are not ESAT-
6 family members, EspA (Rv3616c) and EspB (Rv3881c), which are discussed further below (32, 66).  
Both ESAT-6 and CFP-10 are well-established as being secreted proteins but both lack conventional Sec 
or Tat signal sequences.  ESAT-6 and CFP-10 are encoded by adjacent genes in an operon located in a 
region of the M. tuberculosis genome termed RD1 (for Region of Deletion).  RD1 is absent from the 
attenuated M. bovis BCG vaccine strain which explains why these proteins are absent from BCG (3, 41, 
60).  
It is now recognized that 23 ESAT-6 homologs (EsxA-W) are encoded by the M. tuberculosis 
genome.  Each of these proteins is small, about 100 amino acids in length, and most have a WXG motif 
in the C-terminus (35, 72, 101).  All ESX proteins lack a traditional signal sequence but many are 
detected in the culture filtrate.  Thus, secretion is a characteristic of many, if not all, of the members of 
this protein family (17, 61, 64, 85, 94).  Like esxA (esat-6) and esxB (cfp-10), most of the esx genes in 
M. tuberculosis exist as tandem pairs in the genome.  Five of the paired esx loci exhibit further similarity 
in being clustered with a suite of homologous genes.  These five esx genomic regions have been 
designated ESX-1 through ESX-5 systems (35, 101), with ESX-1 (spanning open reading frames 
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Rv3866 to Rv3883c) being the first and best described of the systems and the system containing the 
genes for the prototype ESAT-6 (EsxA) and CFP-10 (EsxB) proteins (Fig. 1.3). 
In specialized secretion systems of other bacterial pathogens it is common to find the secreted 
effectors encoded in the same genomic region as the secretion apparatus.  Inspection of the other open 
reading frames (ORFs) in the ESX loci reveals conserved proteins with predicted properties that suggest 
functions as part of a secretion system. These include predicted nucleotide binding proteins, membrane 
proteins, and chaperones. 
The ability to conduct genetic manipulation of M. tuberculosis and M. bovis BCG has defined 
the genes in ESX-1 required for ESAT-6 and CFP-10 secretion.  Transposon insertions and deletions of 
individual ESX-1 genes in M. tuberculosis as well as expression of ESX-1 components in BCG, 
demonstrates that the many of the genes surrounding the esxAB operon in ESX-1 are necessary for 
secretion (13, 39, 44, 78, 98).  With the same approach the ESX-1 system was also shown to be 
important for the virulence of M. tuberculosis (39, 56).   
In all, M. tuberculosis gene products spanning Rv3860 to Rv3879c, which includes some ORFs 
beyond the boundaries of ESX-1, have been tested for their involvement in ESAT-6 secretion.  Rv3870, 
Rv3871, and Rv3877 are all demonstrated to be required for ESAT-6 and CFP-10 secretion and can be 
considered core components of the ESX-1 secretion apparatus (13, 39, 44, 98).  Rv3870 and Rv3871 are 
predicted subunits of a membrane-bound AAA ATPase of the FtsK/SpoIIIE family.  Together these two 
proteins possess three ATP/GTP binding motifs (35), and protein interaction studies show that Rv3871 
directly interacts with Rv3870 (98).  These proteins are attractive candidates for providing energy 
necessary for export.  Rv3871 further interacts with CFP-10 (93, 98), which links a secreted substrate to 
the secretion apparatus.  Rv3877 has eleven predicted transmembrane domains (stretches of 
hydrophobic amino acids predicted to span the cytoplasmic membrane) making it reminiscent of the 
SecY translocase protein and best candidate so far for being a membrane-spanning channel.  So far, 
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Figure 1.2. Potential models for SecA2-dependent export.  SecA1 and SecYEG channel are involved in 
export of proteins with signal sequences, while the function of SecA2 remains unclear.  A) SecA2 may 
directly export proteins with or without signal sequences through either the SecYEG channel or an 
unknown channel. B) SecA2 may indirectly export proteins without signal sequences by first exporting 
factors (“protein X”) that function as part of a multiprotein complex/channel responsible for the export 
of proteins lacking conventional signal sequences such as SodA.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13 
 
there are no physical interactions mapped between Rv3870/71 and Rv3877, but it is easy to imagine that 
these proteins work together.  Rv3868, a demonstrated AAA ATPase (58), and Rv3869 proteins are also 
required elements of the ESX-1 secretion system (13).  Rv3689 is a predicted membrane protein lacking 
any obvious functional domain (35).  As in most of the ESX systems, a tandem pair of genes encoding 
PE and PPE proteins is present in ESX-1 (36).  These protein families are named for the Pro-Glu (PE) or 
Pro-Pro-Glu (PPE) motifs present in conserved N-terminal domains.  Although a large percentage (10%) 
of the M. tuberculosis genome encodes these proteins their function is unknown.  Rv3872 (PE35) is 
necessary for ESAT-6/CFP-10 secretion while Rv3873 (PPE68) is not (13, 26, 44).  PE35 may have a 
regulatory function, as esxAB genes are not transcribed in an rv3872 mutant (13).  Of note, PE35 and 
PPE68 themselves appear to be exported as they are detected in M. tuberculosis culture filtrate and cell 
envelope, respectively (26, 32, 70). Other highly conserved ORFs in ESX-1 that are worthy of mention 
are Rv3876 (predicted ATPase), Rv3879c (predicted cytosolic protein of unknown function), Rv3881c 
(EspB, secreted ESX-1 substrate), Rv3882c (predicted membrane protein), and Rv3883c (MycP1, 
predicted serine protease associated with the cell wall) (24).  For Rv3876 and Rv3879c, directed 
mutation showed them not to be required for ESAT-6 and CFP-10 secretion while the other three ORFs 
remain untested in M. tuberculosis (13).  Along with genes in ESX-1, it is now recognized that there are 
other ORFs elsewhere in the genome involved in ESAT-6/CFP-10 secretion.  Rv3614c, Rv3615c, and 
Rv3616c (EspA) are needed for ESAT-6/CFP-10 secretion (32, 59).  Interestingly, these three ORFs 
have homology to Rv3864, Rv3865 and Rv3867, which are all located at the edge of ESX-1.  However, 
inactivation of the paralogous genes at the ESX-1 locus does not result in an ESAT-6/CFP-10 secretion 
defect (13). There is also a connection between Rv3614c and ESX-1 ORFs in that yeast two-hybrid 
analysis shows that Rv3614c interacts with Rv3882c  as well as interacting with itself and Rv3615c 
(MacGurn et al., 2005).  
Not only is EspA required for ESAT-6 and CFP-10 secretion but EspA is itself a secreted ESX-1 
substrate requiring ESAT-6 and CFFP-10 for its own secretion (32).  EspA is a 40 kDa protein lacking a 
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traditional N-terminal signal sequence with no obvious homology to ESAT-6 family members.  The co-
dependence in secretion between ESAT-6, CFP-10, and EspA suggests that these three proteins interact 
prior to secretion or are somehow involved in the secretion process itself.  Perhaps they stabilize each 
other during export or serve as structural components of the actual ESX-1 secretion apparatus (Fig. 1.3).  
Recently, Rv3881c (EspB) which is encoded in the ESX-1 locus was reported to be a fourth ESX-1 
secreted substrate of M. tuberculosis (66).  EspB is a 55 kDa protein rich in alanine and glycine residues 
that also has no obvious signal sequence for export and no homology to EspA or ESAT-6 proteins.  
How the above described proteins work together to secrete ESAT-6, CFP-10, EspA, and EspB is 
actively under investigation.  The identification of protein-protein interactions between ESX-1 
components and secreted substrates is making the biggest impact on our understanding of the system.   
ESAT-6 and CFP-10 physically interact to form a stable 1:1 heterodimer in vitro and ESAT-
6/CFP-10 complexes have been identified prior to secretion (in the cytoplasm) and after secretion (in 
culture filtrates) of M. tuberculosis which indicates the proteins are secreted as a complex (12, 69, 81, 
82, 93, 98). One function of this complex seems to be to stabilize the individual proteins (39, 82).  
Another function is in targeting the complex for secretion.  The C-terminal seven amino acids of CFP-10 
serve as a targeting sequence required for secretion of the heterodimer out of the cell (17).  A truncated 
CFP-10 lacking these seven amino acids still binds to ESAT-6 but the complex is no longer secreted.  
Not only is the C-terminal signal necessary for secretion but it is sufficient to promote secretion by M. 
tuberculosis of ubiquitin, a small heterologous protein (17).  Yeast two hybrid studies show that the C-
terminal region of CFP-10 interacts with the predicted ATPase subunit Rv3871which could then provide 
the energy necessary for secretion of the ESAT-6/CFP-10 complex (17, 93, 98) (Fig. 1.3).  Other 
interactions have been mapped for the ESX-1 system and they reveal the complexity of the system (Fig. 
1.3).  Western-western blotting shows that ESAT-6 and CFP-10 bind to PPE68 (69).  As mentioned 
above, interactions are also reported between Rv3614c and Rv3615c and Rv3882c(59).  Finally, EspB 
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Figure 1.3 The ESX-1 secretion pathway of M. tuberculosis.  A) Potential model of ESX-1 secretion in 
M. tuberculosis.  ESAT-6, CFP-10, EspA, EspB and possibly other unknown proteins (depicted here as 
protein X) are secreted by the ESX-1 system made up of predicted membrane proteins, ATPases, and 
cytoplasmic chaperones. Rv3877 is the leading candidate for being a translocation channel spanning the 
cytoplasmic membrane.  How the proteins are further secreted across the cell wall remains a mystery.    
B) Genetic organization of genes shown by mutation as being required for ESX-1 secretion in M. 
tuberculosis.  Black ORFs encode proteins demonstrated as required for the secretion of ESAT-6 and 
CFP-10 in M. tuberculosis; white ORFs encode proteins not required for export in M. tuberculosis; gray 
ORFs are untested in M. tuberculosis. ESAT-6 and CFP-10 are encoded by esxA and esxB, respectively. 
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binds Rv3879c (66).  Rv3879c in turn binds to Rv3871 (66).  This last set of interactions is particularly 
interesting since EspB secretion by M. tuberculosis depends on ESX-1, but it is CFP-10-independent.  
This suggests that CFP-10 is not responsible for routing EspB to the ESX-1 secretion machine.  The 
interactions suggest that M. tuberculosis Rv3879c, which is not required for ESAT-6 or CFP-10 
secretion (13) but is untested for EspB secretion, could be the missing link.  Even with the increasing 
examples of protein-protein interactions in the ESX-1 system many aspects of ESAT-6/CFP-10 
secretion remain a mystery (Fig. 1.3).   
A Genetic System for Identification of M. tuberculosis Exported Proteins  
 Approximately 20% of the M. tuberculosis genome is predicted to encode exported proteins 
based on scans using bioinformatic algorithms that identify signal sequences or transmembrane domains 
(21, 92).  As mentioned previously, virulence factors of bacterial pathogens are often exported, so a high 
priority is placed on their identification.  Further, exported proteins are often immunogenic and make 
good targets for diagnostic antigens.  Prior efforts to identify exported proteins of M. tuberculosis have 
used biochemical and genetic methods (48).  In this dissertation, I discuss large-scale genetic strategies 
we developed to identify M. tuberculosis exported proteins that use new genetic reporter constructs.  
Here, I will review a previous genetic strategy used to identify M. tuberculosis exported proteins and 
discuss its limitations.  
A reporter for protein export is typically an enzyme that requires translocation beyond the 
cytoplasmic membrane to be active.  Reporters have their native export signal removed, and cannot be 
exported on their own.  Instead, fused signal sequences or transmembrane domains are required to direct 
export of the reporter.  When the protein-reporter fusion is exported, the activity of the enzyme is 
detected as proof of export.  For example, the enzymatic activity may be “reported” on agar plates as 
CFU color change following cleavage of a colorimetric enzyme substrate.   One reporter that has been 
used extensively to detect protein export in bacteria is alkaline phosphatase, or PhoA (20, 46, 57, 62, 63, 
100).  When PhoA has its native export signal removed (‘PhoA) it cannot be exported and remains 
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intracellular.  When fused to a heterologous export signal, the protein-‘PhoA fusion is exported.  When 
bacteria expressing such fusions are plated on agar containing the colorimetric PhoA substrate, the 
colonies turn blue.  Thus, heterogeneous populations of bacteria can be screened for the presence of blue 
colonies in order to identify protein fusions capable of exporting of the ‘PhoA reporter. 
The ‘PhoA reporter has been used to identify M. tuberculosis exported proteins.  The first study 
to do so adapted the reporter for the identification of M. tuberculosis exported proteins using a genomic 
library approach (57).  ‘PhoA was encoded on a library vector downstream from a multiple cloning site.  
Genomic fragments from M. tuberculosis were cloned upstream of the reporter.  The library was then 
electroporated into the non-pathogenic M. smegmatis, and resulting colonies were screened for blue 
color.  Genetic fusions that allowed in-frame fusions of M. tuberculosis exported proteins to ‘PhoA 
result in blue colonies.  Out of 14,000 M. smegmatis library colonies, 12 express active and exported 
‘PhoA fusions.  This study was conducted before the publication of the sequenced M. tuberculosis 
genome, so only three of the 12 sequences are identified as encoding exported proteins.   
 A second study incorporated ‘phoA onto a transposon, and used in vitro transposon mutagenesis 
to randomly insert the reporter in a M. tuberculosis cosmid library.  The mutagenized cosmid library was 
then electroporated into M. smegmatis (10).  Transposon insertion that allows ‘PhoA expression in-
frame with an exported protein results in blue colonies.  In this study, 31 unique proteins capable of 
exporting active ‘PhoA fusions are identified (10).    
 Using ‘PhoA on transposons (TnPhoA) directly in pathogens has proven to be a powerful genetic 
approach for identifying exported virulence factors (46, 100).  This is because the transposon 
simultaneously identifies exported proteins and knocks out the ORFS that encode them.  However, the 
‘PhoA reporter cannot be used directly in virulent M. tuberculosis due to endogenous enzyme activities 
in the pathogen, which is why the approaches described above were carried out in M. smegmatis.  
Therefore, a reporter transposon system that identifies exported proteins directly in the pathogen is a 
desirable genetic tool.  We describe such a tool in Chapter 4 of this dissertation.   
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Large-Scale Genetic Manipulation of Mycobacteria  
In Chapters 2, 3 and 4 of this dissertation, I discuss genetic reporters and genome-wide strategies 
used to identify M. tuberculosis exported proteins.  Our relatively limited understanding of the 
molecular mechanisms behind the ability of M. tuberculosis to cause disease is largely due to difficulties 
in studying this pathogen.  These difficulties include a slow replication rate (24 hour doubling time), the 
requirement for work to be conducted in biosafety level three containment, and the slow development of 
genetic tools.  In regards to this last point, over the last twelve years genetic tools for M. tuberculosis 
have increased in number and sophistication.  The complete genome sequence of M. tuberculosis (21) is 
another significant resource now available.  The result is that genomic-scale studies of M. tuberculosis 
are now feasible.  M. tuberculosis has now been subjected to microarray analysis, signature tagged 
mutagenesis (STM), and saturating transposon mutagenesis all with the goal of identifying genes with 
intracellular or in vivo roles in promoting virulence (16, 22, 80, 90, 91).  Experiments that globally 
analyze bacterial genes provide tremendous amounts of data in a relatively short period of time.  
However, results obtained from these experiments must be independently verified in more direct studies. 
The unifying theme of this dissertation research is the introduction of new tools for genome-wide 
identification of ORFS encoding exported proteins.  Specifically, our goal was to identify new M. 
tuberculosis exported proteins with roles in virulence.  Below is a brief discussion of three large-scale 
genomic analyses used to predict virulence factors in M. tuberculosis: Signature Tagged Mutagenesis 
(STM), Transposon Site Hybridization (TraSH) and Designer Arrays for Defined Mutant Analysis 
(DeADMAn).   A discussion of the attributes and drawbacks associated with these types of analyses is 
also included.  
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Signature Tagged Mutagenesis (STM) 
 STM screens were the first to globally search for virulence factors in the M. tuberculosis 
genome.  These mutagenesis screens were unquestionably successful because they immediately revealed 
important aspects of M. tuberculosis pathogenesis.  In STM, a set of transposons is constructed in which 
each transposon has a unique oligonucleotide tag.  M. tuberculosis is then subjected to transposon 
mutagenesis with each of the uniquely tagged transposons.  Mice are then infected with mixed pools of 
tagged mutants.  The tags can then be amplified from pools of insertion mutants before and after 
infection and detected with a radiolabeled set of probes.  Transposon tags that are missing or 
underrepresented when compared to the input pool following hybridization to the probe indicate strains 
that are attenuated during infection.  Attenuation is likely due to the loss of a potential virulence factor.  
These mutants are then recovered from the input pool and sequenced to reveal the site of transposon 
insertion.  In this manner, the ORF predicted to be responsible for the observed phenotype is identified.  
 Two M. tuberculosis STM screens for virulence factors required during mouse infection were 
published simultaneously.  The first examined an STM mutant library in the M. tuberculosis strain 
MT103 (16).  A total of 1927 mutants were screened in pools of 48, delivered by intravenous injection.  
Out of these, 12 unique ORFS were identified as attenuated for virulence in the mouse lung.  
Interestingly, 9 of the 12 ORFs encode predicted exported proteins.  The second STM screen (22) was 
conducted in the M. tuberculosis Erdman strain.  Out of 576 mutants screened by tail vein injection, 14 
are attenuated in mouse lung.  Three of these mutants discussed in the published report overlap with 
attenuated strains identified in the other STM screen mentioned above (16).  These overlapping mutants 
identified in both studies lack exported proteins and are defective in producing a surface lipid, 
phthiocerol dimycoserosate (PDIM) (38), required for virulence.  The identity of the genes identified in 
these STM screens results underscore the importance of exported proteins in M. tuberculosis 
pathogenesis.  
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Transposon Site Hybridization (TraSH) 
Another strategy used to determine the complement of genes required for growth in vitro, in 
macrophages or in mice, involves saturating transposon mutagenesis in M. tuberculosis and screening 
under different growth conditions using a technique called transposon site hybridization, or TraSH (80, 
89-91).  In these screens, the M. tuberculosis genome is subjected to transposon mutagenesis so that 
insertion in every gene is likely. A pooled library of transposon mutants is then allowed to grow under 
different conditions – in vitro, in macrophages, or in mouse spleens following intravenous injection.  
Sequences adjacent to the transposon insertion in each mutant are amplified from the pool of mutants 
before and after in vitro growth or infection.  Following hybridization to an M. tuberculosis microarray, 
sequences present in the input pools can be compared with sequences represented in the output pools.  
Sequences missing or significantly depleted from the output pool represent genes that when disrupted 
attenuate the ability of the bacilli to replicate.  This strategy serves to predict the genes that are required 
for optimal growth under the condition being studied.   
During construction of the original TraSH mutant library in M. tuberculosis, it was observed that 
some ORFs did not receive insertions under saturating mutagenesis conditions, indicating that these 
ORFs encoded essential genes (90).  It is predicted that a total of 614 genes, representing approximately 
15% of the M. tuberculosis genome, are essential.  Surprisingly, a third of these essential genes have no 
homology to inform on their function.  
When the TraSH library of mutants was used to determine the suite of genes required for growth 
in mouse spleens, 194 M. tuberculosis genes were predicted to be required for in vivo survival and 
replication, representing approximately 5% of the genome (21, 91).  Notably, 107 out of the 194 
potential virulence factors, more than half, have no predicted function, and 25% of them are restricted to 
mycobacteria and closely related species. This data is indicative of how little is known about the 
mechanisms involved in M. tuberculosis pathogenesis.  Once again, the majority of these proteins 
appear to be involved in protein export, exported protein synthesis, or are themselves exported proteins.   
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The TraSH strategy was also applied to a screen to identify mutants defective for growth in primary 
mouse macrophages (80).  This screen was directed towards discovery of gene products required early in 
infection, as replication in macrophages is a necessary first step for spread of the pathogen in vivo.  The 
macrophage study identified 126 genes as necessary for survival in macrophages.  Both the TraSH in 
macrophages and TraSH in mice assays predict genes that encode proven M. tuberculosis virulence 
factors, indicating that these large-scale assays are useful for predicting genes that are important for 
pathogenesis.  
 
Designer Arrays for Defined Mutant Analysis (DeADMAn) 
 The DeADMAn analysis takes advantage of a defined pool of transposon mutants.  (51, 52).  The 
insertion site of 1,425 M. tuberculosis CDC1551 transposon mutants were mapped, and those that fell 
upstream of the final 100 nucleotides of a gene were pooled and used in a screen to define genes 
required for growth in mouse lungs, livers and spleens following intravenous infection.  This pre-
selection made it more likely that the mutants included had transposon insertions that inactivated the 
respective ORF.  Prior to infection, the pool of mutants was further selected based on comparable in 
vitro growth rates – all transposon mutants included in the in vivo screen were equally fit in growth 
medium. The mutant pools were then used to infect mice.  Following infection, the tagged mutants were 
analyzed in a similar manner to the TraSH assays using microarray hybridization.  Out of 530 unique 
transposon insertions in 514 unique genes, 31 transposon mutants in 30 unique genes were identified as 
defective for growth in mouse organs.   
 
 While large-scale genomic screens are powerful methods for providing biological information on 
a whole-organism level, there are drawbacks to these types of approaches.  First, saturating mutagenesis 
screens for genes involved in pathogenesis will always miss those that are essential.  Non-essential 
genes in operons that also contain essential genes may also be missed due to polar effects.  While 
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essential genes are often required for metabolic function and may not represent new classes of virulence 
factors, these families should not be discounted, especially in a pathogen whose only known niche is in 
the cells of infected humans and animals.   Further, essential genes are excellent targets for novel drug 
therapies against tuberculosis.  
Second, successful saturation transposon mutagenesis studies rely on the assumption that every 
ORF is equally mutable and that in the transposition reactions conducted in these studies transposition 
has occurred in every mutable ORF.  While transposons used in M. tuberculosis can insert in a variety of 
sites in the genome, no transposon is completely random, and again, essential genes, as well as operons 
with essential genes, will be missed. Further, there are M. tuberculosis ORFs that are not present on the 
microarrays used in the DeADMAn and TraSH screens.  No data are can be obtained about ORFs that 
are absent from the microarray during these types of large-scale infection screens.   
Another draw back to genome-wide screens is that they must rely on arbitrary cut-offs when 
comparing ratios of representation in input pools vs. output pools.  Cut-offs are necessary to organize the 
massive amount of data that results from high-throughput screens.  All genes that are underrepresented 
below a certain cut-off ratio in the output pools are considered defective, but there will always be some 
degree of false negative and false positive findings.  Careful follow up experiments are required to 
validate results obtained from screening large pools of mutants.  Due to the potential for polar effects 
when using transposon mutagenesis, complementation experiments are also required to demonstrate that 
the mutated ORF is indeed the cause of the observed phenotype.  
 Infection with pools allows a large number of mutants to be screened simultaneously for 
phenotypes in small number of animals.  However, there are known bottlenecks that occur during mouse 
infection.  Following delivery of M. tuberculosis to mice by the intravenous route, approximately 90% 
of bacteria are found in the liver, 9% are in the spleen, and 1% is in the lungs (71).  Therefore, it is 
possible that mutants may appear to be underrepresented in high throughput screens when in fact they 
were never seeded to the lungs.  Also, methods that evaluate pools of mutants may miss important genes 
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due to masking by complementation by other bacteria in trans.  This is a particular concern for genes 
encoding exported proteins.  A co-infecting bacterium that exports a virulence factor may rescue a 
mutant lacking that virulence factor.  In this manner, attenuated mutants might be overlooked. 
Finally, no single genome-wide screen will be able to identify all virulence factors.  The results 
obtained from genome wide screens are dictated by the study design and the types of scientific questions 
asked (31).  Depending on route of infection, organ infected, model system and the chosen time point 
post infection, different sets of genes will be predicted to be important.  Further, there are mutants that 
exhibit no growth defect in organs, but do elicit different tissue pathology and different outcomes in 
long-term survival (47, 99).  Such mutants would be missed in the STM, TraSH and DeADMAn assays.  
However, high-throughput screens are useful in that they provide snapshots of M. tuberculosis biology 
as a whole as it operates under certain conditions.  Data resulting from large-scale genomic screens 
should be viewed in this context.  
 
Summary 
As in other bacterial pathogens, exported proteins of M. tuberculosis are sure to play important 
roles in virulence.  The relatively recent ability to construct M. tuberculosis mutants has greatly 
advanced our understanding of the protein transport systems and the importance of exported proteins to 
virulence of this pathogen.  However, at this point, our understanding of the function of even the best 
studied virulence factors of M. tuberculosis remains minimal.  Future investigations are sure to focus 
more directly on how proteins exported by this pathogen interact with the host and cause disease. 
The focus of this dissertation is the development of new methods to identify and study exported 
proteins of M. tuberculosis.  For many of the proteins identified in this research, these studies provide 
the first experimental evidence of export.  Chapter 2 will describe the use of a new reporter system to 
specifically identify M. tuberculosis proteins exported by the Tat pathway.  Chapter 3 will describe a 
new reporter system with the unique ability to report on protein export during M. tuberculosis growth in 
 24 
host cells.  Chapter 4 will describe a new reporter transposon used to simultaneously identify exported 
proteins of M. tuberculosis and collect mutants lacking these proteins.  The resulting library of M. 
tuberculosis mutants was successfully screened for mutants defective for growth in macrophages as a 
strategy to identify new exported virulence factors. 
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CHAPTER 2 
Identification of functional Tat signal sequences in Mycobacterium tuberculosis proteins 
Justin A. McDonough, Jessica R. McCann, Erin McElvania Tekippe, 
Jason S. Silverman, Nathan W. Rigel, and Miriam Braunstein 
 
 
The twin-arginine translocation (Tat) pathway is a system used by some bacteria to export 
proteins out from the cytosol to the cell surface or extracellular environment.  A functional Tat pathway 
exists in the important human pathogen, Mycobacterium tuberculosis.  Identification of the substrates 
exported by the Tat pathway can help define the role this pathway plays in the physiology and 
pathogenesis of M. tuberculosis.  Here we used a reporter of Tat export, a truncated β-lactamase ‘BlaC, 
to experimentally identify M. tuberculosis proteins with functional Tat signal sequences.  Of the 13 
proteins identified one lacks the hallmark of a Tat exported substrate, the twin-arginine dipeptide, and 
another is not predicted by in silico analysis of the annotated M. tuberculosis genome.  Full-length 
versions of a subset of these proteins were tested to determine if the native proteins are Tat exported.  
For three proteins, expression in a Δtat mutant of M. smegmatis revealed a defect in precursor 
processing compared to expression in wild-type indicating Tat-export of the full-length proteins.  
Conversely, two proteins showed no obvious Tat export in M. smegmatis.  One of this latter group of 
proteins was the M. tuberculosis virulence factor phospholipase C, PlcB.  Importantly, when tested in M. 
tuberculosis a different result was obtained and PlcB was exported in a twin-arginine dependent manner.  
This suggests the existence of M. tuberculosis-specific factor(s) for Tat export of a proven virulence 
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protein.  It also emphasizes the importance of domains beyond the Tat signal sequence and bacteria-
specific factors in determining if a given protein is Tat-exported.   
 
INTRODUCTION 
In bacteria, protein export across the cytoplasmic membrane represents the first step in the 
delivery of proteins to the cell envelope or extracellular space.  Two conserved systems are responsible 
for the majority of this protein export: the general secretion (Sec) and the twin-arginine translocation 
(Tat) pathways (for reviews, see (31, 35).  Both systems export proteins that are synthesized as 
precursors with amino-terminal signal sequences.  In both cases, the signal sequences are comprised of a 
tripartite structure: a charged amino-terminal region, a hydrophobic region, and a carboxy-terminal 
region containing a signal peptidase cleavage site (31, 62).  With most exported proteins, the signal 
sequence is cleaved from the precursor during or immediately after translocation which liberates the 
mature exported substrate. 
A feature that distinguishes Tat signal sequences from Sec signal sequences is the presence of a 
consensus twin-arginine motif, which is defined as S/T-R-R-x-F-L-K (5).  The arginine dipeptide ‘RR’ 
in the motif is a major targeting determinant of the signal sequence as shown by conservative 
substitution of ‘RR’ with a lysine pair ‘KK’ preventing Tat-export of proteins (13, 14, 25, 54).  
Computational Tat signal sequence prediction programs, based on sequence and structural conservation, 
have been developed (4, 45, 52).  These programs are valuable for identifying Tat substrates that adhere 
to the consensus motif; however, they cannot account for species specific differences, unless modified to 
do so, and it remains to be established how useful they are for comprehensive identification of Tat 
exported proteins.  There are two Tat-exported proteins known to exist in nature that lack the twin-
arginines (26, 27).  These exceptions may be members of a larger group of yet-to-be identified Tat 
proteins that rely on features other than the twin-arginine motif for Tat export.  
Another distinguishing feature of the Tat export pathway is that Tat substrates are translocated 
across the membrane in a folded state, with folding being a prerequisite for Tat export (15).  Some Tat 
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substrates require cytoplasmic chaperones for export.  These chaperones may be specific to one Tat 
substrate or they can have a more general effect (23, 28, 38-40).  In these cases, it is thought that 
chaperones function in folding substrates or targeting them to the membrane localized Tat translocase 
complex once folding is complete.  The Tat translocase is composed of TatA, Tat B and TatC proteins, 
although not all bacteria with functional Tat export systems have TatB.  
The Tat pathway is present in many, but not all, bacteria.  In several bacterial pathogens, the Tat 
pathway plays an important role in exporting virulence factors (9, 10, 17, 30, 36, 42, 46, 60).  
Mycobacterium tuberculosis is the bacterial pathogen responsible for tuberculosis, which kills 1.8 
million people a year (64).  Mycobacteria have a functional Tat pathway.  In the fast-growing non-
pathogenic Mycobacterium smegmatis, mutants lacking tatA, tatB, or tatC genes have multiple 
phenotypes including slow growth on agar and sensitivity to β-lactam antibiotics (34, 41).  The latter 
phenotype is attributed to a failure to export the chromosomally-encoded β-lactamase.  In both M. 
smegmatis and M. tuberculosis the endogenous β-lactamases possess Tat signal sequences.  β-
lactamases, which destroy cell wall-targeting β-lactam antibiotics, must be exported to protect bacteria 
from the drugs.  In M. tuberculosis it has not been possible to construct tat mutants (47).  This indicates 
that, in pathogenic M. tuberculosis, the Tat pathway is essential under standard laboratory conditions.  
Without a M. tuberculosis tat mutant, there are fewer approaches available for identifying Tat exported 
proteins and studying the significance of Tat export in this pathogen.   
In this study, we used the M. tuberculosis β-lactamase (BlaC) as a reporter to identify M. 
tuberculosis proteins that possess functional Tat signal sequences.  A truncated ‘BlaC, lacking its 
endogenous signal sequence, is not exported and is unable to protect a mycobacterial β-lactam-sensitive 
mutant (M. smegmatis ΔblaS or M. tuberculosis ΔblaC) from the β-lactam antibiotic carbenicillin (34).  
When a signal sequence from a Tat exported M. tuberculosis protein is fused to ‘BlaC, the hybrid 
protein is exported and confers carbenicillin resistance to Δbla mutant mycobacteria.  Exported ‘BlaC 
fusion proteins can be identified by direct selection of drug resistant colonies on agar containing 
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carbenicillin.  Importantly, the ‘BlaC reporter is Tat specific.  It works only when fused to Tat signal 
sequences and requires both the twin-arginine motif and a functional Tat pathway (34).   
Using a M. tuberculosis genomic library constructed upstream of the ‘blaC reporter, we 
identified signal sequences capable of exporting ‘BlaC in a Tat-dependent manner.  In addition to the 
demonstrated virulence factor and phospholipase C (PlcB) (29, 43), we identified proteins with potential 
roles in carbohydrate and lipid metabolism, copper homeostasis, cell envelope maintenance, and nutrient 
import.  The proteins identified included one lacking a twin-arginine dipeptide and one not predicted by 
in silico analysis.  We also investigated full-length versions of a subset of the proteins identified.  
Importantly, full-length PlcB was exported and twin-arginine dependent when expressed in its native 
host M. tuberculosis.  However, when expressed in M. smegmatis this M. tuberculosis protein did not 
appear to be exported.  This suggests the existence of M. tuberculosis-specific factor(s) that are required 
for Tat-export of a proven virulence protein. 
 
MATERIALS AND METHODS 
Bacterial strains and culture methods.  Bacterial strains used during this work are listed in Table 2.1.  
Luria-Bertani (LB) medium (Fisher) was used for culturing of Escherichia coli.  Middlebrook 7H9 or 
7H10 medium (Difco; BD Biosciences) was used for the culturing of M. smegmatis and M. tuberculosis.  
For M. smegmatis, Middlebrook medium was supplemented with 0.5% glycerol and 0.2% dextrose.  For 
M. tuberculosis, Middlebrook medium was supplemented with 0.5% glycerol and 1× ADS (0.5% bovine 
serum albumin, fraction V [Roche]; 0.2% dextrose; and 0.85% NaCl).  When necessary, media was 
supplemented with 0.05-0.1% Tween-80 (Fisher).  As required, antibiotics were added to Middlebrook 
media at the following concentrations: hygromycin B (Roche Applied Science) 50  µg/ml; carbenicillin 
(Sigma), 50 µg/ml; or kanamycin (Acros Chemicals), 20 µg/ml.  L-lysine at 40 and 80 µg/ml was added 
to agar and liquid media, respectively, for growth of M. smegmatis strains PM759 and JM578. 
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Molecular biology procedures.  Standard molecular biology techniques were employed (48).  The 
Expand high fidelity PCR system (Roche) was used in all PCR reactions and 5.0% dimethyl sulfoxide  
Table 2.1. Strains used in this study 
 
Strain Description Reference 
E. coli   
  K-12 DH5α F- [φ80dΔlacZM15] Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 
glnV44 thi-1 gyrA96 relA1 
Gibco-BRL 
  TOP10 F- mcrA [φ80dΔlacZM15] Δ(mrr-hsdRMS-mcrBC) ΔlacX74 deoR recA1 
endA1 araD139 Δ(ara, leu)7697 galU galK rpsL nupG 
Invitrogen 
  XL-1 Blue [F' proAB, lacIqZΔ M15, Tn10(Tetr)] recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 λ- lac-  
Stratagene 
   
M. smegmatis   
  mc2155 ept-1 (53) 
  MB692 mc2155, ΔtatA (34) 
  JM567 mc2155, ΔtatC (34) 
  PM759 mc2155, ΔblaS1 ΔlysA4 rpsL6 (18) 
  JM578 PM759, ΔtatA (34) 
   
M. tuberculosis   
  H37Rv Virulent (1) 
  PM638 H37Rv, ΔblaC1 (18) 
 
 
 
 
was included in select reactions.  DNA sequencing was performed by either the UNC-CH Automated 
DNA Sequencing Facility (Chapel Hill, NC) or by Eton Bioscience Inc. (San Diego, CA). 
 
Construction of ‘BlaC reporter libraries.  All plasmids used in this study are listed in Table 2.2.  Two 
library plasmids were constructed with a truncated version of M. tuberculosis blaC (referred to as 
‘blaC), amplified from pJM106 by PCR using the primers Lib’blaCfor and Lib’blaCrev (Supplemental 
Table 2.1). 
(i) Library 1.  The resulting ‘blaC amplicon was ligated into the multicopy mycobacterial shuttle vector 
pMV206.hyg, which had been digested with ClaI and NcoI.  The final plasmid was pJES113 (Fig. 2.1A).  
Genomic DNA was isolated from M. tuberculosis strain H37Rv as previously described (6), partially 
digested with AciI and HpaII, and digests with DNA fragments between 0.5 and 5.0-kbp were selected.   
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Table 2.2. Plasmids used in this study. 
 
Plasmid Genotype Description Source 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV206.hyg hyg oriM ColE1 Multicopy mycobacterial shuttle plasmid (55) 
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (55) 
pMV306.kan aph int attP ColE1 Single-copy mycobacterial shuttle plasmid (55) 
pJSC77 aph Phsp60 -HA oriM ColE1 HA tag cloned into pMV261 (21) 
pJM106 cat ‘blaC (M. tuberculosis) 
oriV ori2 
Predicted M. tuberculosis ‘blaC mature sequence 
cloned into pCC1 (Epicentre) 
(34) 
pJES112 bla aph ColE1‘blaC (M. 
tuberculosis) 
M. tuberculosis ‘blaC mature sequence cloned into 
pCR2.1 
This work 
pJES113 hyg oriM ColE1‘blaC (M. 
tuberculosis) 
M. tuberculosis ‘blaC mature sequence cloned into 
pMV206.hyg 
This work 
pJM153 bla aph ColE1Phsp60  (M. 
tuberculosis) 
M. tuberculosis hsp60 promoter cloned into pCR2.1 This work 
pJM157 hyg oriM ColE1 Phsp60, ‘blaC 
(M. tuberculosis) 
M. tuberculosis hsp60 promoter cloned into 
pJES113 
This work 
Y49 
pTrcHisB- 
BlaC 
bla Ptrc-blaC (M. 
tuberculosis) ColE1 
E. coli expression vector for M. tuberculosis blaC  (59) 
pJSS51 bla aph ColE1 ‘plcB (M. 
tuberculosis) 
M. tuberculosis plcB (no signal sequence) cloned 
into pCR2.1 
This work 
pJM171 aph oriM ColE1 Phsp60 ‘plcB-
HA 
1.4-kbp MscI/HindIII fragment containing plcB (no 
signal sequence) from pJSS51 cloned into pJSC77 
This work 
pJM210 bla aph ColE1 Rv0774c (M. 
tuberculosis) 
M. tuberculosis full length Rv0774c cloned into 
pCR2.1 
This work 
pJM211 aph oriM ColE1 Phsp60 
Rv0774c-HA 
913-bp MscI/HindIII fragment containing full length 
Rv0774c from pJM210 cloned into pJSC77 
This work 
pJES146 bla aph ColE1 M. tuberculosis Rv0774c (no signal sequence) 
cloned into pCR2.1 
This work 
PJES147 aph Phsp60‘Rv0774c -HA oriM 
ColE1 
797-bp MscI/HindIII fragment containing Rv0774c 
(no signal sequence) from pJES146 cloned into 
pJSC77 
This work 
pJM212 bla aph ColE1 Rv2843 (M. 
tuberculosis) 
M. tuberculosis full length Rv2843 cloned into 
pCR2.1 
This work 
pJM214 aph oriM ColE1 Phsp60 
Rv2843-HA 
547-bp NruI/HindIII fragment containing full length 
Rv2843 from pJM212 cloned into pJSC77 
This work 
pJM196 bla aph ColE1 Pnative plcB (M. 
tuberculosis) 
M. tuberculosis full length plcB and promoter 
cloned into pCR2.1 
This work 
pJM199 aph oriM ColE1 Pnative plcB-
HA 
2.2-kbp XbaI/HindIII fragment containing full 
length plcB and promoter from pJM196 cloned into 
pJSC77 
This work 
pJM202 bla aph ColE1 Pnative plcA, 
plcB (M. tuberculosis) 
M. tuberculosis full length plcA, plcB, and promoter 
cloned into pCR2.1 
This work 
pJM203 aph oriM ColE1 Pnative plcA, 
plcB-HA 
3.5-kbp XbaI/HindIII fragment containing full 
length plcA, plcB, and promoter from pJM202 
cloned into pJSC77 
This work 
pJM197 bla aph ColE1 Pnative Rv0315 
(M. tuberculosis) 
M. tuberculosis full length Rv0315 and promoter 
cloned into pCR2.1 
This work 
pJM206 aph oriM ColE1 Pnative 
Rv0315-HA 
1.2-kbp XbaI/HindIII fragment containing full 
length Rv0315 and promoter from pJM197 cloned 
into pJSC77 
This work 
pJM216 aph oriM ColEI PplcB, 
plcB(KK)-HA 
Overlapping, self-ligated PCR product amplified 
from pJM199. Contains plcB-KK under control of 
the native promoter 
This work 
pMP327 aph PblaC-blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis full length blaC cloned into 
pMV261 
(34) 
pJM113 aph Phsp60-‘blaC (M. 
tuberculosis) oriM ColE1 
’blaC from pJM106 cloned into MscI-linearized 
pMV261 
(34) 
pJM117 aph PblaC-blaC(KK) (M. 
tuberculosis) oriM ColE1 
M. tuberculosis full length blaC(KK) cloned into 
pMV261 
(34) 
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The genomic digest was cloned into the unique ClaI site immediately upstream of ‘blaC in pJES113.  
The resulting ligation reaction was transformed into E. coli XL-1 Blue (Stratagene).  Approximately 
1×106 hygromycin-resistant E. coli transformants were pooled for plasmid DNA isolation (Qiagen). (ii) 
Library 2.  The second library vector, pJM157, was constructed to carry a mycobacterial promoter 
upstream of the unique ClaI site.  A fragment carrying the promoter and the +1 transcriptional start site 
from M. tuberculosis hsp60 was amplified by PCR from pMV261.hyg using the primers Hsp60for-
BstBI and Hsp60rev2-ClaI (Supplemental Table 2.1).  The resulting PCR product was ligated into 
pJES113, which had been linearized with ClaI, to produce pJM157 (Fig. 2.1B).  For construction of 
Library 2, genomic DNA was isolated from M. tuberculosis strain PM638 (ΔblaC).  Digestion of 
genomic DNA and ligation into the single ClaI site upstream of ‘blaC in pJM157 was conducted as 
described above.  After electroporation into E. coli DH5α (Invitrogen), approximately 8×105 CFU were 
pooled and used to isolate plasmid DNA (Qiagen). 
Selection of exported ‘BlaC fusions.  Library DNA was electroporated into ΔblaS M. smegmatis strain 
PM759 (6, 18).  The resulting transformation was plated onto 7H10 agar media without tween, 
containing 40 ug/ml lysine (Fischer Scientific), 50 µg/ml hygromycin and carbenicillin concentrations 
that ranged from 35-75 µg/ml and incubated at 37°C for a minimum of four days.  The drug resistance 
of colonies that grew up on 7H10 agar with hygromycin and carbenicillin was confirmed by spot test 
analysis on 7H10 agar plates containing (i) both 50 µg/ml hygromycin and 45 µg/ml carbenicillin, and 
(ii) 50 µg/ml hygromycin only.  Strains were further analyzed if spots revealed confluent growth on 
plates containing hygromycin and carbenicillin in comparison to the negative control strain (ΔblaS M. 
smegmatis with plasmid pJM113 that carries a promoter-less ‘blaC) (34).  
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Figure 2.1.  Plasmids used for construction of M. tuberculosis-‘blaC fusion libraries. A) Library 1 
was constructed by ligating fragments of M. tuberculosis H37Rv genomic DNA into the unique ClaI site 
located upstream of ‘blaC in pJES113.  The truncated β-lactamase gene (‘blaC) lacks a promoter, Shine-
Dalgarno sequence, start codon, and signal sequence for export. (B) Library 2 was constructed with 
genomic DNA of M. tuberculosis PM638 (ΔblaC) ligated into the unique ClaI site located upstream of 
‘blaC in pJM157.  The pJM157 plasmid additionally has the mycobacterial hsp60 promoter located 
upstream of the ClaI site, but lacks a Shine Dalgarno site and start codon for ‘blaC.  Both library 
plasmids carry a selectable hygromycin-resistance gene (hyg) and have origins of replication for 
mycobacteria (oriM) and for E. coli (oriE). 
 
 
 
 
 
 
 
 
 
 
 
Recovery of ‘blaC fusion plasmids.  Plasmid DNA was transferred from carbenicillin and hygromycin-
resistant ΔblaS M. smegmatis to E. coli DH5α by electroduction (2).  A small amount of M. smegmatis 
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was transferred from a colony into 20 µl of ice-cold 10% glycerol.  The suspension was mixed by 
vortexing, incubated on ice for 10 minutes, and added to 40 µl of electrocompetent E. coli DH5α.  The 
mixture was transferred to a chilled 0.2 cm gap cuvette and pulsed using conditions typical for E. coli 
electroporation (25-µF, 200 Ohms, 2.5 kV).  Immediately, 1 ml of LB broth was added to the cuvette, 
incubated at 37°C for 1 h and then plated on LB with hygromycin.  Plasmid DNA was purified from 
hygromycin-resistant E. coli (Qiagen).  The M. tuberculosis genomic DNA insert upstream of ‘blaC was 
identified by sequencing with the primer TnBlaCout (Supplemental Table 2.1). 
 
Anti-BlaC antibody.  A 6× histidine-tagged copy of M. tuberculosis BlaC was expressed from Y49 
pTrcHisB-BlaC in E. coli DH5α (provided by Doug Kernodle), and purified by nickel affinity 
chromatography using HIS-Select Nickel Affinity Gel (Sigma) as described previously (59).  Purified 
BlaC was eluted from the nickel column with 300 mM imidazole at a concentration of 1.3 mg/ml and 
used to immunize rabbits together with TiterMax Gold adjuvant (Sigma).  Rabbit immunizations and 
polyclonal antisera collection was carried out by BioSource Custom Immunology Department 
(Hopkinton, MA). 
 
Immunoblot analysis.  Whole cell lysates of M. smegmatis and whole cell lysates of formalin-killed M. 
tuberculosis were prepared, as described previously (7, 19, 33), and analyzed by SDS-PAGE and 
immunoblot.  Polyclonal BlaC antiserum was used in immunoblot analysis at a dilution of 1:10,000 and 
polyclonal 19kDa antiserum (provided by Douglas Young) was used at a dilution of 1:40,000. Anti-
rabbit peroxidase-conjugated antibodies (Biorad) were used as secondary antibody to both anti-BlaC and 
anti-19kDa.  Both monoclonal HA antiserum (Covance) and monoclonal GroEL HAT5/IT-64 antiserum 
(World Health Organization collection) were used at a dilution of 1:20,000, and anti-mouse peroxidase-
conjugated antibodies were used as secondary antibodies (Biorad).  
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Construction of specific M. tuberculosis -‘BlaC fusions 
 
 The nucleotides encoding the signal sequences of Rv2041c and Rv2525c were PCR amplified 
using the primers rv2041ssF, 2401ssR or 2525F and 2525R, respectively (Supplemental Table 2.1).  
Both the forward and reverse primers encoded a BstBI site, and the forward primers also include the 
Shine-Dalgarno sequence from M. tuberculosis hsp60. The amplified fragments were ligated into 
pCR2.1 (Invitrogen), digested with BstBI and then ligated into ClaI digested pJM157, upstream of 
‘blaC. 
Construction of expression constructs for HA-tagged M. tuberculosis proteins.   
(i) hsp60 promoter-driven HA fusions: Rv0774c-HA, ΔssRv0774c-HA, Rv2843-HA, ΔssPlcB-HA.  
Oligonucleotide primers were designed to amplify full-length or truncated genes from M. tuberculosis 
genomic DNA.  Forward and reverse primers were designed each with 5’ extension sequences carrying 
MscI and HindIII restriction sites, respectively (Supplemental Table 2.1).  The resulting PCR product 
was first cloned into the pCR2.1 (Invitrogen) and sequenced.  The cloned gene was then digested with 
MscI and HindIII and the appropriate fragment was isolated and ligated into the mycobacterial shuttle 
vector pJSC77 (21), digested with MscI and HindIII, which carries the hsp60 promoter and multiple 
cloning site upstream of a C-terminal HA tag (Table 2.2).  Due to a MscI site within the Rv2843 gene, 
the strategy was revised in this instance and a NruI site was included instead of MscI on the forward 
primer (Supplemental Table 2.1). 
(ii) native promoter-driven HA fusions: PlcB-HA, Rv0315-HA.  Oligonucleotide primers were 
designed to amplify a fragment of M. tuberculosis genomic DNA which included the full-length gene of 
interest and upstream sequence containing the putative native promoter.  Forward primers were designed 
each with 5’ extension sequences carrying XbaI and HindIII restriction sites, respectively (Supplemental 
Table 2.1).  The resulting PCR product was first cloned into the pCR2.1 (Invitrogen) and sequenced.  
The cloned gene and promoter was then digested with XbaI and HindIII and the appropriate fragment 
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was isolated and ligated into the mycobacterial shuttle vector pJSC77, digested with XbaI and HindIII, 
which removes the hsp60 promoter (Table 2.2).   
(iii) PlcB(KK)-HA. The construct in which the codons for the twin arginine pair of PlcB were mutated 
to encode lysines (KK) was generated as follows.  The PCR primers plcBKKfor2 and plcBKKrev3 
overlapped at the site of mutation and were used in inverse PCR to generate a product from pJM199.  
The resulting PCR product was then end-repaired using the EndIt Kit (Epicentre) following the 
manufacturer’s instructions and self-ligated to create pJM216.  
 
Subcellular fractionation. Cell wall, membrane, and soluble fractions were prepared by differential 
ultracentrifugation as described previously (19, 44).  Briefly, 100 ml cultures of M. tuberculosis were 
harvested by centrifugation at 3,000 x g.  Cell pellets were sterilized by gamma-irradiation in a JL 
Shephard Mark I 137Cs irradiator (Department of Radiobiology, University of North Carolina at Chapel 
Hill) with a dose of 2.4 megarads.  All subsequent steps were performed at 4°C.  Pellets were 
resuspended in 4 ml of breaking buffer (PBS, 1mM phenylmethylsulfonyl fluoride, 0.6 µg/ml each of 
DNase and RNase, and a cocktail of protease inhibitors [2 µg/ml each of aprotinin, E-64, leupeptin, and 
pepstatin A and 100 µg/ml Pefabloc SC]) and then lysed in a French pressure cell.  Unbroken cells were 
pelleted at 3,000 x g for 20 min to generate a clarified whole-cell lysate, which was centrifuged at 
27,000 x g for 30 min to pellet the cell wall.  The supernatant was centrifuged at 100,000 x g for 2 h to 
separate the membrane fraction from the soluble fraction.  The cell wall and membrane fractions were 
washed once and then resuspended in PBS. 
 
Bioinformatic identification of putative twin-arginine signal sequences.  Protein sequences 
corresponding to the 4056 predicted open reading frames (ORFs) of M. tuberculosis H37Rv were 
obtained from TubercuList (Institut Pasteur [http://genolist.pasteur.fr/TubercuList/]) and were entered as 
query sequences in the TATFIND v.1.4 (45) (http://signalfind.org/tatfind.html) and TatP v.1.0 (4) 
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(http://www.cbs.dtu.dk/services/TatP/) search algorithms.  The output for TATFIND v.1.4 is either 
“True” or “False” for a given peptide.  TatP v.1.0 has multiple outputs.  We used the default search 
criteria RRx[FGAVML][LITMVF] and selected only those proteins that had both a predicted tri-partite 
signal peptide with Tat motif according to the prediction program.  We also reviewed the list of 
predicted Tat exported proteins of M. tuberculosis defined by the TigrFAM motif (TIGR01409) (52).  
This list was obtained directly from the TIGR website (http://cmr.tigr.org/tigr-
scripts/CMR/GenomePage.cgi?database=ntmt02). 
 
RESULTS 
Selection of exported M. tuberculosis ORF-‘BlaC fusions 
A truncated M. tuberculosis β-lactamase ‘BlaC, lacking its native signal sequence, can be used in 
mycobacteria as a reporter of export (34).  A special feature of the ‘BlaC reporter is that it only works 
when exported by the Tat pathway.  In a β-lactam-sensitive background, such as M. smegmatis ΔblaS, 
exported ‘BlaC fusion proteins can be detected by their ability to promote growth in the presence of the 
β-lactam antibiotic carbenicillin. 
To experimentally identify M. tuberculosis ORFs with functional Tat signal sequences, we 
constructed genomic M. tuberculosis libraries upstream of the truncated ‘blaC reporter.  Two libraries 
were constructed in multicopy vectors, pJES113 and pJM157, each of which carries truncated ‘blaC 
immediately downstream of a unique ClaI cloning site (Fig. 2.1).  The difference between the vectors is 
that pJM157 contains the mycobacterial hsp60 promoter upstream of the ClaI site to drive expression 
from genomic fragments that lack a promoter.  The hsp60 sequence in pJM157, however, does not 
include a Shine-Dalgarno site or start codon; these elements must be provided by the genomic insert.  
For Library 1, M. tuberculosis genomic DNA was prepared from wild-type strain H37Rv and for 
Library 2, the genomic DNA was prepared from the ΔblaC mutant of M. tuberculosis.  In both cases the 
genomic DNA was cut with ClaI-compatible endonucleases for ligation into the vectors. 
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The libraries were electroporated into the ΔblaS mutant of M. smegmatis and directly plated on 
7H10 medium containing carbenicillin.  Plasmids expressing exported fusion proteins were selected by 
their ability to promote growth in the presence of carbenicillin.  For Library 1, 101 carbenicillin-resistant 
colonies were obtained from an estimated 1×106 M. smegmatis transformants.  For Library 2, 29 
carbenicillin-resistant colonies were obtained from an estimated 9×105 transformants.  Following 
confirmation of carbenicillin resistance of individual transformants, plasmid DNA was isolated and 
sequenced to determine the identity of the genomic DNA insert.  With one notable exception, all 
plasmids sequenced revealed an in-frame fusion with ‘blaC.  The exception was plasmids where the full-
length M. tuberculosis blaC gene was cloned.  In these cases, the blaC insert did not need to be cloned 
in-frame with the reporter sequence on the plasmid.  BlaC was identified in 50% of the carbenicillin 
resistant clones from Library 1.  In Library 2 this problem was avoided by using genomic DNA from 
ΔblaC M. tuberculosis.   
From the two libraries, we identified amino-terminal sequences of ten unique M. tuberculosis 
proteins that promote export of the ‘BlaC reporter (Table 2.3).  To confirm that the fusion proteins 
identified were exported in a Tat-dependent manner, we rescued the fusion plasmids and electroporated 
them into a double ΔblaS ΔtatA M. smegmatis mutant.  This allowed us to test for export in the absence 
of a functional Tat pathway.  All ten fusions that conferred carbenicillin resistance in a ΔblaS mutant 
background failed to confer carbenicillin resistance in the ΔblaS ΔtatA strain.  This indicated that all the 
fusion proteins identified require the Tat pathway to export functional ‘BlaC. 
 
Direct testing of candidate M. tuberculosis Tat signal sequences 
The M. tuberculosis sequences fused to ‘BlaC in the ten active fusions were all predicted to contain 
signal sequences, according to the Signal P 3.0 prediction algorithm (Fig. 2.2A) (3).  Evaluation of the 
exported fusions revealed that the junction with ‘BlaC always occurred close to the predicted signal 
sequence cleavage site of the M. tuberculosis protein.  The greatest distance we observed between a 
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predicted cleavage site and the ‘BlaC fusion junction was 34 amino acids.   This revealed a requirement 
for an appropriately positioned restriction enzyme site near the cleavage site in order to identify a Tat 
signal sequence in our libraries.  It also suggested some proteins may have been missed for this reason.  
For example, in previous work we showed the PlcA signal sequence promotes Tat export of the ‘BlaC 
reporter (34), but PlcA was not identified in the libraries.  From genome gazing and bioinformatic 
predictions (discussed below), we selected Rv2041c and Rv2525c as candidate Tat substrates that may 
have been missed.  Construction and direct testing of ssRv2041c-‘BlaC and ssRv2525c-‘BlaC fusion 
proteins revealed that both confer resistance to β-lactam in a Tat-dependent manner.  This provides 
experimental validation of these additional M. tuberculosis Tat signal sequences (Fig. 2.2B).   
 
Table 2.3.  Functional Tat signal sequences in M. tuberculosis proteins identified with the ‘BlaC reporter. 
 
In slico predictions Protein Description No. Times 
Identified 
in Libraries 
TatP TAT 
FIND 
Tigr 
FAM 
Rv0063 Possible oxidoreductase 1 … … × 
Rv0315 Possible beta-1,3-glucanase 
precursor 
41 × × × 
Rv0483 (LprQ) Possible conserved lipoprotein 2 … … … 
Rv0519c Possible lipase 5 × … × 
Rv0774c Possible lipase; short-chain 
alcohol dehydrogenase family 
12 × × × 
Rv0846c Possible multicopper oxidase 1 × × × 
Rv2068c (BlaC) Class A beta-lactamase  63 × × × 
Rv2350c (PlcB) Phospolipase C  1 × × × 
Rv2833c (UgpB) Possible glycerol-3-phosphate-
binding lipoprotein  
3 × × × 
Rv2843 Possible conserved 
transmembrane Ala-rich protein 
1 … × × 
Rv2041c Possible sugar-binding lipoprotein 0* × × × 
Rv2351c (PlcA) Phospolipase C  0* × … × 
Rv2525c Conserved hypothetical protein 0* × × × 
*Demonstrated by direct testing only 
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Figure 2.2.  M. tuberculosis Tat signal sequences capable of driving the export of ‘BlaC.  Multiple 
sequence alignment (PROMALS, http://prodata.swmed.edu/promals/promals.php) of M. tuberculosis 
sequences capable of directing the export of functional ‘BlaC.  (A) Alignment of sequences identified 
from the genomic libraries.  For a given protein, the shortest stretch of amino acids up to the fusion 
junction with ‘BlaC is shown. (B) Alignment of sequences from fusions directly tested.  Identical amino 
acids are shaded in black, and similar amino acids are shaded in gray.  Underlined are signal sequence 
cleavage sites predicted by Signal P (3).  Cysteine residues in bold indicate conserved residues in 
lipobox motifs that are the predicted site of lipid modification for lipoproteins.  (C) Graphical 
representation of the sequence alignment of the consensus region of the 13 twin-arginine signal 
sequences shown to export functional ‘BlaC.  The height of each stack represents the degree of sequence 
conservation and the size of each letter is proportional to the frequency of the corresponding amino acid 
in that position (http://weblogo.berkeley.edu). 
 
 
 
 
 
 
 
Alignment of functional Tat signal sequences identified with the ‘BlaC reporter.  
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From studies largely conducted in E. coli, the generally accepted twin-arginine consensus motif 
is S/T-R-R-x-F-L-K (x is any polar amino acid).  The twin arginines are nearly always invariant and the 
frequency of occurrence of the other amino acids is reported to exceed 50% (5, 31, 39).  Amino acid 
alignment of the M. tuberculosis signal sequences we identified revealed that all but one contained the 
twin-arginine dipeptide (Fig. 2.2).  The exception was the Rv0063 signal sequence, which has a 
glutamine in the position where the second arginine would be (R-Q-T-F-L).  In terms of the other amino 
acids in the consensus, all were present in > 40% of the sequences except for the final lysine (K).  The 
alignment also revealed conservation of a hydrophobic residue just prior to the S/T amino acid in the 
consensus. 
 
Comparison to in silico predicted Tat signal sequences. 
Multiple Tat signal prediction programs exist, but their ability to accurately and comprehensively 
identify Tat substrates within mycobacteria is unresolved.  We applied two of these web-based 
programs, TatP v1.0 (4) and TATFIND v1.4 (45) to the M. tuberculosis H37Rv genome sequence and 
compared the output to Tat signal sequences predicted by a third prediction program devised by The 
Institute for Genomic Research (TIGR) (TIGR01409) (52).  Of the 4056 ORFs in the M. tuberculosis 
H37Rv genome (11), 95 were predicted to encode proteins with Tat signal sequences by at least one of 
the prediction programs (Supplemental Table 2.2).  There is surprisingly limited overlap between the 
algorithms, with only eleven proteins being predicted by all three programs (Fig. 2.3A).   
We next compared the signal sequences we identified experimentally (Table 2.3, Fig. 2.2) to the 
in silico predictions of the annotated M. tuberculosis genome.  Eight of the proteins we identified were 
predicted by all three programs and three were predicted by two programs (Fig. 2.3B).  Of the remaining 
two signal sequences, one was Rv0063, which lacks the twin arginine and was only identified by the 
TigrFAM prediction program, and the other was LprQ, which was not predicted by any program. 
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Assessment of Tat dependence for full-length proteins with functional Tat signal sequences  
In addition to there being a requirement for a Tat signal sequence, the mature domain also plays 
a role in whether a protein is a Tat substrate.  For this reason, we tested full-length versions of a subset 
of the proteins we identified to see if they were Tat-dependent.   
Signal sequence cleavage is commonly used as an indicator of protein export (37).  To establish the 
utility of this approach for monitoring export of M. tuberculosis Tat substrates expressed in M. 
smegmatis, we first assayed signal sequence cleavage of full length BlaC.  Polyclonal antibodies were 
raised against BlaC and used to detect BlaC expressed in whole cell lysates of ΔblaS M. smegmatis by 
immunoblot (Fig. 2.4).  In the presence of a functional Tat apparatus, BlaC is observed as a predominant 
band running at 30 kDa, which is the predicted size of the exported and processed mature species.  
Expression of BlaC(KK), which has a KK substitution for the ‘RR’ dipeptide, produced a slower 
migrating species which is consistent with a lack of export and accumulation of full-length unprocessed 
BlaC precursor (Fig. 2.4).  In the absence of a functional Tat pathway (in a ΔblaS ΔtatA mutant), a larger 
presumptive precursor species was observed although some smaller mature protein was detected as well. 
These experiments indicated that the protein species observed for each of these strains was a good 
indicator of Tat- and twin-arginine-dependent export. 
We then tested full-length versions of four additional proteins identified with the ‘BlaC reporter 
in wild-type and ΔtatC M. smegmatis.  Proteins were expressed as a C-terminal fusion to the HA epitope 
tag and immunoblot analysis was performed on whole cell lysates.  For Rv0315 and Rv2843, Tat-
dependent processing was observed in M. smegmatis which is indicative of the full-length proteins being 
Tat-exported. A smaller molecular weight and presumably processed form of the protein was seen when 
expressed in wild-type, but this species was significantly reduced in abundance in the ΔtatC mutant (Fig. 
2.5A).  Three bands were observed for Rv0315-HA expressed in wild-type M. smegmatis.  The largest 
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Figure 2.3. Distribution of predicted and experimentally verified M. tuberculosis Tat signal 
sequences. (A) Venn diagram indicating the distribution of M. tuberculosis proteins predicted to have 
Tat signal sequences by TATFIND v.1.4, TatP v.1.0, and/or TigrFAM (TIGR01409) algorithms. (B) 
Venn diagram comparing the proteins predicted in silico with the M. tuberculosis Tat signal sequences 
experimentally identified with the ‘BlaC reporter.  Rv0063 was predicted by TigrFAM only.  LprQ was 
not predicted by any of the programs. 
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molecular weight band is similar in size (~34 kDa) to that of the predicted Rv0315 precursor and is 
present in both wild-type and ΔtatC.  The two smaller protein species are absent or greatly reduced in 
the ΔtatC mutant background.  This suggests that Rv0315 is subject to multiple processing events.   
For the other two full-length proteins tested, no obvious Tat-dependence was observed in 
immunoblots of M. smegmatis whole cell lysates (Fig. 2.5B).  One of these proteins was the virulence 
factor PlcB-HA.  The protein species seen in the wild-type and ΔtatC M. smegmatis strains migrated at 
the predicted precursor size of 57 kDa.  Moreover, when compared to a truncated form of PlcB-HA 
lacking the predicted signal sequence (ΔssPlcB-HA) the full-length product we expressed migrated 
slower than the expected mature product (Fig. 2.5B).  Similar results were obtained with Rv0774c-HA 
and a truncated ΔssRv0774c-HA protein expressed in M. smegmatis.  This suggested that these two 
predicted Tat substrates were not being processed or exported when expressed in M. smegmatis.   
 
Full-length PlcB is exported by the Tat pathway when expressed in its native host M. tuberculosis  
Since M. smegmatis does not have phospholipase C homologs, we considered the possibility that 
PlcB-HA can only be exported by its native host M. tuberculosis.  To test this idea, we expressed full 
length PlcB-HA in M. tuberculosis H37Rv and assayed whole cell lysates by immunoblot analysis.  
Unlike what was observed in M. smegmatis, immunoblots for PlcB-HA in M. tuberculosis whole cell 
lysates yielded two products: a larger species that migrated like the full length precursor seen in M. 
smegmatis and a smaller species that migrated like the expected mature ΔssPlcB-HA product (Fig. 
2.6A).  This suggested that in M. tuberculosis, PlcB-HA is exported and processed.  Subcellular 
fractions prepared from the M. tuberculosis strain were used to show that the observed faster migrating 
product is exported.  Soluble, membrane, and cell wall fractions were prepared from whole cell lysates 
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Figure 2.4. Tat-dependent processing of BlaC in M. smegmatis.  Full-length BlaC was assessed for 
signal sequence processing by immunoblot analysis of whole cell lysates (WCL).  Full length BlaC was 
expressed in a tat+ strain (ΔblaS) or a tat- deletion strain (ΔblaS ΔtatA) of M. smegmatis.  BlaC[KK] 
was expressed in a tat+ strain. WCL of these strains were separated by  SDS PAGE and compared to a 
WCL of ΔblaS M. smegmatis carrying an empty vector (empty).  Bands were detected by immunoblot 
analysis using anti-BlaC antibodies.  The presumed precursor (p) and mature (m) forms of select 
proteins are indicated by arrowheads.   
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Figure 2.5. Assessment of signal sequence processing of M. tuberculosis full-length candidate Tat 
substrates. (A) Full-length constructs expressing HA-tagged Rv0315 and Rv2843 were assessed for 
signal sequence processing in WT or ΔtatC M. smegmatis.  Whole cell lysates were prepared and 
proteins were separated by SDS-PAGE.  Bands were detected by immunoblot analysis using anti-HA 
antibodies.  The presumed precursor (p) and mature (m) forms of select proteins are indicated by 
arrowheads.  The asterisk indicates a second proteolytic cleavage product for Rv0315.  (B) Constructs of 
HA-tagged PlcB and Rv0774c lacking their presumed signal sequences (Δss) were run alongside full-
length versions PlcB-HA and Rv0774-HA expressed in WT or ΔtatC  M. smegmatis.   
 
 
 
 
 
 
 
 
 
 
 
of H37Rv expressing PlcB-HA and analyzed by immunoblot (Fig 2.6B).  Of the two protein species 
seen in the whole cell lysate, the larger product, the presumptive non-exported precursor, was in the 
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soluble cytosolic fraction and the smaller product was primarily in the cell wall.  Thus, when expressed 
in M. tuberculosis the PlcB-HA protein is processed and exported to the cell wall.  As controls for the 
fractionation, we showed the GroEL protein and the 19kDa lipoprotein were enriched in the soluble and 
cell envelope (cell wall and membrane) fractions, respectively.  
The essential nature of the Tat pathway in M. tuberculosis precludes testing full-length PlcB-HA in a M. 
tuberculosis Δtat mutant.  To address whether full-length M. tuberculosis PlcB is a Tat substrate, the 
‘RR’ pair in the PlcB signal sequence was replaced with ‘KK’.  When the PlcB(KK)-HA protein was 
expressed in M. tuberculosis a single precursor sized species was observed (Fig 2.6C).  Together, these 
experiments demonstrated that PlcB is a Tat substrate exported to the cell wall in M. tuberculosis but not 
in M. smegmatis. 
DISCUSSION 
The Tat pathway is important to the virulence and physiology of several bacterial pathogens.  
Because it is absent in mammals, it has been considered a target for development of new antibacterial 
agents (8, 31).  Here we used ‘BlaC as a reporter to identify proteins with functional Tat signal 
sequences and begin understanding the role Tat export plays in M. tuberculosis.  This approach allows 
for the experimental investigation of Tat export in a system where obtaining a Δtat mutant is not 
feasible. ‘BlaC is not the only recognized Tat specific reporter (14, 63), but it is the only such reporter 
that works in a direct selection, as opposed to a screen.  This property of ‘BlaC allowed us to exploit it 
on a genome-wide level.  Previously, Tat reporters have only been used to validate pre-selected 
candidates (49, 57, 58, 63). 
All active ‘BlaC fusions obtained from our libraries were in-frame with an ORF, had predicted 
signal sequences, and were confirmed to be exported in a Tat-dependent manner.  This attests to the 
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Figure 2.6. Full-length PlcB is processed and exported in M. tuberculosis but not in M. smegmatis. 
(A) Full length PlcB-HA and PlcB-HA lacking its signal sequence (Δss) were expressed in wild-type 
(M. sm WT) and tat- deletion (M. sm ΔtatC) strains of M. smegmatis, or a wild-type strain of M. 
tuberculosis (M. tb WT).  Bands were detected by immunoblot analysis using anti-HA antibodies.  The 
presumed precursor (p) and mature (m) forms of PlcB are indicated by arrowheads.  (B). Irradiated 
cultures of M. tuberculosis expressing HA-tagged full length PlcB-HA were fractionated from whole 
cell lysates (WCL) into soluble (S), membrane (M) and cell wall (CW) fractions.  Immunoblot analysis 
was performed to localize HA-tagged PlcB-HA and GroEL and 19kDa lipoprotein controls. (C) HA 
tagged truncated ΔssPlcB, full length PlcB[RR] (wild-type), and PlcB[KK], were expressed in M. 
tuberculosis.  WCL of each strain were analyzed by immunoblot analysis.   
 
 
 
 
 
power of the ‘BlaC reporter.  Our objective was to comprehensively identify the Tat signal sequences of 
M. tuberculosis.  Our two libraries were composed of ~2×106 plasmids combined, which is sufficiently 
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complex to have >99% probability of every M. tuberculosis ORF being represented as a single in-frame 
‘blaC fusion (48).  However, the unanticipated requirement for a fusion junction to be positioned just 
beyond the signal sequence cleavage site means that, despite this level of complexity, some proteins 
were not picked up. This restriction most likely reflects extended sequences of a mature protein 
preventing ‘BlaC folding into an active conformation compatible with Tat export.  Future libraries could 
be improved by increasing the complexity and using smaller randomly sheared genomic DNA inserts to 
overcome limitations that include the lack of available restriction enzyme cleavage sites. 
Of the thirteen Tat signal sequences identified with the reporter, many are in proteins (Rv0063, 
Rv0315, Rv0774c, Rv2525c, BlaC, and PlcB) previously shown to be secreted or cell wall-associated by 
proteomics (22, 24, 32, 43, 51).  Six of them (Rv0846c, Rv2041c, Rv2843, BlaC, LprQ, and UgpB) are 
predicted lipoproteins with a lipobox motif in their signal sequence (Fig 2.2A), which predicts cell 
envelope localization (56).  Recently, in the archaea Haloferax volcanii it was shown that lipoproteins 
can be Tat substrates (20).  BlaC, PlcA, and PlcB are the only proteins we identified that have 
demonstrated functions (β-lactamase and phospholipase C activities, respectively) (29, 43, 59).  The Plc 
proteins are also shown to function in M. tuberculosis pathogenesis.  Simultaneous deletion of multiple 
plc genes results in attenuated virulence of M. tuberculosis in a mouse model of infection (43).   
Much less is known about the remaining Tat signal sequence-containing proteins we identified 
(Table 2.3).  Sequence analysis suggests these proteins have diverse functions as lipases (Rv0519c and 
Rv0774c), a copper oxidase (Rv0846c), a glycosyl hydrolase (Rv0315), an oxidoreductase (Rv0063), 
and substrate-binding proteins of sugar uptakes systems (UgpB and Rv2041c).  Rv2525c is one of the 
proteins identified with no predicted function.  On the basis of bioinformatic predictions this protein was 
previously hypothesized to be a M. tuberculosis Tat substrate and, because of co-regulation with other 
genes, was suggested to have a role in cell wall biogenesis (47).  Both UgpB and Rv2041c are predicted 
by transposon saturation mutagenesis (TraSH) to be essential to M. tuberculosis (50), providing a 
potential clue as to why the Tat pathway can not be inactivated in M. tuberculosis.   
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An advantage of using a genetic reporter to directly identify functional Tat signal sequences is 
that there is no imposed requirement that conserved sequence elements, as defined by other studies, need 
be present.  In this regard, the functional Tat signal sequences we identified should be useful for refining 
Tat prediction algorithms.  Most of the sequences we experimentally identified were predicted by at 
least two of three Tat signal sequence prediction programs consulted.  This suggests that the common 
core elements of these programs are the best predictors.  The signal sequence of Rv0063, which 
possesses a RQ in the Tat motif, was the only one of our experimentally identified sequences lacking a 
twin-arginine dipeptide.  Our identification of Rv0063 is consistent with the recent demonstration that 
its signal sequence can direct Tat export of an agarase reporter when expressed in Streptomyces lividans 
(63).  Although no natural Tat substrate is known to have a RQ pair, there are two examples of bacterial 
Tat signal sequences lacking a ‘RR’ dipeptide (26, 27).  In addition, a RQ substitution in the Tat signal 
sequence of the E. coli TorA protein is able to promote Tat export of a GFP reporter (14).  Interestingly, 
the TigrFAM program predicted Rv0063 to have a Tat signal sequence (52).  We also identified one 
protein, LprQ, which was not identified by any of the three prediction programs.  LprQ was likely 
missed due to its extended N-terminus upstream of the twin-arginine motif (Fig 2.2A).  However, it is 
also possible that the true start codon of LprQ is incorrectly annotated, as there are additional GTG 
codons between the annotated start and the twin-arginine motif.   
In addition to having an amino-terminal Tat signal sequence, there are features of the mature 
domain of a protein, which must be folded, that determine whether it can be translocated by the Tat 
pathway (15).  Recently, some putative Tat signal sequences of E. coli were shown to be able to promote 
export of a fused reporter through Sec or Tat pathways, depending on the unfolded or folded nature of 
the reporter (58).  These apparently promiscuous signal sequences highlight the importance played by 
the mature domain of a protein.  The basic question of how often it is that a functional Tat signal 
sequence is present on a bona fide Tat substrate has only begun to be investigated (58).  For this reason, 
we examined full-length versions of a subset of proteins we identified in wild-type and Δtat M. 
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smegmatis.  Three proteins (BlaC, Rv0315, and Rv2843) showed a Tat-dependent effect, which 
indicates that the native proteins are subject to Tat export.  For Rv0315-HA, the immunoblot analysis 
revealed three protein species in whole cell lysate of wild-type M. smegmatis and two species in lysate 
of tat mutant M. smegmatis (Fig. 2.5A).  A homologous β-glucanase of Bacillus circulans is subject to 
progressive proteolytic processing post-export (61).  Similar proteolytic processing of Rv0315 would 
explain the multiple species seen by immunoblot. 
For two other M. tuberculosis proteins tested there was no difference in the protein species seen 
in whole cell lysate from wild-type and Δtat M. smegmatis (Fig. 2.5B).  In these cases, the size of the 
full-length protein species observed was larger than that of the predicted mature protein.  Thus, no signal 
sequence cleavage or obvious export occurred when full-length versions of these proteins were 
expressed in M. smegmatis.   
The fact that PlcB-HA was unaffected in a M. smegmatis tat mutant was surprising since the Plc 
proteins are demonstrated to be exported to cell wall fractions of M. tuberculosis (43).  Moreover, 
virtually all phospholipase C orthologs in a wide-variety of organisms have predicted Tat signal 
sequences (16) and there are bacterial Plc enzymes proven to be exported by the Tat pathway (9, 36, 46, 
60).  In contrast to what was seen in M. smegmatis, when expressed in M. tuberculosis two species of 
PlcB-HA were evident by immunoblot analysis.  The faster of the two species was exported to the cell 
wall and migrated at the same molecular weight as ΔssPlcB-HA, the expected size of processed mature 
PlcB.  A KK substitution of the twin-arginine motif of full-length PlcB prevented its processing in M. 
tuberculosis.  These results demonstrate that in its native host PlcB is an authentic twin-arginine 
dependent protein.  These data provide an important link between the Tat pathway and virulence factor 
export in M. tuberculosis.   
The above result is also interesting in suggesting that Tat export of a M. tuberculosis virulence 
factor requires a pathogen-specific component.  There are a small number of Tat substrates shown to 
require dedicated chaperones for export (28, 38, 39).  There are also examples of chaperones, such as 
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DnaK, that work with a broader collection of Tat substrates (23, 40).  Perhaps the pathogen-specific 
factor is a chaperone for PlcB that is present in M. tuberculosis but lacking in M. smegmatis.  Although 
the exact function of these chaperones remains to be discerned, proposals for how they work include 
promoting proper folding, protecting the Tat substrate from degradation or delivery to the translocon 
before folding is complete, and delivering the substrate to the translocase (39).  Some of these functions 
relate to the mature domain of the protein, which could account for why a ssPlcB-‘BlaC protein was 
exported by M. smegmatis but the full-length PlcB-HA was not.  Notably, PlcH of P. aeruginosa 
requires PlcR chaperones for its export (12).  However, no obvious PlcR homologues exist in M. 
tuberculosis.  Another possibility is that a conserved component of the M. smegmatis and M. 
tuberculosis Tat systems differs in its substrate recognition abilities.  
 The work presented here demonstrates the power of using a Tat-specific reporter to identify 
functional Tat signal sequences without any preconceived bias regarding the features that define them.  
By examining full-length versions of proteins in wild-type and Δtat M. smegmatis, we showed three of 
the proteins identified to be true Tat substrates.  The results with the other two proteins tested emphasize 
the importance of domains beyond the Tat signal sequence and bacteria-specific factors in defining a 
true Tat substrate.  In our quest to prove the virulence factor PlcB is a true Tat substrate, we discovered 
this protein is exported by the Tat pathway only its native host, indicating the existence and requirement 
for pathogen-specific host factors in its Tat export.   
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Supplemental Table 2.1. Primers used in this study. 
 
Target 
gene 
Oligo name Sequence (5’   3’) Restriction enzyme 
site (5’ extension) 
 
Primers used for library construction 
blaC Lib’blaCfor ATCGATCCGGCATCGACAACCTTG ClaI  
 Lib’blaCrev CCATGGCTATGCAAGCACACCGGCAAC NcoI  
hsp60 Hsp60for-BstBI ATTCGAACGTGGCGAACTCCGTTGTAG BstBI  
 Hsp60rev2-ClaI TATCGATCGGGGATGAAACGGGGGTC ClaI  
Primers used for plasmid construction (HA-tagged constructs) 
plcB PlcBMscIF CGTGGCCATTACCCGCCGACAATTTTTTGC MscI  
 PlcBMscF-2 CGTGGCCATTGGGCCTTGCCCCGGACATTTG MscI  
 plcBMscF-3 GTCTAGAGTCCGGTGGCATTCGTGGTC XbaI  
 plcBXbaF-1 GTCTAGAACCCTTCCCGCTGCGATATCC XbaI  
 PlcBHindR CGAAGCTTGACAGAGACCGCTGGGAATCC HindIII  
 plcBKKfor2 AAGCAATTTTTTGCTAAAGCAGCCGCCGCTAC n/a  
 plcBKKrev3 CTTGGTCATTCCGTCGACGGGGTGTTC n/a  
Rv0315 315MscF-2 GTCTAGAAGAACCAGCACGCCGACAAC XbaI  
 315HindR CGAAGCTTGAAAGACGCGCACCCAGTCG HindIII  
Rv0774c 774MscF CGTGGCCATTATGGCCCGCATGCCAGAGTTG MscI  
 774HindR CGAAGCTTGACCTGTGAGCAGCGGCGCGAAC HindIII  
 Xss774mscIF CTGGCCAACGCACCGGCGGCGGCGATTGGCAC MscI  
Rv2843 2843NruF ATCGCGATTCTTAGAGCAGCACCAGTCATC NruI  
 2843HindR CGAAGCTTGTATCGACGGGCCTGAAGGCAC HindIII  
Primers used for making signal sequence-‘blaC fusions 
Rv2525c 2525F CTTCGAACCGGAGGAATCACTTCGCATGTCGG
TCTCTCGGCGTGATG 
BstBI  
 2525R CTTCGAAGGCCGATGCCGGCGCGGCGCGCAAC
G 
BstBI  
Rv2041c Rv2041ssF CTTCGAACCGGAGGAATCATTCGCAATGATGG
TCAAGCCGTTCGAGCGGCGCAG 
BstBI  
 2041ssR CTTCGAAAGCACACCCAGCGGCCCAGGGA BstBI  
Primers used for sequence determination 
blaC TnBlaCout CAGAATGCGAACCGCTCATC n/a  
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Mycobacterium tuberculosis is an intracellular pathogen that is able to avoid destruction by host 
immune defenses.  Exported proteins of M. tuberculosis, which include proteins localized to the 
bacterial surface or secreted into the extracellular environment, are ideally situated to interact with host 
factors.  As a result, these proteins are attractive candidates for virulence factors, drug targets, and 
vaccine components.  Here we describe a new β-lactamase reporter system capable of identifying 
exported proteins of M. tuberculosis during growth in host cells.  Because β-lactams target bacterial cell 
wall synthesis, β-lactamases must be exported beyond the cytoplasm to protect against these drugs.  
When used in protein fusions, β-lactamase can report on the subcellular location of another protein as 
measured by protection from β-lactam antibiotics.  Here we demonstrate that a truncated TEM-1 β-
lactamase lacking a signal sequence for export (‘BlaTEM-1) can be used in this manner directly in a 
mutant strain of M. tuberculosis lacking the major β-lactamase, BlaC.  The ‘BlaTEM-1 reporter 
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conferred β-lactam resistance when fused to both Sec and Tat export signal sequences.  We further 
demonstrate that β-lactamase fusion proteins report on protein export while M. tuberculosis is growing 
in THP-1 macrophage-like cells.  This genetic system should facilitate the study of proteins exclusively 
exported in the host environment by intracellular M. tuberculosis. 
 
 
 
INTRODUCTION 
Tuberculosis is responsible for nearly two million deaths each year (47).  Mycobacterium 
tuberculosis, the causative agent of this disease, is an intracellular pathogen and the ability of this 
bacterium to survive and grow in macrophages is essential to its virulence.  Multiple processes are likely 
employed by M. tuberculosis to avoid destruction in macrophages.  These include residing in a 
phagosome that fails to mature into an acidified phagolysosome and resisting reactive radicals (as 
reviewed in (32, 48).  As in other bacterial pathogens, M. tuberculosis proteins exported beyond the 
cytoplasm to the bacterial cell envelope (comprised of the cytoplasmic membrane and cell wall) or 
secreted into the environment are ideally positioned to interact with host cell components and promote 
survival in macrophages.  Consequently, exported and secreted proteins make good candidates for 
virulence factors, drug targets for disease intervention, and vaccine antigens.   
Mycobacteria possess two conserved pathways for exporting proteins: the general secretion (Sec) 
pathway and the twin-arginine translocation (Tat) pathway (2, 21, 25, 28, 29, 35).  These systems 
recognize precursor proteins synthesized with amino-terminal signal sequences and transport them 
across the cytoplasmic membrane (10, 26).  The proteins exported by these pathways can remain 
associated with the cell envelope or be further secreted by the bacterium.  The signal sequences of Sec 
and Tat substrates share a similar domain structure; however, Tat substrates are distinguished by the 
presence of the twin-arginine motif, R-R-x-φ-φ (φ = uncharged residue).  The two pathways also differ 
in their mode of transport.  Sec substrates are translocated across the cytoplasmic membrane in an 
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unfolded state, whereas Tat substrates are translocated in a folded conformation.  M. tuberculosis also 
has at least two specialized protein export pathways: the SecA2-dependent system and the ESX-1 
(ESAT-6) system (3, 15, 18, 30, 40). Interestingly, both pathways appear capable of secreting specific 
subsets of proteins that lack conventional Sec or Tat signal sequences. 
In M. tuberculosis, proteomic and genetic methods have been used to experimentally identify 
proteins exported beyond the cytoplasm (reviewed in (21).  The genetic methods rely on reporter 
enzymes that are fused to M. tuberculosis protein sequences and report on the subcellular location of the 
fusion proteins (4, 8, 12, 23, 46).  Surrogate hosts such as non-pathogenic Mycobacterium smegmatis or 
Escherichia coli have been used in most of these studies, often because endogenous enzyme activities in 
M. tuberculosis precluded their use directly in the pathogen.  The use of surrogate hosts is a problem for 
identifying proteins that are only exported by pathogenic M. tuberculosis. 
β-lactamase is an export reporter that was not initially employed directly in M. tuberculosis 
because of endogenous β-lactam resistance.  β-lactamase catalyzes the hydrolysis of β-lactams, a class 
of antibiotic that targets cell wall biosynthetic enzymes located outside of the cytoplasmic membrane.  
Therefore, β-lactamase must be exported beyond the cytoplasm to protect the bacterium from the drug.  
For this reason, when fused to another protein, it can be used as an export reporter with β-lactam 
resistance as a powerful indicator of export.  We recently reported that a ΔblaC mutant of M. 
tuberculosis, lacking the chromosomally encoded β-lactamase BlaC, is β-lactam sensitive (14).  Further, 
we showed that BlaC is a native Tat substrate and that a truncated ‘BlaC lacking a signal sequence can 
function as a reporter of Tat-dependent export directly in a ΔblaC mutant of M. tuberculosis (25).  This 
was shown by fusing a Tat signal sequence to ‘BlaC and demonstrating that the resulting hybrid protein 
confers resistance to the β-lactam antibiotic carbenicillin in the ΔblaC background.  Interestingly, the 
‘BlaC reporter works with Tat but not Sec exported proteins.  Here we expanded the β-lactamase tools 
that can be used directly in M. tuberculosis by demonstrating that the TEM-1 β-lactamase (BlaTEM-1), 
originally identified in a clinical isolate of E. coli (9), functions as an export reporter in the ΔblaC 
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mutant of M. tuberculosis.  The ‘BlaTEM-1 reporter has the significant advantage of being compatible 
with both Sec and Tat signal sequences.  
The proteomic and genetic approaches used in previous work for identifying exported proteins of M. 
tuberculosis are limited by their reliance on in vitro grown bacteria.  Consequently, a potentially 
interesting collection of proteins only exported or secreted while M. tuberculosis are inside host cells are 
missed.  In this report, we demonstrate that β-lactamase reporters have the novel capability of 
identifying M. tuberculosis proteins that are exported during intracellular growth in β-lactam treated 
THP-1 macrophage-like cells.  The system we describe will be of significant value for identifying the 
most interesting category of exported M. tuberculosis proteins – those exported during growth in the 
host environment. 
 
MATERIALS AND METHODS 
 Bacterial strains, media and growth conditions 
Escherichia coli DH5α was grown in Luria-Bertani medium (Fisher) supplemented with the following 
concentrations of antibiotics as required: carbenicillin, 100 µg/ml; kanamycin, 40 µg/ml.   M. 
tuberculosis strains H37Rv (WT), PM638 (ΔblaC, H37Rv) (14) and all derivative strains were cultured 
in Middlebrook 7H9 medium or on Middlebrook 7H10 agar medium (Difco; BD Biosciences) 
supplemented with 10% ADS (0.5% BSA, fraction V [Roche]; 0.2% dextrose; and 0.85% NaCl), 0.5% 
glycerol, and 0.05% tween 80 (Fisher).  Antibiotics for mycobacteria were used at the following 
concentrations: carbenicillin, 50 µg/ml; kanamycin, 20 µg/ml. 7H10 plates supplemented with 
carbenicillin lacked tween, as the combination of tween and carbenicillin appeared detrimental to growth 
of fusion-expressing strains. 
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Construction of ‘blaTEM-1 fusion plasmids 
 Plasmids used in this study are listed in Table 3.1.  All subcloned PCR products were sequenced 
and determined to be error free.  Sequence encoding the mature domain (lacking the N-terminal signal  
 
 
Table 3.1. Plasmids used in this study 
Plasmid Genotype Description Source 
pCC1 cat oriV ori2 CopyControl (single copy) blunt cloning vector Epicentre 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (41) 
pMB219 aph oriM ColE1 Multicopy mycobacterial shuttle plasmid This work 
pMB222 aph Phsp60-ssplcB (M. 
tuberculosis) oriM ColE1 
M. tuberculosis plcB signal sequence in pMV261 
under control of hsp60 promoter 
(25) 
pMB227 aph Phsp60-ssmpt63 (M. 
tuberculosis) oriM ColE1 
M. tuberculosis mpt63 signal sequence in pMV261 
under control of hsp60 promoter 
(25) 
pMB228 aph Phsp60-ssmpt63-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssmpt63-‘blaC in pMV261 under 
control of hsp60 promoter 
(25) 
pJM109 aph Phsp60-ssfbpB-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssfbpB-‘blaC in pMV261 under 
control of hsp60 promoter 
(25) 
pJM111 aph Phsp60-ssplcB-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssplcB-‘blaC in pMV261 under 
control of hsp60 promoter 
(25) 
pJM113 aph Phsp60-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ‘blaC (no signal sequence) in 
pMV261 under control of hsp60 promoter 
(25) 
pJM114 cat oriV ori2 E. coli ‘blaTEM-1 cloned into pCC1 This work 
pJES101 aph Phsp60-ssplcB-‘blaTEM-1 
(E. coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMB222 This work 
pJES102 aph Phsp60-‘blaTEM-1 (E. 
coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMV261 This work 
pJES103 aph Phsp60-ssmpt63-‘blaTEM-
1 (E. coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMB227 This work 
pJES125 bla aph ColE1 M. tuberculosis mpt83 signal sequence and upstream 
sequence cloned into pCR2.1 
This work 
pJES128 aph oriM ColE1 ’blaTEM-1 from pJM114 cloned into BamHI-
linearized pMB219 
This work 
pJES129 aph Pmpt83-ssmpt83-‘blaTEM-
1 (E. coli) oriM ColE1 
M. tuberculosis mpt83 signal sequence and upstream 
sequence from pJES125 cloned into pJES128 
This work 
 
 
sequence) of E. coli BlaTEM-1 was amplified from pUC19 plasmid DNA (Invitrogen) using the 
following primers: TEMbla1 (5’- AGATCTCACCCAGAAACGCTGGTGAAAG) and TEMbla2 (5’- 
GTTACCAATGCTTAATCAGTGAGGCACC).  The resulting PCR product was cloned into the pCC1 
vector (Epicentre) to generate pJM114.  The ‘blaTEM-1 reporter was subcloned as a BglII- BamHI 
fragment into each of the multi-copy vectors described below.  (i) Δss, ‘blaTEM-1. ‘blaTEM-1 was 
digested from pJM114, end-filled with Klenow and cloned into MscI cut pMV261.  The resulting 
plasmid, pJES102, contains the ‘blaTEM-1 reporter without a fused signal sequence cloned downstream 
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of the hsp60 promoter.  (ii) ssplcB-‘blaTEM-1. The ‘blaTEM-1 fragment was subcloned into BamHI cut 
pMB222.  The resulting plasmid, pJES101, contains an in-frame fusion of DNA encoding the signal 
sequence of PlcB/Rv2350c (ssplcB) to ‘blaTEM-1 under the control of the hsp60 promoter.  (iii) 
ssmpt63-‘blaTEM-1.  The ‘blaTEM-1 fragment was subcloned into BamHI cut pMB227.  The resulting 
plasmid, pJES103, contains an in-frame fusion of ssmpt63 (Rv1926c) to ‘blaTEM-1 under the control of 
the hsp60 promoter. (iv) ssmpt83-‘blaTEM-1. DNA encoding the signal sequence and the first 31 amino 
acids of the mature M. tuberculosis Mpt83 (Rv2873) protein along with the native mpt83 promoter (20) 
was amplified from M. tuberculosis genomic DNA using the following primers: mpt83HindIIIF (5’- 
CAAGCTTCGTCGGATCCGTGGTAGGGGATGTC) and mpt83HindIIIR (5’- 
CAAGCTTCGGGGTCAGCCATTGCCGCCGTGG) and cloned into the pCR2.1 vector (Invitrogen) to 
generate pJES125.  A HindIII fragment from pJES125, carrying ssmpt83 and upstream genomic 
sequence, was cloned into HindIII cut pJES128 (Table 3.1).  The resulting plasmid, pJES129, contains 
an in-frame fusion of ssmpt83 to ‘blaTEM-1 under the control of the native mpt83 promoter (Pmpt83). 
 
Protein quantification by immunoblot 
 Whole cell lysates of M. tuberculosis strains were prepared as described previously (2) with the 
following modifications.  M. tuberculosis cultures were grown in 5 ml volumes to mid-exponential 
phase.  The cultures were washed twice and resuspended in PBS 0.02% Tween 80.  An equal volume of 
10% formalin was added to the washed cultures, which were then incubated at room temperature for 1 
hour with frequent mixing by inversion.  The formalin fixation step was necessary to kill M. tuberculosis 
before further processing.  Bacteria were then harvested by centrifugation at 3000 RPM, washed once in 
PBS 0.02% tween to remove residual formalin, and bead-beaten lysates were then obtained from each 
sample.  Protein concentration for each lysate was measured using a bicinchoninic acid protein 
quantification kit (Pierce).  Lysates were boiled for 10 minutes, subjected to SDS-PAGE and 
immunoblots were performed using standard conditions.  Primary antibodies specific for BlaTEM-1 
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were used at a concentration of 1:5000 (QED Biosciences), and horseradish peroxidase-conjugated anti-
mouse secondary antibodies were used at a concentration of 1:20,000.  Bands were visualized using 
Western Lightning Chemiluminescent Reagent Plus (PerkinElmer) and quantified using ImageJ Image 
Processing and Analysis software (http://rsb.info.nih.gov/ij/).  Whole cells lysates with the highest level 
of expression were diluted to enable direct comparison of all hybridization signals on a single blot.  The 
comparative quantification was determined by measuring pixel density of an equal area for each blotted 
lysate in duplicate.  Signal intensity per µg of whole cell lysate loaded was determined and is reported as 
the amount relative to protein detected in the ‘BlaTEM-1 expressing strain. 
 
Macrophage infections 
THP-1 cells were maintained in RPMI (Gibco)/10% heat inactivated fetal calf serum (FCS) at 37 
°C and 5% CO2.  To prepare THP-1 monolayers for infection, cells were spun down at 300 g, washed 
once in RPMI, then resuspended in RPMI /10% FCS at a concentration of 1 × 106 cells/ml.  Cells were 
seeded into 8-well tissue culture slides at 2 × 105 cells/well and treated with phorbol myristate acetate 
(PMA) at a final concentration of 50 ng/ml for 48 hours. 
M. tuberculosis was grown to mid-exponential phase OD600 of 0.5-1.0.   Immediately prior to 
infection, the bacterial culture was pelleted, washed once in PBS containing 0.05% Tween 80 (PBS-
Tw), and resuspended in an equal volume of PBS-Tw.  The culture was then briefly sonicated to break 
up clumps of bacteria, diluted in RPMI/10%FCS medium and added to the THP-1 monolayer at m.o.i. = 
0.1.  THP-1 monolayers were infected with M. tuberculosis strains for 4 hours at 37 °C and 5% CO2.  
Overlaying medium was then removed, the monolayers were washed 3 times with RPMI to remove non-
cell associated bacteria, and triplicate wells were lysed and plated to determine uptake (day 0 time-
point).  The infected monolayers were then overlaid with RPMI/10% FCS, or RPMI/10% FCS 
supplemented with carbenicillin and maintained at 37 °C and 5% CO2.  At 3 days post infection, the 
overlying medium was replenished with RPMI/10% FCS media or media supplemented with 
carbenicillin, as appropriate.  On days 1, 3 and 5 post-infection, triplicate wells for each infection were 
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washed to remove antibiotic and lysed with 0.05% SDS.  The resulting lysates were diluted and plated 
on 7H10 agar to enumerate intracellular bacteria during the course of infection.  On day 0 and day 5 of 
the infection, cell lysates were also plated on 7H10 agar supplemented with 50 µg/ml carbenicillin.  This 
demonstrated that selection of spontaneous β-lactam resistant mutants did not occur during the course of 
infection.  To determine the appropriate carbenicillin concentration necessary to kill intracellular 
bacteria, THP-1 infection experiments were performed with a range of antibiotic concentrations (Fig. 
3.4b).  Carbenicillin at 1 mg/ml was determined to be the lowest concentration of antibiotic that caused 
optimal killing of sensitive intracellular M. tuberculosis and was used in subsequent experiments. 
 
RESULTS 
'BlaTEM-1 is exported by Sec and Tat signal sequences in M. tuberculosis 
β-lactamase is an ideal reporter for protein export because it must be localized beyond the 
bacterial cytoplasmic membrane to effectively protect the bacterium from β-lactam antibiotics.  
Therefore, it can be used in protein fusions to identify proteins that are extracytoplasmic.  An attractive 
feature of a β-lactamase reporter is that a selection for β-lactam resistant colonies can be performed, as 
opposed to a more labor-intensive screen.  In the past, we showed that the endogenous β-lactamase of 
M. tuberculosis BlaC can function as a reporter of export exclusively by the Tat pathway when 
expressed in the β-lactam sensitive ΔblaC mutant of M. tuberculosis or ΔblaS mutant of M. smegmatis 
(25).  Since the Sec pathway is likely responsible for the majority of protein export in M. tuberculosis, 
we were interested in utilizing a β-lactamase reporter that additionally works with Sec exported proteins.  
For this reason, we tested the E. coli TEM-1 β-lactamase (BlaTEM-1) which has been used in other 
bacteria to report on proteins exported by Sec, Tat, Type II and Type III secretion systems (5, 7, 37, 39). 
A series of multi-copy kanamycin-marked ‘blaTEM-1 plasmids were constructed and 
electroporated into the ΔblaC mutant of M. tuberculosis (Fig. 3.1).  The resulting kanamycin resistant 
strains were tested for the ability to grow in the presence of 50 µg/ml of the β-lactam carbenicillin. 
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When the truncated 'blaTEM-1 reporter without a signal sequence was expressed in the ΔblaC mutant of 
M. tuberculosis, the strain remained carbenicillin-sensitive.  In fact, no colonies of the strain expressing 
the truncated ‘BlaTEM-1 grew on agar containing carbenicillin even after extended incubation (Figs. 3.1 
and 3.2).  However, expression of a hybrid protein comprised of a Sec signal sequence from Mpt63, a 
well-established secreted protein of M. tuberculosis (17, 24), fused to 'BlaTEM-1 (ssMpt63-‘BlaTEM-1) 
protected the ΔblaC mutant from carbenicillin, as was evident by the ability of this strain to grow on 
carbenicillin agar plates (Figs. 3.1 and 3.2) .  We similarly tested a fusion protein in which the Sec signal 
sequence of a proven cell wall-associated lipoprotein, Mpt83 (16), was fused to ‘BlaTEM-1.  This 
construct also conferred β-lactam resistance to ΔblaC M. tuberculosis (Fig. 3.1).  Of note, the ssMpt83-
‘BlaTEM-1 fusion protein also included the first 31 amino acids of the mature Mpt83 protein as well as 
the native mpt83 promoter which is reported to be active at very low levels in vitro (16, 34).   
Finally, we tested the signal sequence of PlcB, a proven cell wall-associated phospholipase C, for the 
ability to promote export of enzymatically active ‘BlaTEM-1 (19, 31).  PlcB has a predicted Tat signal 
sequence, and the ssPlcB-‘BlaTEM-1 fusion also allowed ΔblaC M. tuberculosis to grow in the presence 
of carbenicillin (Fig. 3.1).  
To determine whether the ssPlcB-'BlaTEM-1 fusion was exported by the Tat pathway, it was 
tested in ΔblaS M. smegmatis and in a ΔtatA ΔblaS M. smegmatis double mutant (25) in two 
independent experiments.  When the ssPlcB-'BlaTEM-1 fusion protein was expressed in ΔblaS M. 
smegmatis, 92% of colonies were carbenicillin resistant.  However, when the same construct was 
expressed in the ΔtatA ΔblaS mutant only an average 7% of colonies were carbenicillin resistant  
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Fig. 3.1.  Schematic representation of signal sequence-‘BlaTEM-1 fusion constructs.  Mycobacterial 
shuttle plasmids were designed to encode fusion proteins of M. tuberculosis peptide sequence (open 
boxes) with a truncated ‘BlaTEM-1 protein (gray boxes) lacking its native signal sequence.  The hatched 
boxes indicate plasmid-derived peptide sequence that is present as a result of the cloning process.  The 
constructs were driven off the constitutive M. tuberculosis hsp60 promoter for (a) pJES102/‘blaTEM-1, 
(b) pJES103/ssmpt63-‘blaTEM-1, and (d) pJES101/ssplcB-‘blaTEM-1.  The native M. tuberculosis 
promoter located upstream of the mpt83 operon was used to drive expression of (c) pJES129/ ssmpt83-
‘blaTEM-1 (promoters indicated by arrows).  Signal peptidase cleavage sites are indicated by 
arrowheads and by the AxA/G recognition motif for PlcB and Mpt63, and the LAGC lipobox 
recognition motif for Mpt83.  Diagram not to scale; ss, signal sequence. 
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Fig. 3.2.  'BlaTEM-1 does not provide β-lactam-resistance to ΔblaC M. tuberculosis.  Plasmids 
encoding the indicated 'blaTEM-1 fusions were electroporated into M. tuberculosis ΔblaC.  The 
resulting strains were then plated on 7H10 plates supplemented with either kanamycin and 0.05% tween 
or kanamycin and carbenicillin without tween.  Plates were inspected for growth following 21-25 days 
of incubation. Not shown are colonies expressing ssMpt83-‘BlaTEM-1 and ssPlcB-‘BlaTEM-1; growth 
on plates containing carbenicillin for these strains was similar to that conferred by ssMpt63-‘BlaTEM-1. 
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indicating that the Tat pathway functions in the export of this fusion protein.  To show that a functional 
Tat pathway was not required for export of the Sec signal sequence-'BlaTEM-1 fusion, we similarly 
evaluated export of ssMpt63-'BlaTEM-1.  When expressed in ΔblaS and the ΔtatA ΔblaS mutants, 
ssMpt63-'BlaTEM-1 conferred carbenicillin resistance to 90% and 95% of colonies, respectively.  This 
indicated, as expected, no role for the Tat pathway in exporting a Sec signal sequence-'BlaTEM-1 
fusion.  
In each example where a M. tuberculosis signal sequence (Sec or Tat) was fused to ‘BlaTEM-1, 
ΔblaC M. tuberculosis was protected from β-lactam attack.  To demonstrate that the inability of the 
‘BlaTEM-1 reporter lacking a signal sequence to protect against carbenicillin was due to lack of export, 
as opposed to lack of expression, whole cell extracts of  ‘BlaTEM-1 expression strains were prepared 
and assayed for cell-associated β-lactamase.  To test for enzyme activity, we used the chromogenic β-
lactam nitrocefin, which turns red following cleavage by β-lactamase (27).  During a 15 minute 
incubation the nitrocefin was hydrolyzed by all strains expressing ‘BlaTEM-1 constructs, while ΔblaC 
M. tuberculosis demonstrated no activity, similar to PBS alone (data not shown).  Importantly, β-
lactamase activity was detected with the truncated ‘BlaTEM-1 reporter lacking a signal sequence.  In 
fact, the lysate from the ‘BlaTEM-1 strain converted nitrocefin to the red product almost instantaneously 
and faster than any other strain tested.  We similarly detected β-lactamase activity in whole cell lysates 
of ΔblaC M. tuberculosis expressing the 'BlaC reporter lacking its native signal sequence.   
We also compared the level of each ‘BlaTEM-1 fusion protein present in whole cell lysates from the 
respective M. tuberculosis strains by immunoblots with antibodies specific for BlaTEM-1.  This 
revealed a wide variation in the amount of ‘BlaTEM-1 protein produced by the different strains (Fig. 
3.3).  The non-exported ‘BlaTEM-1 expressed off the hsp60 promoter (Phsp60) was the most abundant 
protein detected.  Phsp60 is considered a relatively strong promoter and is, therefore, present on many 
mycobacterial shuttle vectors (42).  In comparison, the Phsp60 driven ssPlcB-‘BlaTEM-1 and ssMpt63-
‘BlaTEM-1 were expressed at lower levels (59% and 0.9% of the level of the non-exported ‘BlaTEM-1 
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construct, respectively).  Since mpt83 is expressed at relatively low levels in vitro we expected the 
ssMpt83-‘BlaTEM-1 fusion to be weakly expressed (16, 34, 38).  In fact, it was nearly undetectable by 
immunoblot, present at only 0.4% of the amount of non-exported ‘BlaTEM-1 construct.  The bands 
detected on the immunoblot are in general agreement with the predicted molecular weight of the 
expressed proteins.  ‘BlaTEM-1, lacking a signal sequence, has a predicted size of 28 kDa.  Since whole 
cell lysates were analyzed in these experiments it is possible to see processed protein and/or uncleaved 
cytosolic precursor, which may explain the larger sized ssPlcB-‘BlaTEM-1 product.  The signal 
sequences of PlcB and Mpt63 would add approximately 3 and 4 kDa, while the Mpt83 signal sequence 
and fused portion of the mature protein would add approximately 11 kDa, if left intact.   
These observations suggested that even though ‘BlaTEM-1 does not promote growth in the 
presence of carbenicillin, a significant amount of β-lactamase was produced and accumulated within the 
bacterium.  Together, our results indicated that in ΔblaC M. tuberculosis 'BlaTEM-1 must be exported to 
confer protection against β-lactam antibiotics, that β-lactam resistance can be used to report on export, 
and that this reporter can be exported by Sec or Tat signal sequences and is compatible with different 
levels of expression.  
 
The ΔblaC mutant of M. tuberculosis is sensitive to β-lactams during intracellular growth in 
human THP-1 cells 
β-lactam antibiotics can be used for clinical treatment of intracellular pathogens such as Listeria 
monocytogenes (33), and have been shown to reduce the population of phagocytosed Staphylococcus 
aureus (1).  This indicates that β-lactams can enter macrophages and inhibit intracellular growth of  
some bacteria.  The ΔblaC mutant of M. tuberculosis is sensitive to β-lactams in vitro, and we set out to 
test if this mutation also makes M. tuberculosis susceptible to β-lactams during growth in host cells. 
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Fig. 3.3. ‘BlaTEM-1 fusion proteins are detected at different amounts in M. tuberculosis whole cell 
lysates.  Protein present in whole cell lysates (WCL) from each of the indicated ΔblaC strains were 
separated by SDS-PAGE and immunoblotted using primary antibody specific for BlaTEM-1.  
Comparative signal was quantified by measuring pixel density of an equal area for each blotted lysate in 
duplicate.  Average signal intensity per µg of WCL is reported as the amount relative to protein detected 
in the ‘BlaTEM-1 expressing strain.  Due to the different amounts of protein in each strain, it was 
necessary to load dilutions of the ‘BlaTEM-1 and ssPlcB-‘BlaTEM-1 expressing lysates so that signal 
from less abundant protein fusions could be simultaneously detected.  There was no detectable signal 
with the WCL from the ΔblaC mutant carrying empty pMV261 plasmid. 
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Intracellular growth of the ΔblaC mutant was not previously evaluated; therefore, we first tested the 
ability of this mutant to grow within human monocytic THP-1 cells.  THP-1 cells were infected at a 
m.o.i. of 0.1 with either the ΔblaC mutant or the virulent parental H37Rv strain.  After a four hour  
period of infection, the THP-1 monolayer was washed to remove non-cell associated bacilli and fresh 
media was added back.  Growth over a five day period was assessed by plating of infected host cell 
lysates for viable bacilli.  The ΔblaC mutant showed no difference in intracellular growth when  
compared to H37Rv (Fig. 3.4a).  Of note, we confirmed that M. tuberculosis does not grow in the THP-
1 culture medium as previously reported (49). 
To determine if the ΔblaC mutant was sensitive to β-lactams during intracellular growth, THP-1 
cells were infected with ΔblaC M. tuberculosis and, following the washes to remove extracellular 
bacilli, media containing different concentrations of carbenicillin was added to the infected monolayers.  
After five days incubation, the infected monolayers were washed to remove carbenicillin and lysed to 
plate for viable bacilli.  In the absence of carbenicillin, the ΔblaC mutant grew in THP-1 cells as 
previously seen.  However, as the concentration of carbenicillin during the intracellular growth period 
increased, growth of the mutant diminished.  At carbenicillin concentrations of > 0.8 mg/ml substantial 
killing of the mutant was observed (Fig. 3.4b).  These results indicated that the ΔblaC mutant is 
sensitive to β-lactam antibiotics during intracellular growth, and it suggested that the β-lactamase 
reporters could be used to study protein export during intracellular growth.  Additional experiments 
showed that a concentration of 1 mg/ml carbenicillin was sufficient to achieve significant killing of the 
ΔblaC mutant of M. tuberculosis in THP-1 cells, and this concentration was used in all subsequent 
experiments. 
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Fig. 3.4.  The ΔblaC mutant of M. tuberculosis does not have a growth defect and is sensitive to β-
lactam antibiotic in human THP-1 macrophage-like cells.  (a) THP-1 cells were seeded into 8 well 
chamber slides, and triplicate wells were infected with either WT H37Rv or ΔblaC M. tuberculosis at a 
m.o.i. of 0.1 bacilli per macrophage.  At 4 hours (Day 0), 1, 3 and 5 days post infection, infected wells 
were washed, lysed, and plated for intracellular bacteria.  Error bars represent standard error of the mean 
of c.f.u. in triplicate wells. (b) THP-1 cells were infected with ΔblaC M. tuberculosis as in (a).  
Following a 4-hour uptake period, wells were washed and indicated concentrations of carbenicillin were 
added to infected wells.  Infected cells were lysed and plated at 4 hours (Day 0) and 5 days post 
infection to enumerate intracellular bacteria. Dashed line represents average intracellular CFU at 4 hours 
post infection.  Error bars represent standard error of the mean of quadruplicate wells combined from 
two replicates. 
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Export of β-lactamase protects intracellular ΔblaC M. tuberculosis from β-lactam antibiotics 
A reporter system that works with intracellularly growing M. tuberculosis would be of great 
value for identifying exported proteins that are expressed and exported only during infection.  Having 
shown that the ΔblaC mutant was sensitive to β-lactams during intracellular growth, we tested if β-
lactamase could be used to report on protein export by M. tuberculosis growing in host cells.  We tested  
fusion proteins expressing the ‘BlaC and ‘BlaTEM-1 reporters for the ability to protect the ΔblaC 
mutant in β-lactam treated THP-1 cells.  In each experiment we compared an exported fusion protein to 
the truncated reporter alone.   
To test the ‘BlaC reporter, which works with Tat exported proteins only, THP-1 cells were 
infected with the M. tuberculosis ΔblaC mutant expressing ssPlcB-‘BlaC or ‘BlaC only.  Media with or 
without 1 mg/ml carbenicillin was added and the course of infection was monitored over a five day 
period.  In the absence of carbenicillin, both strains grew in THP-1 cells during the course of the 
experiment.  However, in the presence of carbenicillin, the strain expressing the truncated reporter alone 
did not grow and was reduced by one log over five days while the strain expressing the exported ssPlcB-
‘BlaC  fusion protein was protected from carbenicillin and grew normally (Fig. 3.5a). 
The ‘BlaTEM-1 fusions were similarly tested.  When THP-1 cells were infected with ΔblaC M. 
tuberculosis expressing either the exported ssMpt63-‘BlaTEM-1 or the ‘BlaTEM-1 reporter alone, only 
the strain expressing ssMpt63-‘BlaTEM-1 fusion grew in THP-1 cells in the presence of carbenicillin.  
The non-exported ‘BlaTEM-1 strain was sensitive to the β-lactam and was reduced in number by one 
log (Fig. 3.5b).  Similarly, ΔblaC M. tuberculosis exporting ssMpt83-‘BlaTEM-1 fusion was able to 
grow in carbenicillin treated THP-1 cells, while the non-exported ‘BlaTEM-1 construct did not confer 
resistance to the ΔblaC mutant (Fig. 3.5c).  
These experiments demonstrated that both the Tat specific ‘BlaC reporter and the more permissive 
‘BlaTEM-1 reporter can report on protein export while M. tuberculosis is growing in β-  
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Fig. 3.5.  M. tuberculosis signal sequences fused to ‘BlaC and ‘BlaTEM-1 protect intracellular 
bacilli from β-lactam antibiotics.  THP-1 macrophage like cells were infected in triplicate wells with 
(a) M. tuberculosis ΔblaC expressing either ssPlcB-‘BlaC or ‘BlaC, (b) M. tuberculosis ΔblaC 
expressing either ‘BlaTEM-1 or ssMpt63‘BlaTEM-1 or (c) M. tuberculosis ΔblaC expressing ‘BlaTEM-
1or  ssMpt83-‘BlaTEM-1.  Infected cells were then left untreated or treated with 1 mg/ml carbenicillin 
(carb).  Wells were washed, lysed and plated 4 hours (d 0), 1, 3 and 5 days post infection.  Each 
experiment was replicated 3 times in the case of (a) and (b), and 4 times in (c), with similar results. 
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lactam treated host cells. The use of β-lactamase reporters with intracellular M. tuberculosis represents a 
powerful tool for the study and identification of proteins exported during growth in host cells. 
 
DISCUSSION 
The exported proteins of M. tuberculosis have been the subject of research attention for some 
time.  This stems from the well-established fact that the majority of bacterial virulence factors and 
antigens are proteins exported out of the cytoplasm to the bacterial cell envelope or secreted out from 
the bacterium (13).  In fact, there is a growing list of M. tuberculosis exported and secreted proteins 
shown to contribute to virulence or to development of a host immune response (21).  Genetic reporters 
have proven to be powerful tools for identifying these extracytoplasmic proteins.  The construction of a 
β-lactam sensitive ΔblaC mutant of M. tuberculosis opened the door for using β-lactamases as reporters 
of protein export directly in M. tuberculosis.  The ‘BlaC reporter can be used as a Tat specific reporter 
while the ‘BlaTEM-1 reporter, shown here, can work with Sec or Tat signal sequences.  An advantage of 
β-lactamase reporters is that they can be used to select for exported fusion proteins, as opposed to more 
labor intensive screening.  In addition, we showed here for the first time that resistance to β-lactam 
antibiotics can be used to report on protein export during intracellular growth of bacteria.  Even in more 
genetically tractable bacterial pathogens, the identification of proteins exported or secreted from within 
host cells is a challenge.   
Because β-lactams target cell wall modifying enzymes, β-lactamases must be exported in order 
to protect against these drugs.  This export requirement was previously exploited with fusion proteins 
expressed in E. coli and other bacteria grown in vitro (5, 22).  Here we showed that BlaTEM-1 can also 
report on protein export directly in ΔblaC M. tuberculosis.  The three M. tuberculosis signal sequences 
tested in our study are from well-established secreted or cell-wall associated proteins.  Mpt63 (Rv1926c, 
16kDa protein) has a predicted Sec signal sequence and is one of the four most abundant M. tuberculosis 
proteins secreted into culture media during in vitro growth (17).  Mpt83 (Rv2873) is a glycosylated 
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lipoprotein (16, 43) that is exported to the cell wall of M. tuberculosis.  Mpt83 has a predicted Sec signal 
sequence with a lipoprotein signal peptidase (LspA) cleavage site and the requisite conserved cysteine 
for lipid modification.  PlcB (Rv2350c, phospholipase C) is a cell wall associated protein of M. 
tuberculosis shown to function in virulence (19, 31).  Unlike Mpt63 and Mpt83, PlcB has a predicted 
Tat signal sequence including a twin-arginine motif (11).  Signal sequences from all three of these 
proteins were able to promote export of a fused ‘BlaTEM-1 reporter on the basis of production of β-
lactam resistance.  Notably, the ssMpt83-‘BlaTEM-1 fusion protein was expressed from the native 
mpt83 promoter and the fusion protein included the predicted signal sequence plus 31 amino acids of the 
mature Mpt83 protein.  This demonstrated the ability of the reporter to work with different strength 
promoters and extended protein sequences.  It is important to note that even though variable levels of 
fusion protein were detected in M. tuberculosis whole cell lysates as determined by immunoblot, each 
exported fusion provided sufficient protection against 50 µg/ml carbenicillin while the most abundant 
‘BlaTEM-1 without an export signal did not confer β-lactam resistance.   
Previously, we showed that the PlcB signal sequence is able to drive export of functional ‘BlaC 
in a Tat- and twin RR-dependent manner (25).  In E. coli the ‘BlaTEM-1 reporter works with both Sec 
and Tat signal sequences (5, 39).  The Sec and Tat pathways appear essential in M. tuberculosis (2, 35, 
36).  Therefore, to investigate the mode of export of the ssPlcB-‘BlaTEM-1 fusion protein it was tested 
in M. smegmatis ΔblaS and in a M. smegmatis ΔtatA ΔblaS double mutant.  A 93% reduction in β-
lactam resistant colonies was observed in the M. smegmatis ΔtatA ΔblaS double mutant.  Thus, the Tat 
pathway is involved in the export of ssPlcB-‘BlaTEM-1, although other export pathways participate as 
well.  The signal sequence of PlcB may be promiscuous in targeting the Tat or Sec pathway for export 
depending on the folded or unfolded nature of a fused reporter element.  Similar results were recently 
shown for some predicted Tat signal sequences in E. coli (45).  
In addition to working with the Sec and Tat pathways, the‘BlaTEM-1 reporter has been used 
with type II and type III secretion systems of Gram-negative bacteria (7, 37).  Since substrates of the 
 88 
type III secretion system lack conventional N-terminal signal sequences, it remains possible that the 
‘BlaTEM-1 reporter will also work with non-conventional exported proteins of M. tuberculosis. 
An interesting category of exported proteins that has been largely overlooked are those proteins 
only expressed and/or exported during the course of infection.  We hypothesize that these are proteins 
exclusively exported in the host environment including virulence factors and protective antigens.  
Further, only a small number of the exported M. tuberculosis proteins identified in vitro have ever been 
directly investigated during intracellular growth in host cells (21).  For most of these studies, 
immunomicroscopy was used to localize the proteins in M. tuberculosis infected macrophages, which 
required development of suitable antibodies.  We reasoned that if β-lactam antibiotics can reach 
intracellular ΔblaC M. tuberculosis, β-lactamase reporters should additionally work during intracellular 
growth.  β-lactam antibiotics do not normally accumulate in eukaryotic cells; however, antibiotics of this 
class freely diffuse in and out of host cells (44), and β-lactam antibiotics are used to treat some 
intracellular bacterial infections (33).  More specifically, β-lactams reach intracellular Staphylococcus 
aureus and Listeria monocytogenes and prevent growth of these organisms in THP-1 cells (1, 6).  Here 
we showed that ΔblaC M. tuberculosis in THP-1 cells was also susceptible to carbenicillin.  Thus, BlaC 
is responsible for M. tuberculosis resistance to β-lactam antibiotics during intracellular growth, 
indicating that the chromosomal blaC is a key factor preventing the use of β-lactams to treat M. 
tuberculosis infection. 
When the set of exported β-lactamase fusion proteins was tested for the ability to protect ΔblaC 
M. tuberculosis from β-lactam treatment during intracellular growth, all exported fusions conferred 
resistance.  In contrast, the truncated non-exported β-lactamase reporters were not protective.  These 
experiments demonstrated the effectiveness of both ‘BlaC and ‘BlaTEM-1 reporters to identify M. 
tuberculosis sequences that drive export of each reporter during growth within host cells.  Because the 
ssMpt83-‘BlaTEM-1 fusion was expressed from the native promoter, our results indicate that Mpt83, a 
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protein of unknown function, is expressed and exported during intracellular infection.  This result is 
consistent with the reported induction of mpt83 in macrophages (38) . 
Several approaches have described proteins exported by M. tuberculosis in vitro, but a different 
suite of proteins may be exported during infection of the host.  The intracellular β-lactamase reporter 
system we describe represents a new genetic tool for studying protein export in M. tuberculosis.  It can 
be used to directly test the intracellular export of a protein of interest.  We also hope to use it in 
combination with multiple rounds of infection and selection of β-lactam resistant clones from a M. 
tuberculosis fusion library.  This should serve to identify the most interesting category of proteins; 
namely, those that are exported during intracellular growth and missed by alternative methods. 
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CHAPTER 4 
 
 
 
Development of a reporter transposon to identify exported virulence factors in 
Mycobacterium tuberculosis  
 
Jessica R. McCann, Justin A. McDonough, and Miriam Braunstein 
 
 
 
 
Exported proteins are defined as those exposed on the bacterial cell surface or 
secreted into the environment.  Proteins exported by Mycobacterium tuberculosis (Mtb) 
are ideally situated to interact and interfere with host factors.  Our objective was to 
comprehensively identify Mtb exported proteins using a β-lactamase reporter for export, 
and then determine which of these proteins is important for virulence.  β-lactamase is an 
enzyme that cleaves β-lactam antibiotics, and it must be exported beyond the cytoplasm 
to confer antibiotic resistance.  We cloned the β-lactamase BlaTEM-1 lacking its native 
export signal sequence ('BlaTEM-1) into a transposon, which was then delivered into β-
lactam-sensitive ΔblaC M. tuberculosis.  Only those cells in which 'blaTEM-1 is inserted 
in-frame with a gene encoding an exported protein will produce an exported β-lactamase 
fusion leading to β-lactam resistance on agar plates.  Because the transposon inserts in 
the ORF, this strategy was used to identify exported proteins of Mtb and simultaneously 
generate a collection of mutants lacking individual exported proteins.  We tested each of 
the 118 unique mutants for growth defects in murine bone marrow derived macrophages.  
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We identified eight mutants with macrophage growth defects; four of these mutants are 
not previously shown to have defects in macrophages. Two mutants with intracellular 
growth defects were also tested in mice.  Our identification strategy provided 
experimental evidence of export for several uncategorized proteins in M. tuberculosis.  
Further, our approach succeeded in identifying mutants with defects in macrophage 
growth.  Further analysis of the exported proteins important for intracellular growth will 
lead to a better understanding of M. tuberculosis pathogenesis.  
 
INTRODUCTION 
 
 Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) disease, is a 
successful intracellular pathogen that causes nearly 2 million deaths each year (107).  To 
cause disease, M. tuberculosis must survive and replicate in macrophages in the lung 
within phagosomal compartments.  One of its survival strategies includes the prevention 
of normal phagosome acidification following uptake by macrophages (85, 106).   A 
common theme for bacterial pathogens is that factors required for virulence are often 
exported proteins (39).  This is not surprising, as exported proteins are ideally localized to 
interact and interfere with host factors that would normally protect against infection.  We 
are interested in defining the suite of exported proteins of M. tuberculosis, including 
those found on the surface of the bacterium or secreted into the extracellular 
environment.  In addition to playing important roles in pathogenesis, M. tuberculosis 
exported proteins are also commonly immunogenic.  Therefore, they are also potentially 
protective and/or diagnostic antigens (5, 47).  Given their potential for roles in virulence 
and immune responses, there has been a great deal of interest in proteins exported by M. 
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tuberculosis.  However, many of the exported proteins of M. tuberculosis are still not 
experimentally identified as such.   Further, even fewer exported proteins have been 
directly tested for roles in M. tuberculosis pathogenesis.  Finally, even for those exported 
proteins with proven roles in virulence not one has an experimentally defined function. 
Our first objective was to perform large-scale identification of exported M. 
tuberculosis proteins, and we planned to do this using a transposon that included a 
reporter for protein export.  A reporter enzyme fused to a protein of interest can inform 
on the subcellular location of that protein by following the activity of the reporter.  The 
use of export reporters is a classic approach to identify proteins that are located beyond 
the cytoplasmic membrane as well as to topologically map the extracellular portions of 
proteins with multiple transmembrane (TM) domains.   One export reporter that has been 
used extensively in bacteria is alkaline phosphatase, or PhoA (16, 58, 61, 99).  This 
enzyme is typically exported by the Sec pathway and it is enzymatically active only after 
transport beyond the cytoplasmic membrane.  Substrates of PhoA can be incorporated 
into agar plates and hydrolyzed by the active enzyme, producing a blue colony for those 
fusions that promote export of PhoA.  Thus, fusions to PhoA can be used in a phenotypic 
screen to report on protein export beyond the cytoplasmic membrane.   Transposon 
mutagenesis with a PhoA export reporter incorporated into the transposon (TnPhoA) has 
been successful in identifying exported virulence factors in several bacterial pathogens 
(97).  One striking example is its use in Vibrio cholerae, the causative agent of cholera.  
In this study, V. cholerae was mutagenized with TnPhoA and the resulting mutants were 
screened for blue colonies on plates impregnanted with the PhoA substrate.  The blue 
mutants have transposon insertions in ORFs encoding exported proteins.  These mutants 
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were then tested for their ability to cause disease in suckling mice.  In this manner, 
components of the cholera toxin co-regulated pilus, a major V. cholerae exported 
virulence factor, was discovered (97).   However, because M. tuberculosis has 
endogenous enzymes that cleave the PhoA substrate, PhoA cannot be used as a reporter 
for protein export directly in this pathogen.  
β-lactamase is another reporter for protein export that has been used previously in 
bacteria (17, 24, 75, 76, 94).  β-lactamase is an exported enzyme that protects the 
bacterial cell wall from attack by β-lactam antibiotics, and it must be exported beyond the 
cytoplasm to be effective (75).  The β-lactamase enzyme requires an N-terminal signal 
sequence for export.  When this signal sequence is removed, the enzyme remains 
cytoplasmic and does not protect against β-lactams (65, 75)  (Fig. 4.1).  Because M. 
tuberculosis is naturally resistant to β-lactams due to an endogenous β-lactamase (BlaC), 
β-lactamase reporters were not previously applicable to this pathogen.  However, with the 
recent construction of a β-lactam sensitive blaC mutant (40, 41) it became possible to 
employ β-lactamase reporters directly in M. tuberculosis.  We previously demonstrated 
that a non-native β-lactamase, BlaTEM-1 (29), works as an export reporter directly in 
ΔblaC M. tuberculosis (65).  Signal sequences derived from M. tuberculosis Tat- or Sec- 
exported proteins are both able to export a ‘BlaTEM-1 reporter lacking its own export 
signals.    
We cloned a truncated β-lactamase (‘blaTEM-1) lacking its own signal sequence 
into the mariner-based transposon Himar-1 (8, 56, 82), and inserted the reporter 
transposon into a non-essential region of the mycobacteriophage phAE159.  While 
genetic tools for the modification of the M. tuberculosis genome exist, they have been 
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slow to develop.  The organism is difficult to manipulate and not very competent for 
taking up foreign DNA. One tool at our disposal is the conditionally replicating shuttle 
phasmid phAE159 (13, 56).  Genetic constructs can be cloned into a non-essential region 
of the mycobacteriophage, which then efficiently delivers foreign DNA to M. 
tuberculosis.  
We delivered the transposon via mycobacteriophage infection of ΔblaC M. 
tuberculosis.  Transposition that placed ‘blaTEM-1 in frame with a gene encoding an 
exported M. tuberculosis protein resulted in production of an exported fusion protein and 
resistance to β-lactam antibiotics.  This strategy allowed us to identify exported proteins 
directly in virulent M. tuberculosis using a positive selection, not a screen.  Only those 
CFU expressing an exported ‘BlaTEM-1 fusion protein should be resistant to β-lactams 
on plates.  Because the transposon interrupts the ORF, nearly all the transposon mutants 
collected will lack the disrupted gene product. Thus, we were able to combine a positive 
selection for the identification of M. tuberculosis exported proteins with collection of M. 
tuberculosis mutants lacking these individual exported proteins.   
We planned to comprehensively identify the exported proteins of M. tuberculosis 
using our reporter transposon in a saturating mutagenesis strategy, and then determine 
which of these exported proteins is required for intracellular growth.  Saturating 
transposon mutagenesis is a powerful tool for making libraries of insertion mutants that 
can then be tested for phenotypes under different conditions.  Two such mutant libraries 
have previously been made in M. tuberculosis  (55, 77, 89).  The first transposon library  
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Figure 4.1.  ‘BlaTEM-1 must be exported beyond the cytoplasmic membrane to 
confer resistance to β-lactam antibiotics.  β-lactam antibiotics (circles) attack the 
growing cell wall of bacteria.  BlaTEM-1 lacking a signal sequence is trapped inside the 
bacterial cell, and cannot disarm the β-lactam.  Fusion of an export signal sequence to 
‘blaTEM-1 allows for export and results in resistance to β-lactam antibiotics. 
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was subjected to a technique called Transposon Site Hybridization (TraSH) to predict 
genes necessary for growth in macrophages or mice.  In this technique, mice or  
or macrophages are infected with libraries of transposon mutants.  Following infection, 
the strains present in the input pool are compared to strains present following infection 
based on microarray hybridization.  Mutants missing or underrepresented in the output 
pool are predicted to be attenuated (77, 89).  A second library was made in a similar 
manner, but selectively pre-screened for transposon insertions likely to interrupt function 
of the entire gene in question.  This strategy, called Designer Arrays for Defined Mutant 
Analysis, or DeADMAn, also evaluated pools of transposon mutants simultaneously for 
those attenuated in mice (55).   
A third transposon mutagenesis study conducted in the vaccine strain M. bovis 
bacille Calmette Guerin (BCG) complements the two saturating mutagenesis studies 
described above.  Pools of M. bovis BCG transposon mutants were evaluated for their 
ability to replicate in macrophages following three rounds of infection (92).  As in the 
TraSH and DeADMAn assays, mutants underrepresented in the outpoot pool by 
microarray hybdridazation are considered to be attenuated (92).   
When large pools of mutants are simultaneously evaluated, it is imperative that 
predictions be validated with careful follow-up experiments.  In addition, the use of 
mutant pools may mask phenotypes of attenuated strains due to trans-complementation 
by neighboring bacteria.  This is a particular concern for mutants that lack secreted 
virulence factors.  In addition, some phenotypes may be exaggerated due to competition 
between strains during co-infections.  Because exported proteins are good candidates for 
virulence factors, we hypothesized our library of mutants would be enriched for strains 
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with intracellular growth defects in macrophages.  Our second objective was to screen 
our library of mutants in macrophages to identify exported proteins that are required for 
M. tuberculosis to grow inside cells.  Each of our β-lactam resistant transposon mutants 
was screened for growth in murine derived bone marrow macrophages.   
Screening of our transposon mutant library complements these other genome-
wide strategies that test pools of mutants.  By screening mutants individually, there is 
more confidence in the experimental outcome.   Out of the 118 unique ORFS able to 
export β-lactamase fusions in M. tuberculosis, we identified 8 exported proteins that were 
required for growth in macrophages.  Four of these had not previously been implicated as 
important for intracellular growth in the approaches described above or any prior studies.   
Thus, our strategy was successful in identifying new exported virulence factors in M. 
tuberculosis.  In addition, only 25 out of 118 exported fusions we identified are in ORFs 
with a predicted function.  For many of the proteins we identified, their ability to promote 
export of ‘BlaTEM-1 is the first experimental evidence of their export.  Such proof of 
export will help to describe the function of many of these proteins.  
 
METHODS 
Bacterial strains and culture methods 
 
All bacterial strains and plasmids are listed in Table 4.1. M. tuberculosis strains 
were cultured in Middlebrook 7H9 or 7H10 supplemented with 0.5% glycerol, 0.05% 
tween and 1x ADS (0.5% bovine serum albumin, fraction V [Roche]; 0.2% dextrose; and 
0.85% NaCl).  When applicable, antibiotics were used at the following concentrations: 50 
µg/ml hygromycin (Roche), 20 µg/ml kanamycin (Acros Chemicals), and carbenicillin 
(Sigma) was used at 20 µg/ml for selection of library mutants or 50 µg/ml carbenicillin 
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for maintentance of control plasmids.  E. coli strains were grown in Luria-Bertani 
medium (LB, Fisher) supplemented with antibiotics when necessary as follows: 150 
µg/ml hygromycin, 40 µg/ml kanamycin, and 100 µg/ml carbenicillin.  
 
Construction of Tn’blaTEM-1 
 
Standard molecular biology techniques were used (87).  All plasmids are listed on 
Table 4.2.  Unless otherwise stated, all PCR reactions were done with the Expand Hi-
fidelity PCR kit (Roche) and 2-5% DMSO was included in all PCR reactions. All PCR 
products were verified by sequencing, and sequencing was done by Eton Bioscience, Inc. 
(San Diego, CA, and Research Triangle Park, NC) or the UNC-CH Automated DNA 
Sequencing Facility (Chapel Hill, NC).  The transposon Tn’blaTEM-1 was constructed as 
follows.  The blaTEM-1 gene was PCR amplified without its signal sequence (‘blaTEM-
1) from pJES102 (65) using primers XbaTem-1F (5’-
ATCTAGACCAGAAACGCCTGGTGAA-3’) and Spe1TemRev (5’-
GACTAGTGCTGGATCCGCAATTGTCTTGG-3’).  The resulting product was 
Spe1TemRev (5’-cloned into pCR2.1 (Invitrogen), creating pJES122.  pJES122 was 
digested with SpeI and XbaI to liberate a ‘blaTEM-1 fragment.  The plasmid pSH1 (Table 
4.2) (56) carries the Himar-1 transposon, as well as the mariner transposase (Tnpmar) 
and an E. coli oriE origin of replication.  Within the inverted repeats of Himar-1 are an 
oriR6K origin of replication and a hygromycin resistance gene.  The oriR6K origin 
allows for replication in λpir E. coli strains, and it facilitates recovery of genomic regions 
surrounding the transposon following insertion into the genome.  Our objective was to 
clone the truncated ‘blaTEM-1 directly downstream of the left inverted repeat at the 
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extreme end of the transposon.  To achieve this, pSH1 was digested with XbaI, resulting 
in a 2.1 kb fragment and a 3.1 kb fragment.  The 2.1 KB fragment was ligated to the 
‘blaTEM-1 
 
Table 4.1 Bacterial strains used in this study 
Strain Genotype Source 
H37Rv Mycobacterium tuberculosis virulent lab strain ATCC 
PM638 M. tuberculosis H37Rv ΔblaC (41) 
MBTB126 PM638::pJES137 This study 
 
 
 
Table 4.2 Plasmids used in this study 
Plasmid Genotype Description Source 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (65) 
pMV306.kan    
pJES102 aph Phsp60-‘blaTEM-1 (E. coli) 
oriM ColE1 
’blaTEM-1 from pCR2.1 cloned into pMV261.kan  (65) 
pSH1 TnHimar-1, oriR6Kg, HygR Shuttle vector carrying the Himar-1 transposon (56) 
pJES123 hygR oriR6K, ‘blaTEM- Intermediate cloning vector This study 
pJES124 hygR oriR6K, ColE1, aph, 
tn’blaTEM-1, TnpMar, λcos 
Shuttle vector carrying Tn’blaTEM-1 This study 
pJES137 hyg int attP ColE1 Phsp6 
‘blaTEM-1 
Integrating hyg marked vector with constitutively 
expressed‘BlaTEM-1  
This study 
 
fragment, resulting in pJES123 (Table 4.2).  This ligation abolished the XbaI site at the 3’ 
end of the ‘blaTEM-1 fragment and contained the hygromycin gene.  pJES123 was 
digested with XbaI and ligated to the 3.1 kb fragment of pSH1 containing the transpoase 
gene.  In this manner, ‘blaTEM-1 was cloned directly downstream of the left inverted 
repeat of the transposon in the final vector, pJES124 (Fig. 4.2).  
 
Construction of Tn’blaTEM-1 delivery phage 
The plasmid pJES124, carrying Tn’BlaTEM-1, was incorporated into 
mycobacteriophage phAE159 as previously described, with some modifications (13).  
phAE159 phasmid was purified using a standard alkaline lysis protocol (87).  Resulting 
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phasmid DNA was digested with PacI, and, following heat inactivation of the enzyme, 
ligated to PacI linearized pJES124 in a ligation µg ratio of 10:1 phage:vector.  The 
ligated phasmid was then packaged into λ phage heads via the λ cos sites present on 
pJES124 using the Max Plax kit (Epicentre).  The λ packaging step allows recovery of 
the newly ligated phasmid following transduction into E. coli. Phasmid DNA was then 
isolated from the resulting hygromycin resistant E. coli, and digested with PacI to ensure 
presence of pJES124.  Phasmid DNA encoding phAE159::tn’blaTEM-1 was then 
electroporated into M. smegmatis. Following electroporation, cells were recovered in 
growth medium for 30 min at 30°C, the permissive temperature for phage replication.  
Then, aliquots of electroporated cells were mixed with M. smegmatis grown to late 
exponential phase and added to top agar.  The top agar mixture was poured onto a solid 
agar, and incubated at 30°C for two to three days, at which point plaques were visible.  
From a single plaque, a high titer lysate of phAE159::tn’blaTEM-1 of at least 1010 plaque 
forming units (PFU) per ml was obtained.  
 
Transposon mutagenesis in M. tuberculosis.   
To create transposon mutants in M. tuberculosis, ΔblaC M. tuberculosis was 
grown to mid exponential phase, washed twice in MP buffer (50 mM Tris-Hcl, pH 7.6, 
150 mM NaCl, 10 mM MgCl2 and 2 mM CaCl2) to remove any residual tween detergent 
from the bacteria.  The mycobacteriophage lysate of 1x1010 was prepared and incubated 
with 109 washed ΔblaC M. tuberculosis to achieve a multiplicity of infection (MOI) of 10 
at 39°C for 6 hours with hourly inversion to mix.  The mixture was then plated on either 
7H10 hyg 50 µg/ml plates, to estimate the total number of transposition events, or 7H10 
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hyg 50 µg/ml carb 20 µg/ml, to select for transposition events that placed ‘BlaTEM-1 in 
the same reading frame as exported proteins.  Mock-infected bacteria were also plated to 
control for spontaneous carbenicillin resistance.  Individual carbenicillin CFU resulting 
from transposition were either patched or grown to mid-exponential phase in 7H9 broth 
supplemented with hygromycin and plated on 7H10 agar with hygromycin and also with 
and without carbenicillin to confirm β-lactam resistance. 
 
Genomic DNA purification and recovery of transposon insertions with flanking 
genomic sequence 
 CFU determined to be β-lactam resistant following transposition were grown to 
late-exponential phase in 7H9 hyg broth.  Cells from 3 ml of culture were spun down and 
the supernatant was discarded.  The remaining pellets were then lysed by vortexing with 
0.6 ml of a 3:1 mixture of chloroform-methanol.  The lysate was then mixed by vortexing 
with 0.6 ml of Tris-equilibrated phenol and then mixed by inversion with 0.9 ml of GTC 
solution (4 M guanidinium thiocyanate, 0.1 M Tris [pH 7.5], 0.5% sarcosyl, with β-
mercaptoethanol added to a final concentration of 1% prior to use). The upper phase was 
collected after centrifugation, and the genomic DNA was precipitated with an equal 
volume of isopropanol.   To determine the site of insertion for each transposon mutant, 
approximately 1 µg of genomic DNA was digested with BssHII and self-ligated.  E. coli 
DH5α λpir was transformed with 1 or 2 µl of each ligation, and plated on LB agar 
supplemented with hygromycin.  Plasmids were then purified from the resulting 
hygromycin resistant colonies, and M. tuberculosis genomic DNA flanking the 
transposon LIR was sequenced from a primer that hybridized to the complementary 
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strand of ‘blaTEM-1.  Resulting sequences were blasted against the M. tuberculosis 
genome for identification.  The predicted amino acid sequences of proteins identified as 
promoting export were analyzed by bioinformatic algorithms that predict export signal 
sequences: TMHMM (91), TopPred (25), TMPRED (46), SignalP (9), Psort (69), LipoP 
(49) and TatP (10). Southern blotting and hybridization were done as previously 
described (14).   
Macrophage Infections 
Macrophage infections were completed as described (54).  Briefly, bone marrow 
derived macrophages were obtained from 6-24 week old female BL/6 mice.  
Approximately 24 hours prior to infection, differentiated macrophages were seeded into 
8-well chamber slides at 2x105 cells/well.  Indicated M. tuberculosis strains were 
inoculated from freezer stocks grown to mid-exponential phase in 7H9 supplemented 
with hyg 50 ug/ml.  Bacteria were washed once in PBS 0.05% Tween 80, resuspended at 
1x106 CFU/ml in DMEM supplemented with 10% FBS, non-essential amino acids and L-
glutamine, and added to macrophages in chamber slides at an MOI of 1.  Macrophages 
were allowed a 4-hour uptake period, after which the infected cells were washed with 
warm DMEM 3 times.  A subset of wells were then lysed, diluted and plated on 7H10 
agar to determine uptake.  Remaining infected wells were lysed, diluted and plated 5 days 
post infection to determine intracellular bacterial growth. 
 
Animal Infections 
 Female 6-10 week old C57 BL/6 mice (Charles River) were used for aerosol 
infection studies.   Mice were maintained in hot-washed cages in a BSL-3 animal facility 
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and given food and water ad libitum.   The indicated M. tuberculosis strains were grown 
to mid-exponential phase, washed once and resuspended in phosphate-buffered saline 
(PBS) with 0.05% Tween 80 (PBS-Tw) to a concentration of 1.2 x 107 CFU/ml. The 
bacterial suspension was placed into the nebulizer jar of a whole-body exposure aerosol 
chamber (Mechanical Engineering Workshop, Madison, WI).  Mice were exposed for 15 
min with a chamber purge time of 20 min.  At specific time points, four mice were 
sacrificed from each group by CO2 asphyxiation.  At days 1 and 14, only lungs were 
removed and homogenized in PBS-Tw with x 0.1 mg/ml cycloheximide (Sigma).  At later 
time points, lungs, livers and spleens were removed and homogenized as described for 
lungs only above.  The homogenates were plated onto 7H10-ADS-glycerol plates with 
0.1 mg/ml cycloheximide to obtain CFU counts.  
  
RESULTS AND DISCUSSION 
Construction of Tn’blaTEM-1 
We previously established that the TEM-1 β-lactamase reporter (‘BlaTEM-1) can 
be exported when fused to M. tuberculosis Sec or Tat signal sequences, and it can be used 
directly in virulent M. tuberculosis (65).  Our objective was to combine this robust 
genetic reporter system, with transposon mutagenesis to comprehensively identify 
exported proteins of M. tuberculosis and collect M. tuberculosis mutants lacking these 
proteins.  It was imperative that the transposon we used have little site specificity for 
insertion, so that it could interrupt ORFs throughout the genome with as little bias as 
possible.  The mariner based Himar-1 transposon inserts at any TA dinucleotide 
sequence.  At least one TA sequence occurs in all but 16 out of the 3995 ORFS in the M. 
tuberculosis genome (20, 55).  Himar-1 is known to distribute randomly throughout the 
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M. tuberculosis chromosome and has been used in saturating transposon mutagenesis 
projects (55, 82, 88).  
 The Himar-1 transposon was encoded on pSH1 (Table 4.2).  Within the inverted 
repeats of the transposon, there is a hygromycin resistance gene and an oriR6K origin of 
replication.  This origin allowed us to later easily recover and sequence sites of 
transposon insertion in the M. tuberculosis genome.  The transposase on pSH1 is encoded 
outside of the transposon, which ensures that transposition is stable once the transposon 
inserts.  We cloned the TEM-1 β-lactamase lacking its own signal sequence (‘blaTEM-1) 
directly downstream of the left inverted repeat in Himar-1, resulting in plasmid pJES124 
(Fig. 4.2).  The cloning strategy was designed so that there is an open reading frame 
running through the inverted repeat and into the truncated β-lactamase reporter.   
β-lactamase hydrolyzes the β-lactam ring of β-lactam antibiotics, rendering them 
ineffective in disrupting the bacterial cell wall.  Therefore, in order to be protective 
against β-lactam antibiotics, β-lactamase must be exported to destroy the drug before it 
reaches its target (Fig. 4.1).  We created our transposon so that only those cells in which 
'blaTEM-1 is inserted in-frame with a gene encoding an exported protein will be resistant 
to β-lactam on agar plates due to the production of an exported M. tuberculosis protein-
‘BlaTEM-1 fusion.   In order to use the β-lactamase reporter, we also needed a β-lactam 
sensitive strain of M. tuberculosis.  M. tuberculosis is naturally resistant to β-lactam 
antibiotics due to export of its native β-lactamase blaC.  For this project, we used a β-
lactam sensitive ΔblaC mutant of M. tuberculosis as our background strain (41).    
Electroporation of foreign DNA into M. tuberculosis is highly inefficient; the best 
efficiencies achieved with electroporation are 104 CFU per µg of DNA (13).  Phage 
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transduction is a far more efficient way to transfer foreign DNA, such as transposons, to 
M. tuberculosis.  During phage infection, every bacterial cell present is likely to receive 
the phage genomic DNA.   We chose the TM4-derived temperature sensitive 
mycobacteriophage phAE159 as our transposon delivery system (8, 13, 56, 100).  The 
phage replicates and is lytic at the permissive temperature of 30ºC.  At 39ºC, it is able to 
translocate its DNA into mycobacteria but does not replicate (8, 13, 56).  This 
mycobacteriophage also has a large deletion in a non-essential region of its genome and 
can be engineered to carry and deliver a transposon.  We engineered the 
mycobacteriophage phAE159 to deliver our Tn’BlaTEM-1 transposon.  The plasmid 
pJES124, carrying Tn’BlaTEM-1, was linearized with PacI, and cloned into the PacI site 
of the phAE159 phasmid.  The ligated phasmid was then packaged into λ phage heads via 
the λ cos sites engineered onto pJES124 (Fig. 4.2).  The λ packaging step allows 
recovery of the newly ligated phasmid following transduction into E. coli.  We isolated 
phasmid DNA from the resulting hygromycin resistant E. coli, and electroporated it into 
M. smegmatis. Following electroporation, cells were recovered in growth medium for at 
30°C, the permissive temperature for phage replication.  Then, aliquots of electroporated 
cells were mixed with M. smegmatis grown to late log phase and added to top agar.  The 
top agar mixture was poured onto a solid agar, and incubated at 30 degrees for two to 
three days, at which point plaques were visible.  From a single plaque, a high titer lysate 
of phAE159::Tn’blaTEM-1 of 1010 plaque forming units (PFU) per ml was obtained.  
 
Construction of the Tn’blaTEM-1 mutant library in M. tuberculosis 
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Using an MOI of 10, ΔblaC M. tuberculosis was infected with the phage 
phAE159::Tn’blaTEM-1 at the non-permissive temperature of 39°C.  A fraction of each 
phage infection was plated on 7H10 plates with hygromycin and without carbenicillin, 
which allowed us to estimate the total number of transposon mutants obtained in each 
phage infection.  The average transposition efficiency was 10-6 hygromycin resistant  
CFU/total input CFU, which is consistent with published transposition efficiencies for a 
similar phage-delivered Himar-1 transposon in M. tuberculosis (59) (Table 4.3).  The 
remainder of each infection was plated on plates supplemented with both hygromycin and 
carbenicillin to select for the β-lactam resistant mutants.   The efficiency for obtaining β-
lactam resistant clones from transposition was much lower, on the order of 10-8 
carbenicillin resistant CFU/total input CFU.  All carbenicillin resistant colonies were 
rechecked by either plating for single colonies or patching on plates supplemented with 
hygromycin plus carbenicillin.  Following confirmation of carbenicillin resistance, 
genomic DNA was prepared from each mutant and digested with BssHII, an enzyme that 
does not cut within the transposon sequence.  The digested genomic DNA was then self-
ligated and transformed into the E. coli DH5α λpir strain.  This strain background 
allowed us to take advantage of the OriR6K origin of replication on the transposon and  
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Figure 4.2.  Map of transposon Tn’blaTEM-1. Signal sequence-less 'blaTEM-1 was 
cloned immediately downstream of the inverted repeat (LIR) on a Himar1-based mariner 
transposon on cosmid pSH1.  Tnpmar, mariner transposase; hygR: hygromycin resistance 
gene.  The cosmid was cloned into the genome of the temperature-sensitive (Ts) 
mycobacteriophage phAE159  (56) and packaged into Ts phage.  The codon sequence of 
the inverted repeat is shown in the same reading frame as the starting codons of 
‘BlaTEM-1.  
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recover hygromycin resistant plasmids carrying the transposon along with neighboring 
genomic sequence.  A sequencing primer was then used to sequence out from the  
transposon to identify the site of transposon insertion in the genome.  BLAST analysis to 
the genome of M. tuberculosis (1) was used to map the exact location of each transposon 
insertion (Supplemental Table 4.1, appended at the end of this Chapter). 
Our objective was to identify as many exported proteins in M. tuberculosis as was 
possible using the β-lactamase reporter.  At the start of the project, we calculated that 
evaluation of 80,000 transposon insertion mutants would give 95% probability that any 
given gene of 1 kb in length in the 4.4 Mb M. tuberculosis genome would be 
represented with at least one transposon insertion in the same reading frame as the 
respective gene.  This calculation was based on the following equation: N = [ln(1-P)/ln 
(1-f)] x 6 reading frames, where N = number of transposon insertion mutants required to 
achieve a probability of P that every ORF of a certain size is represented, and f = fraction 
of the genome represented by each 1 kb gene (87).  After 90 phage infections, 81,000 
transposon mutants had been plated onto the carbenicillin containing plates for the 
selection of transposon insertions in genes encoding exported proteins.  From this pool of 
transposon mutants, 179 colonies were obtained on carbenicillin plates and confirmed to 
be carbenicillin resistant.  Sequence analysis revealed that all 179 of these mutants 
possessed an in-frame fusion of an ORF to the β-lactamase reporter, which demonstrates 
the powerful specificity and selection provided by this reporter in M. tuberculosis.  Some 
ORFs were identified with the transposon more than once.  A total of 118 different ORFs 
were identified.  (Supplemental Table 4.1, appended to the end of this Chapter).  As 
expected from past studies with the Himar-1 transposon in M. tuberculosis, transposon 
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insertions were obtained throughout the genome (82, 88).  Southern blot analysis and 
evaluation of transposon sequences rescued from each mutant further indicated that the 
mutants had only a single transposon insertion (Fig. 4.3).  Interestingly, in 27 out of 37 
cases in which a gene was hit more than once with Tn’blaTEM-1 the insertions occurred 
at exactly the same site.  This occurrence was not due to siblings (amplification of a  
 
Table 4.3 Typical transposition efficienciesa 
CFU Input/ml PFU input/ml Hyg R CFUb Transposition 
efficiency 
Carb R CFU 
1x108 8x109 150 1.4x10-6 4 
8.6x108 3x1010 1320 1.5x10-6 18 
7.5x108 2x1010 470 6.3x10-7 2 
3.8x108 5x1010 340 8.9x10-7 2 
9x108 5x1010 1370 1.5x10-6 8 
                                 Average Transposition Efficiency: 1.2x10-6                  % carb R of total TN insertionsc: 0.9%  
aSample set of transposition efficiencies chosen from over 90 separate reactions to show range of 
results 
bTotal number of hygromycin resistant CFU estimated from samples plated for every phage 
infection  
cAverage percentage of carbenicillin resistant clones calculated from total number of estimated 
hygromycin resistant transposon mutants.  
 
 
mutant prior to plating), as nearly all of the examples of replicate insertions were 
recovered from independent phage infections. 
All 118 ORFs identified as able to export active ‘BlaTEM-1 fusions possessed 
predicted export signals, which are the likely explanation for export.   Using domain 
prediction algorithms we classified each ORF as either possessing a cleavable Sec signal 
sequence, a cleavable lipoprotein signal sequence, a cleavable Tat signal sequence, and/or 
a TM domain (Table 4.4, see materials and methods for algorithms used).  In M. 
tuberculosis, as in many other bacterial pathogens, there also exist unconventional 
exported proteins that lack obvious signals for export (2, 65, 80).  No proteins identified 
with the reporter transposon fell into this category.  Even though all 118 ORFs possessed 
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predicted export signals, for many of these proteins our identification of them with the β-
lactamase reporter transposon is the first experimental evidence they are exported by M. 
tuberculosis.  For 80% of the ORFs we identified there is no known or predicted 
function.  For these proteins in particular, their identification with the reporter transposon 
is significant in establishing a biological property.  This will be useful information for  
 
aTotal transposon mutants is approximated from plating a fraction of each transposition reaction on agar 
containing hygromycin only.   
bVirulent mycobacteria searched: M. leprae, M. bovis, M. ulcerans, and M. avium. 
cThis includes ORFs identified in genomic approaches for identifying virulence factors (19, 28, 55, 77, 89)  
and ORFs shown to be required by direct testing of mutants lacking the ORF in macrophages or  
mice.   
 
determining function of these unknown ORFs.  For integral membrane proteins, the site 
of active β-lactamase insertions provides additional information about protein topology 
since active insertions must be fused to domains localized on the extracytoplasmic side of 
the membrane.  A striking example of how topology mapping can be aided by our study 
comes from evaluating the sites of insertions in the MmpL4 protein.  MmpL4 is a 
polytopic membrane protein active that is predicted to have between 11-12 TM domains 
by bioinformatic algorithms.  Experimental evidence is critical to establishing the  
Table 4.4.  Description of M. tuberculosis Tn’blaTEM-1 transposon library  
No. total transposon mutantsa 81,000 
No. of confirmed carbenicillin resistant insertions sequenced 179 
No. of insertions in ORFs 179 
No. of insertions in-frame 179 
No. of unique ORFs identified 118 
No. of ORFs with Sec signal sequence 43 
No. of ORFs with Tat signal sequence 3 
No. of ORFs with transmembrane domains 72 
No. of ORFs predicted to be lipoproteins 14 
No. of ORFs with homologues only in mycobacteria 47 
No. of ORFs with homologues only in virulent mycobacteriab 17 
No. of ORFs with experimentally demonstrated function 8 
No. of ORFs reported to function in virulencec 28 
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Figure 4.3. Tn’blaTEM-1 inserts randomly throughout the M. tuberculosis genome. 
A)∆blaC M. tuberculosis was infected with phAE159:Tn’blaTEM-1, and 9 ß-lactam 
resistant clones (lanes 1-9) were randomly picked and grown to late exponential phase in 
7H9 supplemented  with  ADS,  glycerol  and   50 µg/ml hygromycin.  Genomic DNA 
was purified from each culture, digested with PstI and separated on a 0.8% agarose gel.  
Digested DNA was then transferred to a nylon membrane and hybridized to a probe 
specific to an internal portion of ‘blaTEM-1. B) Circularized map of the M. tuberculosis 
genome showing sites of Tn’blaTEM-1 insertions.  
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extracellular and intracellular domains of an integral membrane protein.  Different 
prediction programs often disagree on the number and location of potential TM domains 
and protein topology. The MmpL4 protein has a demonstrated role in M. tuberculosis 
virulence and has strong homology to bacterial transporters, but its substrate is unknown 
(34, 55, 74, 89).  We identified three Tn'blaTEM-1 insertions with enzymatic activity in 
the mmpL4 ORF.  By combining the sites of the active Tn’blaTEM-1 insertions with 
earlier data obtained using the alkaline phosphatase (PhoA) reporter in M. smegmatis 
to identify exported protein domains of MmpL4 (16), a total of seven extracytoplasmic 
sites can be delineated in this protein (Fig. 4.4). This experimental data enables 
development of a relatively refined topology map for this virulence factor of unknown 
function.  Interestingly, it is the two largest soluble domains of MmpL4 that are exposed 
on the external side of the membrane.  
Once we sequenced each transposon insertion in our collection of 180 mutants, 
we used a Poisson calculation to determine the probability that all exported proteins that 
could be identified with the β-lactamase reporter transposon had been identified.  This 
number was calculated using the following equation: f[0] = e –m, where f[0] represents the 
still mutable genes that have not yet been recovered, and m is the mean number of hits 
already recovered per gene (45).  This calculation predicted that, following selection from 
81,000 transposon mutants, 19% of future carbenicillin resistant CFU collected would 
still harbor transposon hits in new ORFs not yet identified in our strategy.  In fact, in our 
final infection two out of ten carbenicillin resistant mutants had the transposon inserted in 
new ORFs not identified earlier. Consequently, continued application of this approach is 
likely to identify more M. tuberculosis exported proteins. 
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Figure 4.4.  Topology map of MmpL4.  Transmembrane domains predicted by 
bioinformatic algorithms were combined with data gathered from Tn’blaTEM-1 insertion 
sites (triangles) and PhoA fusions [arrows, (16)] to generate a topological map of 
MmpL4.  Amino acid numbers indicate the beginning and end of each predicted 
transmembrane domain.  
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Our transposon reporter identification strategy has three significant attributes.  
The first is that our identification scheme relies on a positive selection – only those  
mutants with in-frame transposon insertions in ORFs leading to export of the ‘BlaTEM-1 
reporter will grow in the presence of the β-lactam carbenicillin.  The second is that this 
strategy identifies exported proteins directly in virulent M. tuberculosis, and not in a 
heterologous host expressing M. tuberculosis proteins.  The third is that the same β- 
lactam resistant transposon insertions that identify an exported protein most likely disrupt 
the function encoded by that exported protein. Therefore, at the same time as identifying 
exported proteins we are creating a library of mutants lacking individual exported 
proteins that can next be screened for any activity associated with exported proteins.    
 
Transposon insertion mutants with intracellular growth defects 
 One reason for our interest in identifying exported proteins of M. tuberculosis is 
that these proteins are prime candidates for being factors that interact and interfere with 
the host.  It is often the case that virulence factors in bacterial pathogens are exported 
proteins (39).  Since most transposon insertions will disrupt the function of an ORF, we 
hypothesized that our insertion mutant library is enriched for mutants lacking exported 
virulence factors.  Our collection of mapped transposon insertions can be used to find 
mutants with phenotypes, such as defects in virulence, that result from the absence of an 
exported protein.  Upon entry to the lung, M. tuberculosis replicates in alveolar 
macrophages, and this replication is required for the bacterium to cause disease (83).  The 
mechanisms employed by M. tuberculosis to survive and grow in the normally hostile 
macrophage environment are not well understood.  By screening our library of mutants 
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disrupted for exported proteins we proposed that we could identify new genes required 
for intracellular replication of M. tuberculosis.  
We screened our transposon insertion mutants for the ability to grow over 5 days 
in primary murine bone marrow derived macrophages.  Each mutant was tested 
separately in at least two independent experiments.  For ORFs that received multiple hits, 
the transposon mutant with the insertion earliest in the gene was tested as a representative 
mutant.  In each experiment, three independent wells of infected macrophages were 
assayed for each time point.  Macrophage uptake and fold growth over five days for each 
mutant was compared with that of M. tuberculosis MBTB126, a hygromycin resistant 
strain of ΔblaC M. tuberculosis that expresses the truncated ‘BlaTEM-1 on an integrating 
vector.  MBTB126 grew at the same rate and to the same level as WT M. tuberculosis in 
macrophages (data not shown).  Mutants that were significantly different from MBTB126 
in these initial screening assays were tested further.   Eight mutants proved to have 
reproducible and statistically significant intracellular growth defects: mce1A, mce1B, 
rv0199, mmpS5, mce2F, ctaC, ppsB and lppX  (Fig. 4.5).  Each of these eight mutants 
was   further evaluated in macrophage infections with added time points (Figs 4.6 - 4.8, 
4.10).  Of the genes disrupted in these eight insertion mutants, four (mce1A, mce1B, 
rv0199, and mmpS5) are previously implicated as having a role in promoting intracellular 
growth on the basis of TraSH analysis of an M. tuberculosis transposon mutant library in 
macrophages (77).  For the other four mutants (mce2F, ctaC, ppsB and lppX) there is no 
previous report of them being defective for intracellular growth in macrophages.  Thus, 
our screening of M. tuberculosis transposon mutants in macrophages successfully 
identified M. tuberculosis transposon mutants lacking exported ORFs with growth 
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defects in macrophages.  All eight mutants were tested for their ability to grow in broth 
culture, and none were defective when compared to MBTB126 (Fig. 4.10 and data not 
shown).   
For these eight exported proteins, only CtaC, PpsB and LppX have a predicted 
function.  For the other five, there is no available amino acid sequence similarity to 
inform on function.  Below, we summarize our data and the current state of knowledge 
about the disrupted genes and associated genomic locus for each of these eight mutants. 
 
Mce1A, Mce1B, Mce2F 
The first Mce protein (Mce1A) was discovered when an M. tuberculosis genomic library 
was transformed into Escherichia coli and DNA sequences that promote enhanced entry 
into non-phagocytic HeLa cells were selected (6).  Because of its identification as a 
protein able to confer cell invasion capability, it was named Mce for mycobacterial cell 
entry. When the genome sequence of M. tuberculosis was examined, it became apparent 
that mce1A is the third gene in an operon and that four separate mce operons (mce1-4) 
exist in the genome.  Each operon is composed of a suite of 8-13 similarly arranged genes 
that are demonstrated to be transcribed as a single polycistronic message (22, 52) (Fig. 6).  
Near the start of each operon, there are two ORFs with homology to YrbE, a predicted 
integral membrane protein with similarity to permease proteins of ATP binding cassette 
(ABC) transporters (21, 53, 98) .  In mce operons the yrbE pair is followed by six genes 
each encoding members of what is now referred as the Mce protein family (MceA-
MceF). The 24 Mce proteins in M. tuberculosis share similar domain structures and 
several conserved motifs. 
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Figure 4.5.  Average fold growth of M. tuberculosis Tn’blaTEM-1 mutants 
compared to that of MBTB126. Bone marrow derived macrophages were infected with 
the indicated strain.  At 4 hours (Day 0) and 5 days post infection, infected macrophages 
from triplicate samples were lysed and plated for intracellular bacilli.  The fold growth 
over five days was calculated for each strain and compared to that of MBTB126 for each 
respective experiment.  The error bars represent standard deviation of the mean for at 
least three independent experiments per strain. *, p ≤ 0.05. 
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Each Mce is predicted to be exported due to the presence of a single N-terminal signal 
sequence or TM domain (21, 60, 98).  Eight of the Mce proteins are predicted to be 
structurally similar to beta-barrel outer membrane proteins of bacteria (72).  The mce1, 3 
and 4 operons also possess homologous downstream ORFs, which have been referred to 
as Mce associated proteins (Mas) (21). Using the Tn’blaTEM-1 transposon we identified 
14 proteins of mce loci as being exported (Fig. 4.6).  For nine of these proteins, this 
represents the first experimental evidence they are exported and expressed by M. 
tuberculosis. 
We obtained active transposon insertions in three of the 4 mce operons (mce1, 
mce2, and mce4).  Within the mce1 operon, we recovered Tn’blaTEM-1 insertions in  
nearly every gene.  Interestingly, only the insertions in mce1A and mce1B resulted in 
macrophage growth defects when tested in our assay (Fig. 4.6).  However, in the TraSH 
screen for transposon mutants with intracellular growth defects, insertions in each of the 
genes spanning from mce1B to mce1F lead to underrepresentation in the output pool 
following macrophage infection (77).   In a separate study, an allelic exchange mutant 
that knocked out expression of the entire mce1 operon was constructed and directly tested 
in macrophages.  However, this mutant grew better than WT in cultured macrophages 
and was deemed hypervirulent (90).  With the exception of not seeing intracellular 
phenotypes for mutations in genes downstream of mce1B, our results agree with the 
TraSH analysis of pooled M. tuberculosis mutants in macrophages.  The disparity 
between phenotypes in these studies may be due to the nature of insertions in each of the 
genes and/or how downstream genes are affected in individual mutants.  Another possible 
explanation for the differences in experimental outcomes is that TraSH pooled infections  
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Figure 4.6.  Some M. tuberculosis mce::tn’blaTEM-1 mutants have growth defects in 
macrophages, while others do not.  A) Representation of the mce1, mce2 and mce4 
operons in M. tuberculosis H37Rv.  Black triangles indicate TnTEM insertions that 
resulted in macrophage growth defects.  Grey triangles mark TnTEM insertions that did 
not lead to attenuation. B-D) M. tuberculosis MBTB126 or B) mce1A::tn’blaTEM-1, C) 
mce1B tn’blaTEM-1, or D) mce2F::tn’blaTEM-1 were used to infect bone marrow 
derived macrophages.  At 4 hours (Day 0), 3 and 5 days post infection, macrophages 
were lysed and plated to enumerate intracellular bacteria.  Error bars indicate standard 
deviation of the mean. *, p≤0.05.  Each graph shows representative data from 4 
independent experiments. 
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are essentially competition assays.  Subtle defects may be exaggerated during co- 
infections; phenotypic defects may not be evident when mutants are examined 
individually.Our mutant with a Tn’blaTEM-1 insertion in mce2F was also attenuated for 
intracellular growth (Fig. 4.6). To our knowledge there is no prior demonstration of a role 
in macrophage growth for the mce2 operon.  In fact, unlike mce1, mce3, and mce4, 
expression of the mce2 operon has not previously been observed under any infection 
conditions tested (52).  The fact that we recovered an active Tn’blaTEM-1 insertion in 
mce2F indicates that in our plate-grown M. tuberculosis this gene is expressed.  
Moreover, the intracellular growth phenotype we observed for the Tn’blaTEM-1 
insertion mutant in mce2F not only indicates the importance of Mce2 to growth 
inmacrophages but (Fig. 4.6D) also indicates Mce2F expression by M. tuberculosis 
during intracellular growth.  
Unlike our results of testing downstream mutations in mce1¸ in mce2 the 
attenuated mutant we obtained has a transposon insertion in the last gene in the mce 
operon.  Because the mce2F gene is the final gene in the mce2 operon, it is unlikely that 
the phenotype we observed for this Tn’blaTEM-1 mutant is due to polar effects on 
downstream genes.  Nonetheless, complementation experiments are still necessary to 
establish with certainty that the mutant phenotype of the mce2F transposon mutant is due 
to the insertion in mce2F.  Such complementation experiments are currently underway.  
We also recovered several insertion mutants throughout the mce4 operon (Fig. 4.6).  
However, none of these resulted in growth phenotypes in macrophages.  The same was 
true in the TraSH in macrophages analysis of mce4, in that none were reproducibly 
underrepresented following macrophage infections with pools of mutants (77).  
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 The role of the mce operons in M. tuberculosis remains unclear.  As mentioned 
above, there might be a role in bacterial uptake by host cells.  Mce1A facilitates uptake of 
latex beads by HeLa cells (6).   Notably, Mce proteins Mce3A and Mce4A also promote 
uptake of coated beads or recombinant E. coli by HeLa cells (38, 86), but Mce2A does 
not.  However, in respect to a potential role in cell entry it is noteworthy that in 
macrophage and in mouse studies with various mce mutants there is no suggestion Mce 
functions in initial infection or macrophage uptake (48, 90).  We also did not see any 
differences between MBTB126 and the various mce::tn’blaTEM-1 mutants when 
comparing macrophage uptake of each strain.  However, it remains a possibility that 
redundancy between mce operons is masking phenotypes of individual mutants.   
The presence of two putative ABC transporter permeases in each operon has led to a 
separate hypothesis that each mce operon encodes an ABC transporter apparatus (21, 48, 
98).  ABC transporters are protein complexes that function in the import or export of a 
wide-variety of molecules across membranes (12).  ABC transporters sometimes rely on 
surface-localized substrate binding proteins to import substances.  Interestingly, Mce 
proteins share homology with substrate binding domains of proteins involved in ABC 
transport (21, 53).    
It is possible that the Mce proteins work together to transport lipids (21, 105).  A 
study that described a screen for genes that interact with mce family members identified 
many genes with predicted functions in lipid transport or modification as potential 
interactors (48).  Additionally, the mce1 operon includes an ORF encoding FadD5, a 
protein with homology to fatty acid synthases.  Further suggestion that Mce proteins may 
have a lipid related function comes from experiments performed with Rhodococcus, a 
 128 
soil actinomycete related to M. tuberculosis.  In a study of cholesterol catabolism in 
Rhodoccocus a region of the genome that shares homology with genes in M. tuberculosis 
mce4 was identified (105).  When the Rhodococcus mce4 homologs are deleted, the 
mutant strain is no longer able to grow on cholesterol indicating a function in cholesterol 
transport or catabolism (68, 105).  Thus, it is tempting to speculate that the role of at least 
mce4 in M. tuberculosis may be in cholesterol uptake.  Cholesterol is important for 
phagocytosis of mycobacteria and inhibition of phagosome maturation (31, 42, 73). 
 
 
Rv0199  
 Considered to be a “core mycobacterial gene” (63), Rv0199 is found in all 
Mycobacterium genomes sequenced thus far, but virtually nowhere else.  While there is 
very little homology to inform on its function, it is interesting to note that Rv0199 is 41% 
similar to the mce-associated protein Rv1972 encoded at the end of the mce3 operon.   
The protein encoded by Rv0199 is predicted to have a single TM domain 
proximal to the N-terminus of the protein (AA 42-64), indicating that the majority of the 
protein is located in the cell envelope.  The Tn’blaTEM-1 insertion is in the middle of the 
ORF (Fig. 4.7A).  Consistent with our demonstration that an in-frame insertion of 
Tn’blaTEM-1 in Rv0199 resulted in a macrophage growth defect (Fig. 4.7B), this ORF 
was predicted to play a role in virulence by two independent screens for mutants 
attenuated for growth in mice and macrophages.  The first was the TraSH analysis of M. 
tuberculosis mutants in mice that showed a Rv0199 transposon mutant is 
underrepresented in output pools following infection (89).  The second was screening of 
pooled M. bovis BCG transposon mutants for attenuated phenotypes in cultured  
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Figure 4.7.  M. tuberculosis rv0199::tn’blaTEM-1 has a growth defect in 
macrophages  A) Organization of genes surrounding Tn’blaTEM-1 insertion (triangle) in 
Rv0199.  B) Macrophages were infected with rv0199::tn’blaTEM-1, and intracellular 
growth of bacilli was monitored at the time points indicated as described for Fig. 4.6.  
Error bars indicated standard deviation of the mean.  Graph shows representative data 
from 7 experiments. *, p ≤0.01 
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macrophages.  This screen identified transposon mutants in genes surrounding and 
including Rv0199 as underrepresented in mutant pools grown in macrophages over 72 
hours (92).  Because this region, spanning from Rv0199 to  Rv0208c, codes for several 
predicted membrane proteins that are involved in pathogenesis, it was renamed the 
virulence associated membrane protein region, or VAMP (92) for intracellular growth 
following macrophage infection with transposon mutant pools (77).  In comparison to 
other studies, our study is the first to test a transposon mutation in rv0199 on an 
individual basis.   We can not rule out the possibility that the macrophage growth defect 
we observed for rv0199::tn’blaTEM-1 is due to polar effects on downstream genes.  The 
stop codon for Rv0199 overlaps the start codon of Rv0200, another ORF with no 
homology to any gene outside of mycobacteria.  Rv0200 is also implicated as important 
for growth in macrophages in pooled infections (92) (Fig. 4.7A).  The potential virulence 
roles for the genes surrounding rv0199, as well as the likelihood that Rv0199 is co-
transcribed with its downstream neighbor, make it imperative that we perform 
complementation assays to determine if the lack of rv0199 function is indeed the cause of 
the macrophage growth phenotype.   
   
MmpS5  
M. tuberculosis encodes several mycobacterial membrane proteins, a protein 
family restricted to mycobacteria and a few closely related genera.  Members of the Mmp 
family are divided into two groups – small, or MmpS, and large, or MmpL.  MmpS5 
(Rv0677c) is one of four MmpS proteins in the M. tuberculosis genome.  Each MmpS 
protein is small, approximately 140 amino acids in length, and shares 59-70% similarity  
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Figure 4.8.  M. tuberculosis mmpS5::tn’blaTEM-1 has a growth defect in 
macrophages, but a  mmpL5 ::tn’blaTEM-1 insertion mutant does not.  A) Relative 
location of mmpS5 in the M. tuberculosis H37Rv genome.  The black triangle indicates a 
Tn’blaTEM-1 insertion that resulted in a macrophage growth defect, and the grey 
arrowhead indicates a Tn’blaTEM-1 insertion that did not lead to attenuation. B) Bone 
marrow derived macrophages were infected as described for Fig 4.6.  Error bars represent 
standard deviation of the mean.  *, p=0.01.  The graph shows representative data from 
one of five independent experiments.  
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with the other MmpS family members. Repeated testing of our mmpS5::Tn’blaTEM-1 
mutant in murine bone marrow macrophages revealed an intracellular growth defect (Fig. 
4.8). While its name implies that it is a membrane protein, our bioinformatic analysis 
revealed a cleavable signal sequence, as opposed to a TM domain at the beginning of 
MmpS5.  The probability that MmpS5 has a signal peptide is 0.921, well above the 
threshold value of 0.5 for the prediction algorithm (9).  Further, MmpS5 was identified as 
a protein secreted into the culture filtrate of M. tuberculosis (60).  Thus, MmpS5 may be 
mislabeled as a membrane protein, but not necessarily misannotated as an MmpS protein 
due to its strong homology with the three other MmpS family members in M. 
tuberculosis.  
No direct investigation of function or role in virulence has been conducted for any 
of the MmpS proteins.  However, in all cases the mmpS genes are placed directly 
upstream of genes that code for MmpL proteins.  Therefore, it is likely that each mmpS-L 
pair is co-transcribed, although co-transcription has not been experimentally shown.  It is 
hypothesized that the functions of MmpS and MmpL proteins are linked.  Beyond screens 
for phenotypes in pools of transposon mutants (55, 77, 89), there have been further direct 
studies of MmpL proteins, but not of MmpS proteins, in pathogenesis (34).   
MmpL proteins are predicted to be part of the Resistance, Nodulation and 
Division (RND) family of molecules.  MmpL proteins typically have 12 TM domains 
with two large domains predicted to reside on the extracytoplasmic face of the bacterial 
membrane.  This predicted toplogy is supported by the sites of insertion we identified for 
‘BlaTEM-1 and TnPhoA reporters in MmpL4 (16), Fig. 4.4).  In other bacteria, some 
RND family members function as efflux pumps (74, 104).  The best-characterized efflux 
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pumps of the RND family are in Gram-negative bacteria, and usually rely on cooperative 
function of an associated outer membrane canal protein (OMP) and a membrane fusion 
protein (MFP). One example of such a complex is the AcrA-AcrB-TolC efflux system in 
E. coli.  AcrB is the RND family member and an integral membrane protein.  AcrA acts 
as the MFP, and is found in the periplasm.  The OMP is TolC, which is an outer 
membrane protein. The coordinated action of the RND pump with the MFP and OMP 
proteins allows the pump to expel compounds directly to the outside of the bacterial cell, 
bypassing the periplasmic space (37, 74).  It has been suggested that members of the 
MmpL family share similarity with the AcrB transporter protein (33, 34). In E. coli, AcrA 
(the MFP) stimulates the activity of the AcrB pump  (3, 70).  One possibility for a 
function of the MmpS proteins is a role in activation of MmpL pumps.  However, at this 
time such a function is pure speculation as there is little sequence homology between 
MmpS proteins and the activating proteins of Gram-negative pumps.    
There are 12 MmpL proteins in M. tuberculosis H37Rv.  Insertional inactivation 
of 11 of these showed that 4 are required for pathogenesis in mice, while MmpL3 is 
predicted to be essential for in vitro growth, as attempts to inactivate it have been 
unsuccessful (34, 88).  Some mmpL genes, as is the case for mmpL7 and mmpL8, are 
surrounded by lipid synthesis and export genes, so it was predicted that these MmpL 
proteins are involved in transport of lipids beyond the cytoplasm.  This turns out to be 
true.  MmpL7 is required for export of phthiocercol dimycocersosate (PDIM) and 
MmpL8 is required for export of the sulfolipid SL-1 (19, 27, 28, 35).  Unfortunately, 
these studies do not shed light on the function of MmpS proteins in M. tuberculosis.  
Neither MmpL7 nor MmpL8 are associated with an MmpS protein counterpart.  If the 
 134 
functions of MmpS and MmpL are indeed coupled for transport or efflux, the four MmpS 
proteins may work with more than one of the 12 different MmpL transporters in M. 
tuberculosis.  We recovered Tn’blaTEM-1 insertions in mmpL1, mmpL4, mmpS2, 
mmpS5, mmpL5 and mmpL9 (Supplemental Table 4.1, Fig. 4.4), but, aside from 
mmpS5::tn’blaTEM-1, none of these led to a significant growth defect in macrophages.  
A recent study suggests a possible efflux function for MmpS5.  While testing the 
potential use of azoles in treatment of mycobacteria, it was shown that mmpS5 and 
mmpL5 may code for a complex that contributes to azole resistance.  Strains 
spontaneously resistant to azole drug over-express mmpS5 and mmpL5 (67). It is not yet 
tested whether M. tuberculosis strains that lack MmpS5 and/or MmpL5 are more 
sensitive to killing by azoles.   
Until we perform complementation, it remains possible that the insertion in 
mmpS5 is having polar effects on the expression of mmpL5, as the coding sequences of 
the two genes overlap.  However, a transposon inserted in the mmpL5 gene that truncated 
its final 508 amino acids did not result in an intracellular growth phenotype for this 
mutant, which argues against this possibility (Fig. 8A).  It is still necessary to perform 
complementation experiments for mmpS5::tn’blaTEM-1 and these experiments are in 
progress.  
 
CtaC  
Like other bacteria, mycobacteria produce energy by establishing a proton 
gradient across the cytoplasmic membrane.  This gradient is generated as electrons flow 
down the electron transport chain (ETC).  Electrons released from an initial donor pass  
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Figure 4.9.  Location of ctaC::tn’blaTEM-1 insertion, and predicted topology of 
CtaC.  A) The relative location of ctaC in the M. tuberculosis genome is shown.  The 
black triangle indicates the site of Tn’blaTEM-1 insertion.  B) Membrane topology of 
CtaC as predicted by the TMHMM algorithm (91).  The site of ‘BlaTEM-1 fusion is 
indicated with a triangle.   
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through a series of alternating oxidized and reduced flavoproteins, quinones and 
cytochromes.  This process terminates, in the case of aerobic respiration, in the reduction 
of O2 to H2O.  During this process, protons are transported to the extracytoplasmic side of 
the membrane, establishing an energy gradient that can be harnessed for the generation of 
ATP.  In silico analyses suggest that mycobacteria contain multiple terminal respiratory 
oxidases, one of which is the four-subunit cytochrome c oxidase complex responsible for 
catalyzing the reduction of oxygen when O2 is sufficiently available (50, 66, 78). 
The ctaC gene encodes the membrane bound subunit II of the cytochrome c 
oxidase.  It has three predicted TM domains (91), one of which resides in a possible 
cleaved export signal sequence in the N-terminus (9).  CtaC protein is found in culture 
filtrate, despite the strongly predicted TM domains, indicating that some protein is shed 
into the medium during in vitro growth (60).  We can combine the information provided 
by TM and signal sequence prediction algorithms with the sites of our active 
Tn’blaTEM-1 insertions to predict the protein topology of CtaC.  We predict that the N-
terminus is on the cytoplasmic side of the membrane followed by three TM domains (Fig. 
4.9B).  The cytochrome oxidase domain is predicted to span from AA 116 to AA 322. 
Therefore the active domain of CtaC is beyond the extracyotoplasmic face of the 
membrane, and its orientation is similar to that predicted for Bacillus subtilis CtaC (11). 
 CtaC is predicted to be essential in M. tuberculosis H37Rv and an attempt to 
delete the gene is M. tuberculosis is reported to have been unsuccessful (64, 88).  It is 
likely that we were able to obtain our Tn’blaTEM-1 insertion in ctaC because the 
majority of the functional protein remains unaltered.  Our insertion is in the extreme C- 
 
 137 
 
 
 
 
Figure 4.10. M. tuberculosis ctaC::tn’blaTEM-1  has a growth defect in macrophages 
but not in broth culture, and has a colony phenotype on agar plates. A) Macrophage 
infection done as described for Fig. 6.  Error bars indicate standard deviation of the mean.  
*, p = 0.02.  Graph shows representative data from three independent experiments. B) M. 
tuberculosis MBTB126 or ctaC::tn’blaTEM-1 were inoculated to OD 0.1 in 7H9 
supplemented with ADS, glycerol, tween and hygromycin.  Growth of triplicate cultures 
of each strain was monitored by optical density at OD600 for the time period indicated.  
Graph shows representative data from five independent experiments. C) M. tuberculosis 
MBTB126 or ctaC::tn’blaTEM-1 were grown to mid-exponential phase in 7H9 and 
spread on 7H10 agar plates.  Colonies were examined after an incubation period of 25 
days at 37º. 
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terminus of the protein and would truncate the final 13 amino acids.  This insertion 
mutant had a reproducible growth defect in macrophages in our experiments (Fig 4.10A). 
Unlike the attempts made in M. tuberculosis, a ctaC mutation in the non-
pathogenic M. smegmatis is viable, although the mutant has a growth defect in 7H9 
medium (64).  To ensure that the macrophage growth defect we observed was not simply 
due to a lack of overall fitness, we compared the growth rate of the ctaC::tnTEM-1 
mutant strain to MBTB126 and saw no difference (Fig. 4.10B).  A colony phenotype was 
also observed for the ctaC::tn’blaTEM-1 mutation when grown on 7H10 agar 
supplemented with tween.  While the MBTB126 CFU were compact and slightly rough 
around the edges, the ctaC::tn’blaTEM-1 mutant CFU were very rough, spread out and 
varied in size (Fig. 4.10C).  
As mentioned above, we observed that our ctaC::tn’blaTEM-1 mutant had an 
intracellular growth defect when compared to MBTB126.  One explanation for this 
phenotype is that the decreased intracellular growth of the ctaC::tn’blaTEM-1 mutant 
results from compromised CtaC activity and reduced establishment of a membrane 
potential for the generation of ATP.  Another possibility is that the intracellular growth 
defect of ctaC::tn’blaTEM-1 may be caused by polar effects of this mutation, and not the 
insertion in ctaC itself (Fig. 4.9A).   The ctaF gene is directly downstream of ctaC.   CtaF 
shares high homology with cytochrome c subunit proteins in other mycobacteria and 
Rhodococcus, and is highly likely to be co-transcribed with ctaC because its translational 
start codon is only 7 nucleotides from the translational stop of ctaC (1, 4, 26).  It is 
possible that CtaF works in concert with CtaC and contributes to the structure of the 
multi-subunit cytochrome c oxidase in mycobacteria, or it may function in another 
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capacity.  Complementation experiments that restore CtaC expression to the 
ctaC::tn’blaTEM-1 mutant are required to make any meaningful conclusions about the 
role of CtaC in M. tuberculosis intracellular growth.  
 
PpsB, DrrC and LppX  
Pathogenic mycobacteria have unusually thick cell envelopes composed of unique 
lipids (51).  One of these unique outermost surface lipids is phthiocerol dimycocerosate 
(PDIM) (7, 71).  In numerous studies, M. tuberculosis mutants that do not make or do not 
properly localize PDIM to the outer surface of the bacterium are attenuated for virulence.  
The majority of the genes responsible for synthesizing, modifying and exporting PDIM in 
M. tuberculosis are found in neighboring clusters in the genome.   PpsA-E are encoded 
within a single poly-cistronic message that starts with fadD26 (Rv2930), continues with 
the drrABC locus and ends with papA5 (18, 26). The next gene in the PDIM genomic 
region codes for mycocerosic acid synthase (mas), which is followed by the co-
transcribed fadD28 and mmpL7 genes (18). The final gene in the PDIM cluster encodes 
the lipoprotein LppX (Fig. 4.11A).  
We identified three carbenicillin resistant clones with Tn’blaTEM-1 insertions in 
genes known to be required for PDIM synthesis or localization: ppsB, drrC and lppX. 
(18, 19, 28)  (Fig. 4.11A).  Both the ppsB and lppX Tn’blaTEM-1 insertion mutants 
showed intracellular defects when compared to MBTB126 (Fig. 4.11).  To our 
knowledge, this is the first direct testing of ppsB or lppX mutants for intracellular growth 
in macrophages.  Further, TraSH did not predict them to be important for growth in 
macrophages (77).  A published insertion mutant in the third gene that codes for the 6-
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transmembrane domain protein DrrC, was previously tested and reported to be defective 
for growth in macrophages (18).  However, our drrC::tn’blaTEM-1 mutant, with an 
insertion truncating the protein at amino acid 57 (Supplemental Table 4.1) showed no 
growth defect in macrophages in 4 independent experiments (Fig. 4.11D).  Differences in 
M. tuberculosis strain backgrounds or macrophage assays may have led to the 
discrepancy between our observed data and published results.  
We have clues to the function of most of the gene products encoded in the PDIM 
region (44).  Each Pps protein is a type I modular polyketide synthases responsible for 
turning C18+ fatty acids generated by fatty acid synthase I into phthiocerol, the precursor 
to the M. tuberculosis PDIM.  PpsA-E take the fatty acid initially activated and supplied 
by FadD26 (102, 103) and elongate it by adding saturated alkyl groups in a stepwise 
manner.  PpsE makes the final modification, which serves to complete the synthesis of 
phthiocerol (18, 103).  In the meantime, Mas generates mycocerosic acids from modified 
C12-C18 fatty acids (7, 103).  These mycocerosic acids become linked to the Pps-modified 
acyl chains of phthiocerol, resulting in phthiocerol dimycocersosate (PDIM),and PapA5 
is an acyltransferase that is responsible for this linkage (71, 103).   
Once the complex lipids are constructed, DrrC, MmpL7 and LppX are required 
for proper transport of PDIM across the cytoplasmic membrane to its final destination at 
the bacterial surface.  DrrABC are predicted to form an ATP-binding cassette (ABC) type 
of transporter (30), where DrrA is thought to be the ATP binding component and DrrB or 
DrrC is the likely integral membrane protein that transports substrates beyond the 
cytoplasmic membrane.  A DrrC insertion mutant is able to make PDIM, but unable to  
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Figure 4.11.  M. tuberculosis ppsB::tn’blaTEM-1 and lppX::tn’blaTEM-1 have 
intracellular growth defects, but the drrC::tn’blaTEM-1 mutant does not. A) 
Representation of insertions in the PDIM production and transport locus of M. 
tuberculosis. Black arrowheads represent Tn’blaTEM-1 insertions that resulted in 
attenuation in macrophages.  The gray arrowhead indicates a Tn’blaTEM-1 insertion that 
did not lead to attenuation. Rv2943-2944 encode for potential transposase genes from an 
insertion element. Rv2943a possibly contains a frame-shift mutation.  B-D) Murine bone 
marrow-derived macrophages infected with M. tuberculosis MBTB126 or B) 
ppsB:tn’blaTEM-1, C) lppX::tn’blaTEM-1, or D) drrC::tn’blaTEM-1. Infections were 
done as described in Fig. 4.6.  Error bars indicate standard deviation of the mean.  *, p 
<0.01. Each graph shows representative data from one of 3 or 4 independent replicates.    
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properly localize it to the cell wall (18).  The polytopic MmpL7 membrane protein is also 
required for export of PDIM to the cell wall. An insertion mutant in mmpL7 makes 
PDIM but does not localize it to the cell surface  (18, 28).  Finally, the lipoprotein LppX 
is responsible for the localization of PDIM to the outermost bacterial surface (57, 60, 93).  
When the PDIM molecules of lppX mutants were examined, they are unaltered when 
compared to PDIM extracts obtained from WT M. tuberculosis.  However, it was 
discovered that, unlike WT bacteria, the lppX insertion mutant does not shed PDIM 
molecules into the culture medium (93).  The LppX crystral structure revealed that this 
mycobacterial protein resembles E. coli proteins LolA and LolB, both of which are 
required for localization of lipoproteins at the outer membrane (93, 95, 96).  LolA is 
active in the periplasm of E. coli, acting as a chaperone to transfer lipoproteins to the 
outer membrane lipoprotein localization factor LolB (101).  The predicted structures of 
LppX, LolA and LolB share a hydrophobic cavity where lipids are predicted to bind.  
C16-C18 fatty acids do bind to purified LppX, and virtual modeling demonstrates that the 
hydrophobic cavity is the appropriate size to accommodate a PDIM molecule (93).  
The active Tn’blaTEM-1 insertion we identified in ppsB serves to demonstrate 
that PpsB is an exported protein.  To our knowledge, this is the first evidence of PpsB 
being an exported protein in M. tuberculosis.  TM domain prediction servers differ on the 
existence and number (0-6) of TM domains PpsB contains (46, 91). In a large-scale 
proteomics study, PpsE is reported in the membrane fraction of M. tuberculosis (108).   
As for PpsB, our bioinformatic analysis of the PpsE amino acid sequence predicted 0-5 
transmembrane segments (46, 91).  The ppsB::tn’blaTEM-1 mutant carries an insertion 
following AA 613.  This site of insertion is at the beginning of the predicted acyl 
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transferase domain of the protein that is likely responsible for covalently acylating fatty 
acids extended initially by PpsA (103).  The ß-lactam resistance resulting from our 
Tn’blaTEM-1 insertion in ppsB indicates that at least a small relative portion of the 
predicted acyl transferase domain faces the extracytoplasmic face of the bacterial 
membrane.  
While we are the first to report that lppX and ppsB transposon mutants exhibited 
intracellular growth defects, these results were not surprising.  It is well established that 
mutants with defects in PDIM synthesis or transport are attenuated for virulence.  
Examination of other data surrounding the host reaction to infection with PDIM-less 
mutants gives clues as to why these mutants are defective for intracellular growth.   
Insertions in fadD26, mmpL7, or drrC all result in attenuation when compared to the 
intracellular growth of WT bacteria (19, 81).   M. tuberculosis mutants that lack PDIM 
are more sensitive than WT to RNI and SDS in vitro, suggesting that the PDIM outer 
layer may act as a permeability barrier for the bacterium (18).  Another aspect of PDIM’s 
role in pathogenesis is its interaction with host innate immune response elements.  The 
PDIM-less mutants induce more production of the pro-inflammatory cytokines TNFα 
and IL-6 than WT M. tuberculosis in infected macrophages.  This was true for both the 
fadD26 and mmpL7 insertion mutants, indicating that having PDIM and having it 
properly localized are equally important for dampening a pro-inflammatory response 
(81).  It is possible that the intracellular and in vivo growth defects of PDIM mutants 
stem from the inability to dampen the immune response and adequately resist RNI or 
other stresses produced by macrophages.  
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Whole animal aerosol infections with Tn’blaTEM-1 mutant strains  
 
 Mice are often used as a model system for tuberculosis disease.  Following 
inhalation of 100-200 M. tuberculosis bacilli into the lungs, one of the first events 
observed is bacterial replication in lung alveolar macrophages.   Rapid growth and 
dissemination of the bacteria occurs 14 - 21 days following infection, at which point, the 
adaptive immune system curtails further growth.  Lymphocytes that specifically 
recognize the bacteria sequester intracellular M. tuberculosis in granuloma-like lesions, 
and bacterial populations persist at a steady state.  Mouse strains that are relatively 
resistant to infection, including the C57BL/6 mice used in our studies, typically succumb 
to disease between 150 and 200 days post infection (15, 43).   
M. tuberculosis must be taken up by and replicate in lung macrophages to 
establish infection following aerosol exposure.  For this reason, we hypothesized that our 
Tn’blaTEM-1 mutants with macrophage growth defects would also be defective in a 
whole-animal model of tuberculosis infection.  For two of our eight mutants, the process 
of testing them in a mouse model of tuberculosis infection has begun but is not yet 
complete.  The mutants chosen for the initial evaluation have transposon insertions in 
mmps5 or ppsB.  These mutants were chosen, in part, because there is no prior direct 
testing in mice of M. tuberculosis mutants with mutations in these genes.  Each of the 
strains was delivered by aerosol to C57BL6 mice.  One day post-aerosol infection, four 
mice from each infected group were euthanized.  The lungs of the sacrificed animals 
were homogenized and plated to recover viable CFU to measure the initial dose of 
bacteria received.  At later time points, the bacterial burden in lungs, liver, and spleen 
was determined in groups of animals.  This allowed growth and dissemination of M. 
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tuberculosis to be followed throughout the course of each infection.  Long-term survival 
in sets of animals was also followed.  In these animal experiments, mice were infected in 
parallel with MBTB126, which was used as the parental control strain, for comparison.    
MmpS5 
 Mice infected in parallel with the mmpS5::Tn’blaTEM-1 mutant or MBTB126 
were evaluated for bacterial burden in organs over time and for length of long-term 
survival.  No differences were observed in the growth or persistence of the mmps5 mutant 
in lungs at multiple time points post-infection (Fig. 4.12A).  There was also no difference 
observed in the ability of the mmps5 mutant to disseminate to liver and spleen or to grow 
in these organs over time (data not shown).  Furthermore, there was no difference in the 
length of survival of animals infected with the mmpS5::Tn’blaTEM-1 mutant versus 
those infected with MBTB126 (Fig. 4.12B).  
While it is important to repeat this experiment, initial results suggest that mmpS5 
has a reproducible growth defect in primary murine macrophages but does not have a 
growth defect in the organs of C57Bl/6 mice following a low-dose aerosol infection.  An 
mmps5 mutant has not previously been directly tested in macrophages or mice, but has 
been assayed in the pool of transposon mutants evaluated in the TRaSH studies, which 
allows prediction of the possible contribution the mmpS5 gene plays in mice and 
macrophages (77, 89).  While it seems odd that mmpS5::tn’blaTEM-1 had an intracellular 
growth defect but no defect in the animal model of tuberculosis, our results are consistent 
with TraSH.  The TraSH analysis of transposon mutants in pooled infections indicates 
that MmpS5 is important for growth in macrophages, but not in mice (77, 89).   
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Figure 4.12.  The mmpS5::tn’blaTEM-1 mutant was not attenuated in mouse lungs, 
and did not affect survival of infected animals. C57Bl/6 mice were infected with the 
indicated M. tuberculosis strains by aerosol delivery. A) At 1, 14, 25 and 79 days post-
infection, lungs of 4 infected animals per strain were homogenized, diluted and plated for 
resident CFU. Error bars indicate standard deviation.  B) Eight infected mice per strain 
were monitored for survival over the period of days indicated.   
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PpsB 
PpsB is one of the polyketide synthases responsible for extending lipid molecules 
on their way to becoming PDIM.  While other mutations in the PDIM locus have been 
tested for their importance in whole animal models of tuberculosis (19, 28, 81), a ppsB 
mutant has not previously been tested.  Our Tn’blaTEM-1 insertion presumably disables 
the majority of PpsB (Fig 4.11A).  We inoculated mice by aerosol with low doses of 
either the ppsB::tn’blaTEM- 1 mutant or MBTB126, and compared the course of disease 
in each group of mice as described above (Fig. 4.13). We found that organ burdens of the 
mutant strain were one log lower over a 79-day long infection period than that of the 
parent strain of M. tuberculosis.  Further, the mutant strain had approximately 1 log fewer 
bacteria disseminating from the lung to the liver and spleen than the parent strain (Fig. 
4.13).   
The importance of PDIM to pathogenesis was first shown in signature tagged 
mutagenesis experiments, where insertions in genes required for PDIM synthesis, 
modification or export result in mutants that are attenuated for growth in vivo (19, 28, 
81).  Insertion mutations in the fadD26 promoter (which would presumably disrupt 
transcription of all downstream pps genes and therefore does not make PDIM) result in 
reduced growth in mouse lungs over 3 weeks (18, 19, 28).  This fadD26 mutant also has a 
defect in persisting in the lung (81).  In our hands, the ppsB mutant strain did not have a 
similar persistence defect, as the bacterial populations in the lung remained at  
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Figure 4.13.  The M. tuberculosis ppsB::tn’blaTEM-1 mutant was attenuated for 
growth in mouse lung, liver and spleen following infection by aerosol.  C57Bl/6 mice 
were infected with approximately 102 CFU of M. tuberculosis MBTB126 or the 
ppsB::tn’blaTEM-1 mutant.  At 1 and 14 days post inoculation, lungs were removed from 
4 infected animals per strain per time point.  At 25 and 79 days, lungs, livers and spleens 
were removed.  At all time points, dissected organs were homogenized, diluted and plated 
for CFU.  Each time point represents data from 4 animals per strain. Error bars depict 
standard deviation.  *, p≤0.03. 
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approximately 1 log lower CFU than WT.  However, a persistence defect may have been 
observed if the organ burdens were determined at a later time point.  Based on previous 
work of others, reviewed above, we suspect our ppsB transposon mutant is not 
synthesizing PDIM, and the lack of PDIM is the most likely cause of the defective 
intracellular and in vivo growth phenotypes we observed. 
 
CONCLUSION 
 
 In this work, we constructed and utilized a new reporter transposon for large-scale 
identification of exported proteins in M. tuberculosis.  By combining the β-lactamase 
reporter of protein export with transposon mutagenesis of M. tuberculosis, we were able 
to establish the subcellular localization of 118 unique M. tuberculosis proteins and 
simultaneously collect a library of mapped mutants with insertions in the genes encoding 
these exported proteins for subsequent analyses.      
An important feature of our transposon-based reporter strategy is that it operates 
as a selection, not a screen.  Transposon insertions that result in exported ‘BlaTEM-1 
fusions will grow in the presence of β-lactam antibiotics.  Screening for an exported 
fusion phenotype is commonly required with the use of other reporters of protein export 
(16, 36, 58, 99) and is a much more labor-intensive approach.   To screen over 80,000 
Tn’PhoA insertions in the M. tuberculosis genome would have required at least 400 
plates, each with approximately 200 CFU for an average of <1 CFU per plate expressing 
a construct capable of exporting ‘PhoA.   Further, rigorously screening over 80,000 
transposon mutants individually for intracellular growth defects would have been 
impossible.  However, a positive selection that allowed us to collect a library of mutants 
lacking exported proteins made screening for phenotypes on an individual scale feasible.  
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Interestingly, all false positive carbenicillin resistant clones were obtained while 
troubleshooting our selection strategy.  Once our selection concentration of carbenicillin 
was optimized at 20 µg/ml, 100% of the carbenicillin resistant clones obtained had 
‘blaTEM-1 in frame with a gene predicted to encode an exported protein.  There was a 
potential to identify mutants that became spontaneously resistant to β-lactams due to 
Tn’blaTEM-1 insertion in genes that code for cell wall synthesis or maintenance 
components, as formation of the bacterial cell wall is the target of β-lactam attack  (109).  
However, we did not identify any transposon mutants that fell into this category.   
 Our β-lactamase fusions provided us with a powerful method to gain 
experimental evidence of the exported nature of individual proteins.  The exported 
fusions also helped to define the extracellular domains of integral membrane proteins.  
We obtained multiple insertions in some proteins with more than one TM domain.  By 
combining the information from algorithms that predict TM domains with the site of 
Tn’blaTEM-1 insertion, we could predict the location of extracellular domains for 
integral membrane proteins (Fig. 4.4).  The mapping of extracytosolic domains will be 
particularly useful in studying the many membrane proteins we identified that have no 
known function.  
Our first objective was to comprehensively identify the exported proteins of M. 
tuberculosis.  However, as with every strategy that uses whole genome approaches, we 
were not able to collect insertion mutants in every protein exported by the bacterium. 
Using a calculation based on a Poisson distribution (45), we calculate that our screen is 
not yet saturated, and one in every five carbenicillin resistant Tn’blaTEM-1 insertions 
identified in future rounds of selection will be in an exported ORF we have not yet 
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identified.  Also, because transposon insertion is a pre-requisite for our identification 
strategy, we could not select for exported proteins that are essential for growth – the 
genes that encode this class are predicted to make up approximately 20% of the genome 
(26, 88).  We also could only select for exported fusions that were expressed and 
exported under the experimental conditions used – growth on 7H10 agar with 20 µg per 
ml of carbenicillin at 37 ºC for 3-4 weeks. Additionally, we hypothesize that there is a 
suite of proteins exclusively expressed or exported when M. tuberculosis resides in the 
host.  Such proteins would be missed in our plate-based selections.   We are currently 
developing strategies to identify this subset of exported proteins (See Chapter 3).   
There are also likely to be several genes encoding exported proteins that, even if 
receiving an in-frame insertion, cannot code for active fusions because their products are 
not exported if fused to ‘BlaTEM-1.  The attachment of the β-lactamase moiety might 
block interactions with export machinery, or create a fusion that is too large to be 
exported. It is also possible that ‘BlaTEM-1 fusions to specialized export substrates are 
indeed exported, but not functional because they are not properly folded.  We had 
hypothesized that proteins exported by specialized transport pathways in M. tuberculosis 
could be discovered by our Tn’blaTEM-1 reporter system.  This β-lactamase reporter has 
been used in the past to report on the location of proteins exported by the Type III (23, 
62) and Type IV (32) specialized pathways in other pathogens.  Type III and IV secreted 
substrates lack classical signal sequences.  However, every exported ‘BlaTEM-1 fusion 
we identified was to a protein with a predicted Sec or Tat signal sequence or TM domain 
(Table 4.4 and Supplemental Table 4.1).  M. tuberculosis encodes at least two specialized 
export systems: SecA2 and ESX-1. These export pathways are required for M. 
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tuberculosis pathogenesis, and both export a small subset of proteins that lack N-terminal 
signal sequences (2, 79). To test whether the specialized systems of mycobacteria were 
capable of exporting substrates fused to ‘BlaTEM-1, we directly fused the ESX-1 
substrate ESAT-6 and the SecA2 substrate SodA to our β-lactamase reporter in different 
conformations.  None of the resulting fusions conferred resistance to β-lactams on plates 
when expressed in ΔblaC M. tuberculosis, despite being expressed in the bacilli as shown 
by immunoblot (data not shown).  Thus, we believe there are M. tuberculosis 
unconventional exported proteins that we will miss with our reporter transposon.  
Notably, when we found multiple mutants with Tn’blaTEM-1 inserted in the same 
gene, there was a strong likelihood of seeing the insertion at the identical position.  This 
was true in 27 out of 37 occurrences.  For example, we identified six identical insertions 
in six independent phage infections in the ORF encoding Rv3802c.  In fact, the majority 
of identical insertions were recovered from separate phage infections, which indicates 
they are not siblings but arose independently.  The only known requirement for Himar-1 
insertion is a TA dinucleotide recognition sequence.  We hypothesized that a potential 
reason for the recovery of repeat identical insertions was that not all TA sites in an ORF 
will allow ‘BlaTEM-1 to be expressed in frame with the fused exported protein.  
However, when we made in silico insertions in every TA site in rv3802c, approximately 
half would have led to in frame expression of ‘BlaTEM-1.  We did obtain active 
‘BlaTEM-1 fusions along the length of proteins, thus there is no obvious problem with 
fusing mature domains of exported proteins to this reporter.  However, a possible 
explanation for the identical repeat insertions is that the fused β-lactamase may, in some 
cases, inhibit proper folding of the fused protein which may block export.  Conversely, 
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the fused domain may inhibit folding of ‘BlaTEM-1, causing the enzyme to be inactive. 
Therefore, for some exported proteins, only certain fusions may allow detectable export 
of ‘BlaTEM-1 following transposition.  Inclusion of a flexible amino acid linker in front 
of and in frame with the reporter is a strategy we may use in designing similar reporter 
systems in the future.  A linker may allow ‘BlaTEM-1 and its fused protein to fold 
independently of each other, which could lead to the identification of more exported 
protein fusions 
 We screened our library of transposon mutants in exported proteins for the ability 
to grow in macrophages.  This identified eight transposon mutants with growth defects in 
macrophages over five days.  For four of these mutants, CtaC, Mce2F, PpsB and LppX, it 
was shown for the first time that they were important for intracellular growth.  Of the 
eight attenuated mutants, only PpsB, LppX and CtaC have a predicted function.  Future 
experiments will focus on complementing the mutant phenotypes and determining the 
molecular roles these exported proteins have in virulence. 
We hypothesized that transposon mutants with macrophage growth defects would 
have growth defects in the early phase of mouse lung infection, when macrophage 
replication is most evident (43).  Of the two mutants that we tested in mice, the ppsB 
mutant proved to be defective for growth in both models while the mmpS5 mutant did 
not.  The different results between the two mutants in animals was surprising because the 
ppsB mutant was not more attenuated in macrophages than the mmpS5 mutant; in fact, no 
Tn’blaTEM-1 mutant was statistically more attenuated for intracellular growth than any 
other (Fig. 4.5).  We conclude that a growth phenotype in cultured macrophages (a cell-
autonomous system) is not necessarily an indication that a particular mutant will be 
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unable to replicate in the more complex environment of the  mouse lung.  In reviewing 
the TraSH analysis data performed on M. tuberculosis mutants in macrophages and mice, 
there is also a subset of genes predicted as being required for growth in cultured 
macrophages that are not similarly predicted as being required in mice (77, 89).  The 
mmpS5 mutant is an example of one gene in this group and we obtained the same results 
in our testing of the mmpS5::tn’blaTEM-1 mutant in macrophages and mice (Figs. 4.8B 
and 4.12A).  It was proposed that this difference seen in the TraSH analysis may be due 
to the fact that TraSH mutants attenuated in mice were evaluated in spleen, not in lung, 
where macrophage replication is occurring initial exposure via the inhalation route (77).  
However, we evaluated our mmpS5 mutant in macrophages and in lung, and saw no 
attenuation in vivo.  There are also genes predicted by the TraSH studies as being 
defective in mice but not in macrophages – insertions in the mce4 operon fall into this 
category.  These mutants may represent ORFs that are not required in the early stages of 
infection, but are necessary for dissemination and persistence of the bacteria within the 
host.  Our results led us to conclude that we cannot assume that attenuation in cultured 
cells will translate into attenuation in vivo, and vice versa.  We hypothesize that the 
attenuation of particular mutants in macrophages may be masked by complex host-
mycobacterial interactions in vivo.  Therefore, we can use cell assays to identify 
macrophage responses that are specific to individual M. tuberculosis mutants. The 
characterization of phenotypes witnessed in small-scale macrophage culture will help our 
understanding of M. tuberculosis pathogenesis.  
Our screen for Tn’blaTEM-1 mutants with intracellular phenotypes complements 
the TraSH saturating mutagenesis infection assays performed in macrophages (77).  For 
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those mutants identified in both assays, our individual infections provide more detailed 
information about mutant phenotypes. However, the results from our screen and those 
obtained with TraSH pooled infection do not always agree.  One complication of the 
TraSH analysis is that a certain degree of background noise will always be associated 
with high-throughput hybridization-based strategies.  False positive and false negative 
results will occur (77, 89).   It is also possible that differences in site of insertion played a 
role in disparate observations between our mutant analysis and TraSH results. If the 
insertion sites for the TraSH mutants were available, it would be interesting to compare 
the sites of insertion.  Comparing sites of insertion could allow us to narrow down 
functional domains of a virulence factor.  Screening pools of mutants, as was done in 
TraSH, may accentuate phenotypes by competition – strains that grow only marginally 
slower may be outcompeted by more fit strains upon group infections.  This may explain 
why some ORFs predicted by TraSH as important in macrophages were not predicted by 
us to be important tested as a single mutant in isolation.  Finally, it must be emphasized 
that for both TraSH and our screening Tn’blaTEM-1 mutants, follow up 
complementation experiments are required to prove any ORF encodes a virulence factor.   
 The library of mapped mutants generated in this study is a useful tool for 
exploring the roles that M. tuberculosis exported proteins play in pathogenesis and host-
microbial interactions. In the future, this library can be further exploited to identify 
exported proteins required under different conditions.  For example, the library could be 
screened for mutants unable to survive in IFN-gamma activated macrophages, where the 
engulfed bacilli are subjected to upregulated antimycobacterial defenses (84, 106).  
Mutants unable to survive this attack will help to identify exported proteins specifically 
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required to protect intracellular bacilli after the onset of adaptive immunity.  The ability 
of this pathogen to block phagosome acidification and phagosome-lysosome fusion is a 
hallmark of M. tuberculosis virulence.  Our library of mutants could also be screened for 
those unable to halt phagolysosomal fusion or acidification to find exported proteins 
required for the prevention of this macrophage process.  
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Supplemental Table 4.1 Location of Tn’blaTEM-1 insertions resulting in carbenicillin 
resistance 
Rv number Gene Tn insert site (AA/Total AA) Export Signal† 
Prior Proof of 
Export# 
Rv0064  346/979 TM (8) (1, 6) 
Rv0064  347/979 TM (8) (1, 6) 
Rv0072**  199/349 TSP+TM(5)  
Rv0092 ctpA 204/761 TM (7)  
Rv0092 ctpA 204/761 TM (7)  
Rv0116c  90/251 SSP (6) 
Rv0125 pepA 228/355 SSP (1, 6) 
Rv0169* mce1A 449/455 TM (2) (2) 
Rv0170* mce1B 223/347 SSP (6) 
Rv0171* mce1C 221/516 SSP  
Rv0171* mce1C 512/516 SSP  
Rv0171* mce1C 252/516 SSP  
Rv0172* mce1D 67/531 SSP (6) 
Rv0173* lprK 209/391 LSP (6) 
Rv0174* mce1F 336/516 SSP (6) 
Rv0175* mce-assoc 203/214 TM (1)  
Rv0175* mce-assoc 203/214 TM (1)  
Rv0178* mce-assoc 171/245 TM (1)  
Rv0178* mce-assoc 171/245 TM (1)  
Rv0197 betP 375/594 TM (12)  
Rv0199*  74/220 TM (3)  
Rv0199*  74/220 TM (3)  
Rv0204c  52/413 TM (7)  
Rv0209*  133/362 TM (3)  
Rv0265c  42/331 TSP (6) 
Rv0312  492/621 TM (6)  
Rv0346c ansP2 117/488 TM (5)  
Rv0361*  163/276 TM (1)  
Rv0402c* mmpL1 816/959 TM (11) (6) 
Rv0402c* mmpL1 816/959 TM (11) (6) 
Rv0412c  370/440 TM (4-5)  
Rv0418 lpqL 29/501 LSP  
Rv0432 sodC 106/241 LSP  
Rv0450c* mmpL4 254/967 TM (12) (1) 
Rv0450c* mmpL4 212/967 TM (12) (1) 
Rv0450c* mmpL4 197/967 TM (12) (1) 
Rv0453* PPE11 20/519 TM (6) (6) 
Rv0483 lprQ 445/451 TSP  
Rv0483 lprQ 445/451 TSP  
Rv0483 lprQ 445/451 TSP  
Rv0483 lprQ 445/451 TSP  
Rv0506* mmpS2 29/148 TM (2) (6) 
Rv0506* mmpS2 29/148 TM (2) (6) 
Rv0517*  234/503 TM (10)  
Rv0534c menA 101/240 TM (7)  
Rv0583c* lpqN 34/229 LSP (6) 
Rv0594* mce2F 476/517 SSP  
Rv0676c* mmpL5 457/965 TM (12) (1) 
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Rv number Gene Tn insert site (AA/Total AA) Export Signal† 
Prior Proof of 
Export# 
Rv0677c* mmpS5 65/143 SSP (6) 
Rv0783c emrB 530/541 TM (13)  
Rv0837c**  184/343 TM (1)  
Rv0876c  449/549 TM (10) (6) 
Rv0931c pknD 592/665 TM (1)  
Rv0931c pknD 583/665 TM (1)  
Rv0934 pstSI 268/375 LSP (1, 6) 
Rv0983 pepD (mtb32b) 236/465 TM (2)  
Rv1004c**  417/420 TM (7)  
Rv1004c**  417/420 TM (7)  
Rv1009 rpfB 93/363 LSP  
Rv1078** pra 128/241 TM (3)  
Rv1096  288/292 SSP  
Rv1096  288/293 SSP  
Rv1157c*  173/372 SSP  
Rv1164 narI 156/247 TM (5)  
Rv1164  narI 156/247 TM (5)  
Rv1230c*  94/412 TM (4)  
Rv1230c*  94/412 TM (4)  
Rv1239c corA 351/367 TM (2)  
Rv1319c  80/535 TM (6)  
Rv1319c  80/535 TM (6)  
Rv1319c  80/535 TM (6)  
Rv1368 lprF 205/262 LSP  
Rv1419**  31/158 SSP (6) 
Rv1435c**  97/234 SSP+TM (2)  
Rv1567c**  17/111 TM (2)  
Rv1567c**  17/111 TM (2)  
Rv1591*  79/322 TM (4)  
Rv1591*  79/322 TM (4)  
Rv1591*  79/322 TM (4)  
Rv1635c*  224/557 TM (10)  
Rv1648**  221/269 TM (8)  
Rv1707*  378/487 TM (11)  
Rv1707*  28/487 TM (11)  
Rv1728c*  68/257 TM (2)  
Rv1728c*  68/257 TM (2)  
Rv1728c*  68/257 TM (2)  
Rv1728c*  68/257 TM (2)  
Rv1743 pknE 393/567 TM (1)  
Rv1774c* TB8.4 35/111 SSP (6) 
Rv1779c  140/598 TM (4)  
Rv1819c  240/640 TM (6)  
Rv1836c  507/678 TM (4)  
Rv1860* apa, mpt32 197/326 SSP (6) 
Rv1886c* fbpB (Ag85B) 274/326 SSP (1, 6) 
Rv1886c* fbpB (Ag85B) 274/326 SSP (1, 6) 
Rv1886c* fbpB (Ag85B) 201/326 SSP (1, 6) 
Rv1887*  294/380 TM (2) (1, 6) 
Rv1887*  294/380 TM (2) (1, 6) 
Rv1891*  70/136 SSP  
Rv1984c cfp21 160/218 SSP (6) 
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Rv number Gene Tn insert site (AA/Total AA) Export Signal† 
Prior Proof of 
Export# 
Rv2040c  245/307 TM (7)  
Rv2068c^ blaC 16/308^ TSP (6, 7) 
Rv2080** lppJ 167/188 LSP (6) 
Rv2091c*  121/245 TM (1)  
Rv2113*  333/398 TM (8)  
Rv2113*  333/398 TM (8)  
Rv2113*  333/398 TM (8)  
Rv2113*  333/398 TM (8)  
Rv2113*  333/398 TM (8)  
Rv2127 ansP1 446/490 TM (12)  
Rv2200c ctaC 351/364 TM (3) (6) 
Rv2200c ctaC 351/364 TM (3) (6) 
Rv2203*  88/231 TM (1)  
Rv2240c*  106/266 TM (3)  
Rv2240c*  106/266 TM (3)  
Rv2240c*  106/266 TM (3)  
Rv2240c*  106/266 TM (3)  
Rv2264c  517/593 SSP+TM (1)  
Rv2284 lipM 30/432 LSP  
Rv2284 lipM 236/432 LSP  
Rv2290** lppO 55/172 LSP (3) 
Rv2290** lppO 55/172 LSP (3) 
Rv2290** lppO 55/172 LSP (3) 
Rv2290** lppO 55/172 LSP (3) 
Rv2290** lppO 55/172 LSP (3) 
Rv2301 cfp25,cut2 25/231 SSP (6) 
Rv2320c rocE 384/477 SSP+TM (10)  
Rv2339* mmpL9 409/963 TM (12)  
Rv2394 ggtB 576/644 TM (4)  
Rv2394 ggtB 576/644 TM (4)  
Rv2395  20/223 TM (16)  
Rv2443 dctA 124/492 TM (9)  
Rv2443 dctA 124/492 TM (9)  
Rv2585c  53/588 LSP (6) 
Rv2599**  110/144 SSP  
Rv2639c  40/111 TM (4)  
Rv2721c*  407/700 TM (2) (6) 
Rv2905* lppW 263/315 LSP (6) 
Rv2905* lppW 31/315 LSP (6) 
Rv2932 ppsB 614/1557 TM (6)  
Rv2938  drrC 67/277 TM (6)  
Rv2945c** lppX 82/234 LSP (1, 5, 6) 
Rv3036c TB 22.2 47/228 SSP (6) 
Rv3090**  64/296 SSP  
Rv3103c**  38/146 TM (1)  
Rv3209*  161/187 SSP  
Rv3209*  74/187 SSP  
Rv3209*  74/187 SSP  
Rv3209*  74/187 SSP  
Rv3253c  49/496 TM (12)  
Rv3253c  56/496 TM (12)  
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Rv3350c* 
    PPE56 
932/3717 TM (30-79)  
Rv number Gene Tn insert site (AA/Total AA) Export Signal† 
Prior Proof of 
Export# 
Rv3267  458/499 SSP (1, 6) 
Rv3390* lpqD 39/237 LSP  
Rv3390* lpqD 149/237 LSP  
Rv3413c*  187/300 TM (1)  (6) 
     
Rv3476c kgtP 265/450 TM (11)  
Rv3484 cpsA 347/513 SSP+TM (1) (6) 
Rv3494 mce4F 539/565 TM (5)  
Rv3496c mce4D 38/452 TM (1)   
Rv3496c mce4D 38/452 TM (1)   
Rv3497c mce4C 345/358 SSP+TM (1)  
Rv3497c mce4C 260/358 SSP+TM (1)  
Rv3498c mce4B 350/351 SSP  
Rv3584* lpqE 143/183 LSP (6) 
Rv3689*  384/452 TM (6)  
Rv3779**  616/667 TM (13)  
Rv3802c  336/336 SSP  
Rv3802c  336/336 SSP  
Rv3802c  336/336 SSP  
Rv3802c  336/336 SSP  
Rv3802c  336/336 SSP  
Rv3802c  336/336 SSP  
Rv3835  385/449 TM (2) (6) 
Rv3835  385/449 TM (2) (6) 
Rv3861**  467/481 TM (1)  
Rv3901c**  57/150 SSP  
Rv3910  1075/1185 TM (15)  
Rv3910   1075/1185 TM (15)  
 
† As predicted by the bioinformatic algorithms identified in Materials and Methods.  Abbreviations:  AA, 
amino acid; SSP, Sec signal peptide; TSP, Tat signal peptide; LSP, lipoprotein signal peptide; TM (#), 
transmembrane domains [number predicted by TMHMM (8) and TMPred (4)].  
*, Loci with at least 30% similarity at the amino acid level found only in mycobacteria 
**, Loci with at least 30% similarity at the amino acid level found only in the virulent Mycobacterium 
species M. avium, M. bovis, M. leprae, M. marinum, M. tuberculosis or M. ulcerans 
^, Tn’blaTEM-1 was inserted immediately downstream of a portion of the BlaC signal sequence that 
remains after deletion of the majority of the blaC coding region.  
#, References that describe export of respective ORF are numbered in parentheses. 
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CHAPTER 5 
 
 
 
DISCUSSION 
 
 Mycobacterium tuberculosis is the causative agent of tuberculosis, arguably the 
most successful bacterial disease in the history of mankind.  Despite the fact that 
tuberculosis is a curable disease, an estimated 2 billion people are infected by M. 
tuberculosis, and the disease kills nearly 2 million people each year (56).  To cause 
disease, the bacterium must survive and replicate in macrophages - a cellular 
environment normally hostile to invading bacteria.  M. tuberculosis manipulates 
macrophage responses to prevent its own destruction.  The bacilli also protect themselves 
against attack mounted by the innate immune response (42, 43, 54).  As is true for other 
bacterial pathogens (17), M. tuberculosis exported proteins play central roles in 
promoting pathogen survival in the host.   
In this thesis research the overarching goal was to identify exported proteins of M. 
tuberculosis and determine if they play roles in virulence.  The unifying theme 
throughout this dissertation is the development and application of new genetic reporter 
systems to identify M. tuberculosis exported proteins.  In Chapter 2, the primary 
objective was to identify the substrates of the conserved Tat export pathway of M. 
tuberculosis.  Chapter 3 describes our efforts to create a genetic tool that could be used to 
report on M. tuberculosis proteins exported by intracellular bacilli.   Finally, the focus of 
Chapter 4 was to identify M. tuberculosis exported proteins important for growth in 
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macrophages on a genome-wide scale.  In this Discussion, I briefly review the results of 
this thesis research in the context of M. tuberculosis research as a whole.  I will also 
discuss potential future experiments that will take advantage of these new genetic tools. 
 
Identification of functional Tat signal sequences in M. tuberculosis proteins 
As discussed in Chapter 2, our first major objective was to identify substrates of 
the Twin-Arginine Translocation (Tat) pathway in M. tuberculosis.  The Tat pathway has 
an important role in virulence for other bacterial pathogens (7, 9, 15, 22, 40) .  
Mycobacteria possess a functional Tat pathway, and the M. tuberculosis β-lactamase 
BlaC is a Tat substrate (28, 32).  Further, phospholipase C (Plc) enzymes, which are 
known M. tuberculosis virulence factors, have functional Tat signal sequences in their N-
termini (28, 29, 33).  Therefore, evidence exists that the Tat pathway in M. tuberculosis is 
also important for virulence.  We hypothesized that the Tat pathway exports additional 
proteins with roles in pathogenesis and sought to identify these proteins.  It would be 
ideal to investigate the role of the Tat pathway by analyzing the phenotypes of M. 
tuberculosis Δtat deletion strains.  However, the Tat pathway is essential (44) in M. 
tuberculosis, which makes using Δtat mutants to investigate the effect of the Tat pathway 
on virulence not an option.  It should be noted that the essentiality of the Tat pathway 
makes its components attractive targets for new anti-tuberculosis therapies.  
We set out to identify proteins exported by the Tat pathway in M. tuberculosis 
using an alternative genetic approach.  Using ‘BlaC, as a reporter specific for Tat 
exported substrates, we selected ORFs that possess functional Tat signal sequences from 
a M. tuberculosis genomic library.  In this work, exported fusions were identified by 
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selecting β-lactam resistant colonies following electroporation of the M. tuberculosis-
‘blaC library into M. smegmatis.  This is the first time any Tat-specific reporter was used 
in a positive selection strategy to identify proteins with Tat signal sequences.  Prior to 
these studies, there were only predictions of potential M. tuberculosis Tat substrates 
based on bioinformatic algorithms (2, 31, 38).   These algorithms are trained using known 
and predicted Tat substrates from a limited number of bacterial species, which notably 
does not include mycobacteria.  In comparison, our approach was an unbiased way of 
identifying M. tuberculosis sequences able to export a Tat specific reporter.   
We identified 13 M. tuberculosis signal sequences capable of exporting ‘BlaC in a 
Tat specific manner.  The above mentioned Tat prediction algorithms identified 95 
potential Tat substrates in M. tuberculosis.  However, only 10 unique Tat signal 
sequences were identified in our library.  The additional three were demonstrated as able 
to export ’BlaC by directly fusing the Tat export signal to ‘BlaC and testing for β-lactam 
resistance on plates when the fusion is expressed in M. smegmatis.   One of these 13 
proteins was not predicted by any algorithm to be a Tat substrate, indicating that the 
unbiased library approach was useful in identifying new M. tuberculosis Tat substrates. 
Further, our ‘BlaC reporter was recently used by another laboratory to demonstrate that 
four more potential M. tuberculosis proteins possess functional Tat signal sequences (26).     
There was little overlap in the number of Tat-exported proteins predicted by three 
different algorithms.  Experimentally evaluating potential Tat substrates is therefore 
critical, and will help to hone the criteria these algorithms use to identify Tat exported 
proteins from primary sequence.  An unanticipated pitfall of this strategy was that ‘BlaC 
was only exported and active when fused directly downstream of the cleavage site of Tat 
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signal sequences.  This requirement likely reflects the fact that Tat substrates must be 
folded in the cytoplasm before they are exported (14).  While the algorithms may 
overestimate the number of Tat substrates that are actually found in M. tuberculosis, the 
requirement for Tat signal sequences to be positioned immediately adjacent to the ‘BlaC 
mature protein domain is at least partly responsible for the small number of potential Tat 
substrates we identified.  Extended mature sequence of a foreign protein may interfere 
with proper folding of ‘BlaC, and cause the protein to be degraded before it could be 
exported.  Another possibility is that improperly folded hybrids may have been exported 
as inactive fusions.  Thus, even though our goal was to comprehensively identify M. 
tuberuclosis proteins exported by the Tat pathway, there are likely more substrates 
encoded in the genome that we missed with our strategy.  It may be worthwhile to revisit 
the library design and optimize it so that smaller genomic fragments, likely to contain a 
signal sequence only, would be inserted downstream of a promoter and upstream of 
‘blaC.  In this manner, we may be able to experimentally identify more Tat substrates of 
M. tuberculosis.  The addition of a sequence encoding a flexible amino acid linker 
upstream of ‘blaC in the library vector may also allow for a wider range of fusions to 
drive export of the reporter in a Tat dependent manner.  A linker between fused sequence 
and ‘BlaC may allow the reporter to fold independently of the Tat sequence driving its 
export, increasing the number of detectable exported fusions. 
Besides BlaC itself and the Plc enzymes, the substrates identified have amino acid 
sequence similarity  to redox proteins, substrate-binding proteins involved in nutrient 
uptake and lipases.  Aside from Plc, we have not yet shown that the respective full-length 
proteins have roles in pathogenesis or are exported exclusively through the Tat pathway 
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in M. tuberculosis.  However, two of the substrates are predicted to be essential for in 
vitro growth of the bacilli, providing some clues as to why the Tat pathway components 
cannot be deleted in M. tuberculosis (44, 45).  Further characterization of each substrate 
will be required to determine their dependence on the Tat pathway for export as well as 
their potential roles in virulence.  
 
β-lactamase can function as a reporter of bacterial protein export during M. 
tuberculosis infection of host cells 
In Chapter 3 of this dissertation, I describe the development of a β-lactamase 
reporter for general protein export that can be used when fused to substrates of Sec and 
Tat export pathways in mycobacteria.  Established reporters for studying export of M. 
tuberculosis proteins, such as alkaline phosphatase (5, 23) and staphylococcus nuclease 
(16) have drawbacks; they report on protein export based on labor intensive colony 
phenotype screens, and can not be used directly in M. tuberculosis due to endogenous 
activity in the pathogen.  Our β-lactamase reporter is derived from standard cloning 
vectors and has been successfully used in the past to report on the subcellular localization 
of proteins exported by both conserved and specialized pathways in bacteria (8, 10, 12, 
25).  We developed a system that allows us to identify colonies expressing M. 
tuberculosis reporter fusions using a selection, not a screen.  We obtained the β-lactam 
sensitive ΔblaC M. tuberculosis mutant from a collaborator (18), and used it prove that a 
heterologous β-lactamase lacking its own signal sequence, ‘blaTEM-1, could be 
expressed and exported by mycobacterial Tat and Sec signal sequences directly in M. 
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tuberculosis.  Further, unlike fusions to ‘BlaC, fusion of mature domains from foreign 
proteins fused to ‘BlaTEM-1 did not interfere with export or activity of the reporter.  
Strategies previously used to identify exported proteins of M. tuberculosis have 
always been conducted with in vitro grown bacilli (5, 16, 39, 49).  This is true for the 
library approach described in Chapter 2 of this dissertation, as well as for the transposon 
reporter approach described in Chapter 4.  We hypothesize that there is a set of proteins 
only expressed or exported inside host cells and that these proteins, which are the best 
candidates for being virulence factors, are overlooked by evaluation of in vitro grown 
bacteria.  Even for more genetically tractable intracellular bacterial pathogens, this is a 
challenging category of virulence factors to identify.  Importantly, we demonstrate in 
Chapter 3 that when M. tuberculosis is growing in host cells, ‘BlaTEM-1 still works to 
report on export.  Intracellular bacilli expressing a signal sequence-‘BlaTEM-1 fusion are 
protected from β-lactam treatment (27).  In the future, a potential use for this reporter is 
to identify those proteins exclusively exported in macrophages.  The strategy outlined 
below is one way we could work to achieve this goal.  A library of M. tuberculosis 
genomic fragments fused to the ‘blaTEM-1 reporter will be constructed.  The resulting 
plasmid library will be electroporated into ΔblaC M. tuberculosis, and transformants 
would be pooled and used to infect macrophages or mice.  Following uptake of the 
bacilli, infected macrophages or animals will be treated with β-lactam antibiotic.  
Intracellular M. tuberculosis not expressing an exported fusion should be sensitive to β-
lactam treatment and fail to grow.  However, strains in the library pool exporting a 
‘BlaTEM-1 fusion will grow and become enriched during the intracellular infection.  
Surviving strains would then be tested for their ability to survive on plates in the presence 
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of β-lactam.  The fusions of interest would be expressed and exported in vivo, and would 
therefore allow for survival during intracellular β-lactam treatment but not during in vitro 
β-lactam exposure.   Following rounds of infection where strains surviving infection in β-
lactam treated macrophages are used to re-infect β-lactam treated macrophages or mice, 
we should selectively enrich for those strains exporting fusions within macrophages.  The 
fusions that are recovered should identify new proteins exclusively exported in vivo.  
Such proteins are strong candidates for being virulence factors.  The Tat-specific ‘BlaC 
reporter could also be used in a similar assay to find Tat-dependent proteins only 
exported in vivo.  However, because the ‘BlaTEM-1 reporter works with protein fusions 
that drive export via both the Tat and Sec pathways of mycobacteria, a second Tat-
specific reporter might not be required.  If this strategy is successful, it may be widely 
applicable to the identification of in vivo exported proteins in other intracellular 
pathogens.  
Future use of the β-lactamase reporter might also include subcellular localization 
of M. tuberculosis exported proteins within infected macrophages.  We could use 
commercially available anti-‘BlaTEM-1 antibodies in an immunoelectron microscopy 
assay to localize intracellular M. tuberculosis exported protein fusions to the reporter.  
Another possibility is to use the reporter in conjunction with an intracellular  β-lactamase 
substrate that becomes fluorescent when cleaved.  The substrate, CCF2 (57), has been 
used in the past to show translocation of Type III and type IV secreted bacterial effector 
‘BlaTEM-1 fusions into host cells (10, 12, 25).  Upon translocation of an active bacterial 
protein-‘BlaTEM-1 fusion into host cytoplasm, the CCF2 is cleaved and becomes 
fluorescent.  The fluorescence is then detected by microscopy or plate reader. There are at 
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least three examples of M. tuberculosis proteins exported out from the bacilli to the 
phagosomal membrane and beyond.  The translocation of these proteins from within the 
intracellular bacterium to the host phagosomal membrane or cytoplasm is detected by 
immunoelectron microscopy (3, 13, 55).  Using a fluorescent substrate, it could one-day 
be possible to screen a library for M. tuberculosis ‘BlaTEM-1 fusions exported into the 
cytoplasm of infected macrophages. Exported proteins of interest could also be directly 
fused to the ‘BlaTEM-1 reporter and their intracellular location examined.  Some 
modifications to the CCF2 system are required before it can be used to directly detect M. 
tuberculosis proteins exported beyond the phagosome.  At this point in time, the CCF2 
substrate appears to permeate the entire host cell, including the phagosome.  Thus, all 
exported M. tuberculosis exported proteins fused to the reporter are likely to cleave the 
substrate, including those that never transit beyond the phagosomal membrane.  Live M. 
tuberculosis must be manipulated under biosafety level 3 (BL3) conditions.  Therefore, 
the analysis requires a fluorescence microscope in the BL3 laboratory.  Alternatively, the 
CCF2 detection protocol must be made compatible with the fixation conditions used to 
kill intracellular M. tuberculosis before it is taken out of BL3 containment.  
 
Development of a reporter transposon to identify exported virulence factors in M. 
tuberculosis  
Finally, we constructed a β-lactamase reporter transposon for identifying exported 
proteins encoded throughout the genome of M. tuberculosis.  The use of a reporter 
transposon is a powerful and classic strategy, but existing reporter transposons are not 
useful in M. tuberculosis due to endogenous activity.  We built a new genetic tool to 
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allow this type of investigation to be conducted directly in the pathogenic bacillus.  Many 
exported proteins are only predicted as such on the basis of bioinformatic algorithms.  
Further, much of the M. tuberculosis genome has no predicted function, and proof of 
export will help to define function for these proteins.  Even for those well-established 
exported M. tuberculosis proteins, there are very few with directly demonstrated 
functions in pathogenesis.   
We placed ‘blaTEM-1 in a Himar-1 transposon.  We chose this transposon 
backbone because it has been successfully used in other saturating mutagenesis strategies 
in M. tuberculosis.   Transposon insertions that placed ‘blaTEM-1 downstream and in 
frame with an export signal in the M. tuberculosis genome resulted in production of a 
protein- β-lactamase fusion.  Export of these fusions led to β-lactam resistance on plates.  
Using the Tn’blaTEM-1 reporter transposon we built, we could positively select for in-
frame insertions that lead to the export of M. tuberculosis-‘BlaTEM-1 fusion proteins.  
Our goal was to comprehensively identify the exported proteins encoded by the 
M. tuberculosis genome.  It is predicted that 15-20% of the proteins encoded by M. 
tuberculosis are exported (11).  This would equate to approximately 800 proteins.  If 20% 
of these proteins are essential (21, 45), we predict there should be 640 proteins potentially 
identifiable with Tn’blaTEM-1.   Here, we identified 118 unique exported proteins.  
However, a Poisson calculation predicts that even after selecting from over 81,000 
transposon mutants, there is still a 20% chance of identifying new exported ORFs if we 
continued this project (20).   We also predict that there is a set of exported proteins 
incapable of transporting active ‘BlaTEM-1.  We had hypothesized that the ‘BlaTEM-1 
reporter would also be compatible with substrates of mycobacterial specialized export 
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pathways such as ESX-1 (1) and SecA2 (37).  However, we did not identify any of these 
proteins with our Tn’blaTEM-1 selection strategy.  In fact, every protein identified with 
the reporter appears to be a classical exported protein in either possessing an N-terminal 
Sec or Tat-type signal sequence or TM domain.   
We went on to directly test the feasibility of using ‘BlaTEM-1 to report on 
translocation of unconventional exported proteins.  We directly fused ESX-1 substrate 
ESAT-6 (19, 50) to either the N- or C- termini of ‘BlaTEM-1 and were unable to detect 
export.  ESAT-6 is known to form tight heterodimers with CFP-10, another small protein 
exported by the ESX-1 pathway (6, 30, 35, 36, 48, 50).  These dimers form prior to and 
are likely required for export of both binding partners.  The fusion to ‘BlaTEM-1 fusion 
coudl have blocked this dimerization.   The ‘BlaTEM-1 reporter also did not work when 
fused to SodA, a SecA2 exported protein (4).  Thus, these specialized export mechanisms 
are likely to be incompatible with the ‘BlaTEM-1 reporter.  To our knowledge, no 
reporter fusion has been successfully used to identify the subcellular location of any 
specialized secretion pathway substrate of M. tuberculosis.  
 Using our reporter transposon, we identified 118 exported proteins of M. 
tuberculosis.  An attribute of our strategy is that the reporter is carried on a transposon.  
Thus, while identifying exported proteins, we simultaneously constructed a mapped 
library of M. tuberculosis transposon mutants lacking individual exported proteins.  We 
screened our library for mutants for growth defects in resting macrophages, and identified 
eight attenuated mutants.   
 Four of the eight attenuated mutants, mce2F::tn’blaTEM-1, lppX::tn’blaTEM-1, 
ppsB::tn’blaTEM-1 and ctaC::tn’blaTEM-1, had insertions in ORFs never before shown 
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to be important for growth in macrophages.  For the other four mutants, 
mce1A::tn’blaTEM-1, mce1B::tn’blaTEM-1, rv0199::tn’blaTEM-1 and 
mmpS5::tn’blaTEM-1, the ORFs receiving insertions are predicted to be important for 
growth in macrophages in large-scale pooled infections (34, 46, 51).  None of these 
mutants had previously been tested individually for the ability to grow in macrophages.  
Three of the eight respective ORFs have a predicted function, the other five do not.  
Further characterization of the eight attenuated mutants we identified must be prioritized.  
It would be interesting to first focus on Rv0199.  It is restricted to mycobacteria, and is in 
a genetic locus that is predicted to be required for intracellular and in vivo growth  (46, 
51).  Genetic complementation and aerosol infection of mice are two assays that could be 
done immediately to better characterize the role of Rv0199 in pathogenesis.  
We can further analyze our library of mutants in ways that can help determine the 
function of M. tuberculosis exported proteins in virulence.  When resting macrophages 
engulf M. tuberculosis, the bacillus prevents acidification of the phagosomes in which 
they reside (54).  The ability to block phagosome acidification is believed to be important 
to M. tuberculosis growth in macrophages.  Activation of macrophages in culture by 
addition of IFNγ results in phagosome-lysosome fusion, acidification of the M. 
tuberculosis containing phagosome, and inhibition of intracellular M. tuberculosis growth 
(24, 47, 52, 53).  Recently, an M. tuberculosis pH sensitive mutant was tested for its 
ability to grow in activated macrophages.  This M. tuberculosis mutant is killed in 
activated macrophages while WT M. tuberculosis persists (52).  Along these lines, our 
Tn’blaTEM-1 mutant library could next be screened for strains that are defective for 
survival in activated macrophages.  The ability of M. tuberculosis to survive acidic 
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intracellular conditions is considered an important virulence mechanism for the bacillus, 
and this set of proteins may make attractive drug targets.   Another virulence trait of M. 
tuberculosis is its ability to persist long after the onset of adaptive immunity following 
infection (41).  This type screen may also help identify exported proteins important for 
M. tuberculosis persistence.  
At the start of this work, we were interested in exported proteins because of their 
potential role in virulence, but had no genetic tools that could be used to identify and 
inactivate them directly in M. tuberculosis.  In this thesis, we demonstrate that β-
lactamase reporters are tools we previously lacked for characterization of the suite of M. 
tuberculosis exported proteins.  Along with providing valuable information on the 
exported nature of 118 M. tuberculosis proteins, the reporter systems in themselves 
provide a valuable resource to the M. tubercuosis research community, where useful 
genetic tools are comparatively few.   Future studies will expand on this work by 
exploiting the reporters and the Tn’blaTEM-l library to identify proteins exported by the 
bacilli in host cells, as well as those required for intracellular defenses against 
macrophage attack.  A better understanding of M. tuberculosis exported proteins will 
ultimately reveal the ways in which this pathogen interacts with the host to cause disease.   
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